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To screen for novel ribosomally synthesised antimicrobials, in-silico genome 
mining was performed on all publically available fully sequenced bacterial 
genomes by December, 2009. Using the nisin biosynthetic enzymes as driver 
sequences, 49 novel type 1 lantibiotic clusters were identified from a number of 
species, genera and phyla not usually associated with lantibiotic production. The 
prevalence of these clusters, and individual and random ORFs, indicates that 
these antimicrobial genes are more widespread than previously thought.  
 Traditional fermented beverages which have also been a source of 
antimicrobial producers have been developed by many different societies and 
are believed to confer health benefits on the consumer. Functional foods are a 
growing sector of the food industry, and there is a desire to develop traditional 
fermented beverages as functional beverages, including their application as 
non-dairy probiotic delivery systems, for this market. A crucial step towards 
commercialisation is the characterisation of the microbial content of these 
traditional beverages. To achieve this goal, we applied next-generation 
sequencing techniques to analyse the bacterial and yeast populations of the 
organic, symbiotically-fermented beverages kefir, water kefir and kombucha. 
Kefir, a milk-based beverage, is fermented by a complex association of bacteria 
and yeast which are contained within a polysaccharide matrix, which takes the 
form of kefir ‘grains’. These grains and fermentates were shown to contain 
different bacterial populations, in that Lactobacillus dominate in the grain, and 
Lactococcus are the most abundant genus in the milk. Levels of Acetobacter 
varied, and Leuconostoc levels increased from grain to milk. The fungal 
component was dominated by the yeast Kazachstania, Naumovozyma and 
 iv 
Kluyveromyces. A number of minor components were also revealed, many of 
which had not previously been associated with kefir. Water kefir is similar in 
concept to milk kefir, in that symbiotic grains are responsible for fermentation. 
These grains are composed of dextran, and the medium that is fermented is a 
sucrose/water solution. The dominant microorganism in each of the grains and 
fermentates was Zymomonas, an ethanol-producing bacterium that had not 
previously been detected on such a scale. Other genera present included LAB 
and acetic acid bacteria. It was established that the fungal component was 
composed of Dekkera, Hanseniaspora, Saccharomyces, Zygosaccharomyces, 
Torulaspora and Lachancea.  The final fermented beverage investigated, 
kombucha, is a fermented, tea-based beverage, with the associated 
microorganisms contained within a cellulosic pellicle that floats above the 
fermentate. The bacterial portion, long thought to be composed of Acetobacter, 
was shown to be dominated by Gluconacetobacter. In addition, there was a 
significant abundance of Lactobacillus. The yeast populations were found to be 
dominated by Zygosaccharomyces. Both water kefir and kombucha also 
contained a number of trace microorganisms which had not been discovered 
previously in these beverages. These studies represent the most accurate 
description of these populations to date, and should aid in future starter design 
and in determining which species are responsible for specific attributes of the 
beverages. 
Finally, high-throughput robotics was applied to screen for the presence 
of antimicrobial producers associated with these beverages. This revealed a low 
frequency of bacteriocin production amongst the bacterial isolates, with only 
 v 
lactococcins A, B and LcnN of lactococcin M being identified. However, a 
proteinaceous antimicrobial produced by the yeast Dekkera bruxellensis, 
isolated from kombucha, was found to be active against Lactobacillus 
bulgaricus. Partial purification determined the compound to be negatively 
charged, active in a pH range of 3-8 and to have a mass >30 kDa. SDS-PAGE 
analysis revealed the presence of 5 proteins, indicating more than one protein 
may be involved in antimicrobial production, and that further purification is 
necessary. Ultimately, the fungal component of these beverages may merit 
further attention with respect to the identification of antimicrobial producers.  
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1.1 ABSTRACT 
As a consequence of their frequently high potency, their gene-encoded nature 
and the rarity with which resistance occurs, post-translationally modified, 
ribosomally synthesized, antimicrobial peptides are viewed as having 
considerable potential as novel chemotherapeutic agents. Perhaps the best 
studied of these modified antimicrobial peptides are the lantibiotics which are 
distinguished by the fact they contain the unusual, modified amino acids, 
lanthionine and β-methyllanthionine. Traditional approaches to lantibiotic 
discovery have involved the use of well-diffusion, deferred antagonism as well 
as broth/photometric-based assays. However, these have been supplemented 
with strategies that involve the use of high-throughput technologies, PCR-based 
detection, engineering of known lantibiotics and in-silico mining. Here we 
review the strategies that have been successfully employed to identify novel 
lantibiotics and other modified, ribosomally synthesized antimicrobial peptides.  
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1.2 Introduction 
This chapter describes the different strategies that can be, and have been, 
employed to identify/create novel post-translationally modified, ribosomally-
synthesized antimicrobial peptides. These are peptides which are first 
synthesized as immature peptides which then undergo enzyme-mediated, post-
translational modification and the cleavage of a N-terminal leader region to 
form fully-functional, mature peptides. In recent years the number of such 
antimicrobials has increased noticeably through the identification of novel 
forms of well-known families, such as the lantibiotics, and the inclusion of 
additional families of antimicrobials, such as the cyanobactins, thiopeptides, 
microviridins and amatoxins. Some of these are thought to be viable 
alternatives to the antibiotics which are currently employed clinically and, 
indeed, it is hoped that their use could stave off the issues arising as a 
consequence of resistance to existing antimicrobials. Here we will review the 
strategies employed to identify a representative, and possibly the most 
extensively studied, family of modified antimicrobial peptides, the lantibiotics, 
and highlight how these have been and can be applied to screen for other 
modified peptides. 
 
1.3 The lantibiotics 
Bacteriocins are small, heat-stable antimicrobial peptides, produced by bacteria, 
and are typically active against species closely related to the producer, but can 
also exhibit activity across genera. Bacteriocin producers are naturally immune 
to their own bacteriocins as a consequence of possessing specific self-protective 
 - 4 - 
mechanisms. There are a wide range of existing and potential commercial and 
medicinal applications for these peptides. Due to the continuous discovery of 
novel antimicrobial peptides, one of the original bacteriocin, and highly cited, 
classification systems, devised by Klaenhammer (Klaenhammer, 1993) to classify 
bacteriocins produced by Gram positive, lactic acid, bacteria, has undergone 
several revisions. The most recent classification (Rea et al., 2011) represents an 
updating of a system proposed by Cotter et al (Cotter et al., 2005b) and 
recommends that Gram positive bacteriocins, and indeed bacteriocins in 
general, could be divided into 2 Classes, consisting of Class I, the post-
translationally modified bacteriocins, and Class II, the unmodified bacteriocins. 
Class I Gram positive bacteriocins can be subdivided into 3 groups, (a) the 
lantibiotics/lantipeptides, (b) the labrinthopeptides and (c) the sactibiotics, 
although further groups are likely to be ultimately added. These can be further 
subdivided according to amino acid composition and the number of peptides 
involved. Gram positive bacteriocins from within Class II can be divided into 4 
groups, which can also be further subdivided (Rea et al., 2011) (Figure 1a).  
 The lantibiotics/lantipeptides, i.e. Class Ia bacteriocins, which are the 
primary focus of this manuscript contains 4 subgroups. Types 1 and 2 are the 
lantibiotics (so named because they are lanthionine-containing antibiotics) 
while types 3 and 4 are the bacteriocin-like lantipeptides. The generic name 
given to lantibiotic structural prepropeptides is LanA. These are gene-encoded 
(by lanA) and undergo subsequent modification via cleavage of a N-terminal 
leader region (required for export and directing post-translational modification)  
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Figure 1 
A. The Classification of Gram-positive bacteriocins  
B. The enzyme-mediated synthesis of the lantibiotic subtilin 
(i) Lanthionine dehydratase (LanB) catalyses the dehydration of Serine and Threonine residues 
to form Dha and Dhb respectively  
(ii) Lanthionine synthetase (LanC) catalyses a condensation reaction between the sulphydryl 
group of cysteines and the dehydrated residues 
(iii) Following the cleavage of the leader peptide by LanP, LanT transports the mature peptide 
across the cell membrane 
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and the modification of the C-terminal (propeptide) region. The modifications 
which are specifically associated with this family of peptides occur as follows; 
specific serine and threonine residues contained within the propeptide are 
dehydrated to form dehydroalanine and dehydrobutyrine, respectively. When 
these modified residues interact with an intrapeptide cysteine, a thioether bond 
is formed resulting in the formation of the eponmymous amino acids, 
lanthionine (Lan, from Dha) or β-methyl lanthionine (meLan, from Dhb), 
respectively (Figure 1b). These structures play a critical role in the antimicrobial 
activity of the peptides such as, in the case of the prototypical type 1 lantibiotic, 
nisin, facilitating the binding to a lipid II target (Hsu et al., 2004).  
Similarly, the contribution of these structures to the resistance of 
lantibiotics to high temperature and proteolytic enzymes is also apparent (Suda 
et al., 2010). The distinction between type 1 and type 2 lantibiotics is based on 
the modification enzymes involved. Type 1 peptides are modified by two 
catalytic enzymes i.e. LanB, a lanthioine dehydratase, and LanC, a lanthionine 
synthetase. Type 2 lantibiotics are modified by LanM enzymes which perform 
both the dehydratase and cyclase functions. The lanM/lanBC genes are the 
most highly conserved genes within lantibiotic gene clusters; a trait which has 
been utilized, through the use of degenerate primers and in-silico screens to 
identify novel lantibiotic-encoding clusters (see below). The type 1 and 2 
lantibiotics can be further subdivided on the basis of homology with respect to 
the amino acid sequence of the prepropeptide. There also exist a number of 
two-peptide lantibiotics i.e. lantibiotics which are active through the combined 
activity of two lanthionine-containing peptides (Lawton et al., 2007b). 
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The aforementioned nisin is currently the best studied of all bacteriocins 
and has been used as a food preservative in over 50 countries. However, as a 
consequence of the emergence of microbial resistance to therapeutic 
antibiotics, there have been a number of investigations into the use of nisin and 
novel lantibiotics against clinically relevant pathogens. This stems from the fact 
that the antimicrobial activity of lantibiotics can be greater than that of classical 
antibiotics and the fact that they can target very sensitive components of the 
bacterial cell, such as the aforementioned lipid II. To date, approximately 60 
lantibiotics have been isolated from Gram positive bacteria (Firmicutes and 
Actinobacteria) (Table 1). Although the majority of these have been identified 
using traditional bioactivity-based screens, we are at the dawn of a new age in 
technological advancements, in which in-silico, molecular and bioengineering-
based approaches can complement and, potentially ultimately supersede, the 
reliable but increasingly out-dated, culture-based methods employed for 
lantibiotic discovery. Here we review the use of these various approaches 
(Figure 2).  
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 Table 1. The screening method and source employed to discover known lantibiotics  
 
Lantibiotic  Producer Class/Group Mode of Discovery  Strain Source Reference  
Nisin A Lactococcus lactis Type 1, Nisin Group  Incidental (Observed Inhibition) Dairy Culture (Whitehead 1933)  
Nisin Z Lactococcus lactis Type 1, Nisin Group  Not Specified  Not Specified  (Mulders et al., 1991) 
Nisin F Lactococcus lactis Type 1, Nisin Group  Overlay Assay  Fresh Water Catfish 
Faeces  
(de Kwaadsteniet et al., 
2008) 
Nisin U Streptococcus 
uberis 
Type 1, Nisin Group  Deferred Antagonism Assay Not Specified  (Wirawan et al., 2006) 
Nisin U2 Streptococcus 
uberis 
Type 1, Nisin Group  Deferred Antagonism Assay Not Specified  (Wirawan et al., 2006) 
Nisin Q Lactococcus lactis Type 1, Nisin Group  Not Specified  Hikosan River Water  (Zendo et al., 2003) 
Lacticin NK34 Lactococcus lactis Type 1, Nisin Group  Lawn Spotting Korean Fermented Fish 
(Jeotgal) 
(Lee et al., 2008) 
Subtilin Bacillus subtilis Type 1, Nisin Group  Incidental (Observed Inhibition)  Not Specified  (Jansen and Hirschmann, 
1944) 
Ericin (A and S) Bacillus subtilis Type 1, Nisin Group  Not Specified  Not Specified  (Stein et al., 2002) 
Entianin Bacillus subtilis Type 1, Nisin Group  Microtiter Autoinduction 
Bioassay 
Tunisian Desert (Fuchs et al., 2011) 
Microbisporicin Microbispora 
corallina 
Type 1, Nisin Group  High-throughput Screen  Uncommon 
Environmental 
Actinomycetes 
(Castiglione et al., 2008) 
Planosporicin Planomonospora 
alba 
Type 1, Nisin Group  High-Throughput Screen  Uncommon 
Environmental 
Actinomycetes 
(Castiglione et al., 2007) 
Clausin  Bacillus clausii Type 1, Epidermin Group  Not Specified  Not Specified  (Bouhss et al., 2009) 
Staphylococcin T Staphylococcus 
cohnii 
Type 1, Epidermin Group Not Specified  Human Throat (Furmanek et al., 1999) 
Epidermin Staphylococcus 
epidermidis 
Type 1, Epidermin group Not Specified  Not Specified (Allgaier et al., 1986) 
Gallidermin  Staphylococcus 
gallinarum 
Type 1, Epidermin group Not Specified  Chicken Crests  (Kellner et al., 1988) 
Mutacin I Streptococcus 
mutans 
Type 1, Epidermin group Stab Assay Several (Streptococcus 
Mutans)  
(Hamada and Ooshima, 
1975) 
Mutacin III Streptococcus 
mutans 
Type 1, Epidermin group Not Specified  Caries-Active Female (Qi et al., 1999) 
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 Table 1. The screening method and source employed to discover known lantibiotics  
 
Lantibiotic  Producer Class/Group Mode of Discovery  Strain Source Reference  
Mutacin 1140 Streptococcus 
mutans 
Type 1, Epidermin Group Deferred Antagonism Assay Not Specified  (Hillman et al., 1998) 
Mutacin B-Ny266 Streptococcus 
mutans 
Type 1, Epidermin group Deferred Antagonism Assay Not Specified  (Morency et al., 1995) 
Staphylococcin AU-26 Staphylococcus 
aureus 
Type 1, Epidermin Group Deferred Antagonism Assay Vagina (Scott et al., 1992)  
BSA  Staphylococcus 
aureus 
Type 1, Epidermin Group In-Silico CA-MRSA Isolates (Daly et al., 2010) 
Streptin Streptococcus 
pyogenes 
Type 1, Streptin group Molecular Not Specified  (Karaya et al., 2001) 
Pep5  Staphlyococcus 
epidemidis 
Type 1, Pep5 Group  Deferred Antagonism Assay Not Specified  (Kellner et al., 1989) 
Epicidin 280 Staphlyococcus 
epidemidis 
Type 1, Pep5 Group  Not Specified Not Specified (Heidrich et al., 1998) 
Epilancin K7 Staphlyococcus 
epidemidis 
Type 1, Pep5 Group  Not Specified Human Nasal Cavity  (Pulverer and Jeljaszewicz, 
1975) 
Epilancin 15X Staphlyococcus 
epidemidis 
Type 1, Pep5 Group  Not Specified Wound Infection (Ekkelenkamp et al., 2005) 
Salivaricin 9  Streptococcus 
salivarius 
Type 2, Lacticin 481 Group In-Silico  Not Specified  (Wescombe et al., 2011) 
Lacticin 481 Lactococcus lactis Type 2, Lacticin 481 Group Spot Assay Dairy (Picard et al., 1990) 
Thermophilin 1277 Streptococcus 
thermophilus 
Type 2, Lacticin 481 Group Not Specified Raw Milk (Kabuki et al., 2007) 
Bovicin Hj50 Streptococcus 
bovis 
Type 2, Lacticin 481 Group Agar Well Diffusion Assay Raw Milk (Xiao et al., 2004) 
Macedocin Streptococcus 
macedonicus 
Type 2, Lacticin 481 Group Well Diffusion/Overlay Assays Greek Kasseri Cheese (Georgalaki et al., 2000) 
Butyrivibriocin AR10 Butyrivibrio 
fibrisolvens 
Type 2, Lacticin 481 Group Deferred Antagonism Assay   Rumen (Kalmokoff and Teather, 
1997) 
Ruminococcin A 
(RumA/B) 
Ruminococcus 
gnavus 
Type 2, Lacticin 481 Group Not Specified  Male Gut Flora (Ramare et al., 1993) 
Variacin  Micrococcus 
varians 
Type 2, Lacticin 481 Group Well Diffusion Method Salami  (Pridmore et al., 1996) 
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 Table 1. The screening method and source employed to discover known lantibiotics  
 
Lantibiotic  Producer Class/Group Mode of Discovery  Strain Source Reference  
Streptococcin A-FF22 Streptococcus 
pyogenes 
Type 2, Lacticin 481 Group Deferred and Simultaneous 
Antagonism Assays 
Patient Throat Cultures (Tagg et al., 1973) 
Butyrivibriocin 
OR79A/OR79B 
Butyrivibrio 
fibrisolvens 
Type 2, Lacticin 481 Group Deferred Antagonism Assay   Dairy Cow Rumen (Kalmokoff et al., 1999) 
Mutacin II Streptococcus 
mutans 
Type 2, Lacticin 481 Group Deferred Antagonism Assay   Saliva of Healthy 
Children 
(Novak et al., 1994) 
Mutacin K8 
(mukA123+A') 
Streptococcus 
mutans 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Not Specified  (Robson et al., 2007) 
Salivaricin A1 Streptococcus 
pyogenes 
Type 2, Lacticin 481 Group Molecular (Hybridization) Oral Strain  (Simpson et al., 1995) 
Salivaricin A Streptococcus 
pyogenes 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Oral Strain  (Ross et al., 1993) 
Salivaricin A2 Streptococcus 
salivarius 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Human Saliva (Hyink et al., 2007) 
Salivaricin B Streptococcus 
salivarius 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Human Saliva (Hyink et al., 2007) 
Salivaricin A2/3/4/5 Streptococcus 
rattus 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Human Saliva (Wescombe et al., 2006)  
Nukacin ISK-1 Staphylococcus 
warneri 
Type 2, Lacticin 481 Group Not Specified  Nukadoko, Fermented 
Rice Bran 
(Kimura et al., 1998) 
Nukacin 3299 Staphylococcus  
simulans 
Type 2, Lacticin 481 Group Deferred Antagonism Assay Bovine Mastitis Cases  (Nascimento et al., 2002) 
Nukacin KQU-131 Staphylococcus 
hominis 
Type 2, Lacticin 481 Group Not Specified  Thai Fermented Marine 
Fish 
(Wilaipun et al., 2008) 
Mersacidin Bacillus sp Type 2, Mersacidin Group Not Specified  Indian Soil Sample  (Chatterjee et al., 1992) 
Plantaricin-C Lactobacillus 
plantarum 
Type 2, Mersacidin Group Deferred Antagonism/Well 
Diffusion Assay 
Fermentations 
(Without Starter 
Cultures) 
(Gonzalez et al., 1994) 
Michiganin A Clavibacter 
michiganensis 
Type 2, Mersacidin Group Not Specified  Plant Pathogen  (Holtsmark et al., 2006)  
Actagardine Actinoplanes 
liguriae 
Type 2, Mersacidin Group Not Specified  Indian Garden Soil (Parenti et al., 1976) 
Ala (0) - Actagardine  Actinoplanes 
liguriae 
Type 2, Mersacidin Group Not Specified  Not Specified  (Vertesy et al., 1999) 
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 Table 1. The screening method and source employed to discover known lantibiotics  
 
Lantibiotic  Producer Class/Group Mode of Discovery  Strain Source Reference  
Deoxyactagardine B 
(DAB) 
Actinoplanes 
liguriae 
Type 2, Mersacidin Group Molecular (Hybridization) Not Specified  (Boakes et al., 2010) 
Smb (SmbA/B) Streptococcus 
mutans 
Type 2, LtnA2/Mersacidin Molecular  Oral Strain  (Yonezawa and Kuramitsu, 
2005) 
Plantaricin W (Plwa/b) Lactobacillus 
plantarum 
Type 2, Mersacidin/LtnA2 Not Specified  Wine (Pino Noir)  (Holo et al., 2001) 
Staphylococcin C55 
(C55α/β) 
Staphylococcus 
aureus 
Type 2, Mersacidin/LtnA2 Lawn Spotting/CFU Counts  Superficial Skin Lesions  (Dajani and Wannamaker, 
1969)  
Haloduracin (BhaA1/A2) Bacillus 
halodurans 
Type 2, Ltn α In-Silico  Soil (Lawton et al., 2007a) 
(Mclerren et al., 2006) 
Lichenicidin (BliA1/A2) Bacillus 
licheniformis 
Type 2, Ltn α In-Silico  Not Specified  (Begley et al., 2009) 
Lacticin 3147 (Ltnα/β) Lactococcus lactis Type 2, Mersacidin/Ltn α Incidental (Observed Inhibition) Cheese Culture (Ryan et al., 1995) 
Cytolysin Ll/Ls Bacillus 
halodurans 
Type 2, Cytolysin Group Deferred Antagonism Assay Not Specified  (Brock and Davie) 
Lactocin-S Lactobacillus sakei Tyoe 2, Lactocin S Group Deferred Antagonism Assay Fermented Dry Sausage (Mortvedt and Nes, 1990) 
Cinnamycin Streptoverticillum 
griseoverticillatum 
Type 2, Cinnamycin Group Not Specified  Japenese Soil (Benedict et al., 1952) 
Duramycin A Streptomyces 
cinnamomeus 
Type 2, Cinnamycin Group Not Specified    Not Specified (Shotwell et al., 1958) 
Duramycin B Streptomyces 
griseoverticillatus 
Type 2, Cinnamycin Group Phospholopase A  Inhibitor 
Screen 
Not Specified  (Fredenhagen et al., 1990) 
Duramycin C Streptomyces 
griseoluteus 
Type 2, Cinnamycin Group Phospholopase A  Inhibitor 
Screen 
Not Specified  (Fredenhagen et al., 1990) 
Ancovenin Streptomyces sp. Type 2, Cinnamycin Group Enzyme Inhibitor Screen  Tokyo Soil Sample (Kido et al., 1983) 
Carnocin UI49 Carnobacterium 
sp. 
Not Determined Spot Assay Fresh Fish (Stoffels et al., 1992) 
Paenibacillin  Paenibacillus 
polymyxa 
Not Determined Deferred Antagonism Assay 
(Filter Membranes)  
Fermented Foods  (He et al., 2007) 
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Figure 2 
Methods used to screen for novel peptides. These include traditional culture-
based analyses such as well diffusion, deferred antagonism and broth assays, 
bioengineering and other molecular approaches such as PCR, mutagenesis and 
in-silico mining.  
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1.4 Traditional (culture-based) screening methods 
The first historical report of bacteriocin production dates to 1877 when Pasteur 
and Joubert (Pasteur and Joubert, 1877) noticed that bacteria isolated from 
urine samples inhibited Bacillus anthracis. This was followed in 1925 by a report 
prompted by the observation that species of Escherichia coli inhibited the 
growth of one another. A 1928 study of the limiting factors in lactic 
fermentation concluded that cell inhibition was “determined by the 
concentration of a definite, soluble and diffusible substance excreted by the 
cells”. Similarly, in 1933, Whitehead, by process of elimination, deduced that 
the inability of a certain milk sample to accommodate the growth of starter 
lactic acid bacteria was due to a proteinaceous, heat stable, inhibitory 
substance produced by two strains of streptococci (since re-classified as 
lactococci) found in the original milk sample (Whitehead, 1933). This substance 
was later named nisin (Mattick and Hirsch, 1947).  
Despite the technological revolution which has occurred in the 
intervening years, the majority of lantibiotics have been identified using 
methods that are not extensively dissimilar from those employed in the early 
years of lantibiotic research and which rely on identifying the ability of one 
bacterial strain (producer) to inhibit the growth of another (indicator). However, 
rather than its identification as a consequence of the coincidental observation 
of antimicrobial activity, as was the case for nisin, the identification of novel 
antimicrobials using this strategy has most frequently been as a result of 
purpose-built screens employing specific techniques and numerous bacterial 
species. These can be performed in a variety of ways. One of the most common 
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of these traditional approaches is the deferred antagonism assay. This involves 
pipetting a set volume of the producer strain onto the appropriate agar, and 
following incubation, semi-molten agar seeded with an indicator organism is 
then overlaid. An alternative is the agar well diffusion assay. In this case, the 
appropriate molten agar is inoculated with indicator cells. This is allowed to cool 
before wells are bored. To each well, cell-free supernatant from the producer 
microorganism or purified peptide is added and, after appropriate incubation 
(to allow growth of the indicator and diffusion of the antimicrobial), 
antimicrobial activity can be assessed. 
Broth/photometric-based assays can also be employed. Here, the 
indicator strains are inoculated into broth and cell free supernatant from the 
producer organism or purified peptide is added prior to incubation. After a 
period of time, cell density is measured using, for example, an absorbance plate 
reader, revealing if the growth of the indicator culture has been inhibited. With 
the exception of standardized assays, such as those recommended by the 
National Committee for Clinical Laboratory Standards for minimum inhibitory 
concentration determination (Marshall et al., 1996), the specific details as to 
how agar and broth-based assays are carried out can vary from laboratory to 
laboratory. Regardless of these variations, a significant limitation of these 
functional assays is that novel lantibiotic producers may be overlooked if the 
parameters employed, such as pH, incubation temperature, time of incubation, 
carbohydrate source and indicator strain selection, are not optimal. Once 
antimicrobial activity is detected and revealed, through the use of proteases 
such as proteinase K, pepsin, trypsin and α-chymotrypsin, to be proteinaceous 
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in nature, the next step most frequently involves efforts to purify the peptide, 
most frequently via high-performance liquid chromatography (HPLC) coupled 
with mass spectrometry. The family of antimicrobials to which the inhibitor 
belongs can be definitively established through nuclear magnetic resonance 
(NMR) spectroscopy, although other efforts to elucidate the amino acid 
sequence of the peptide, through N-terminal peptide sequencing or mass 
spectrometry, can be valuable. The availability of data with respect to the 
amino acid sequence (or partial amino acid sequence) of the peptide can in turn 
also enable the identification of the gene cluster of interest through reverse 
genetics or upon genome sequencing of the strain. 
Culture-based approaches have facilitated the identification of novel 
lantibiotic producers from a variety of sources such as milk, fermented foods, 
oral cavities, faecal samples and soil. The frequent use of a starting material 
that possesses a diverse microbiota stems from the supposition that microbes 
that need to compete in such environments are most likely to be antimicrobial 
producers. While here we provide just a few, select, examples, the source of 
other lantibiotic-producing bacteria is collated in Table 1. Ryan et al. (Ryan et 
al., 1996) chose to screen lactococci isolated from kefir grains with the intention 
of finding a Lactococcus capable of producing a potent bacteriocin. It was 
anticipated that such a strain could be used commercially as a starter strain that 
more successfully control spoilage and pathogenic microbes in food 
fermentations. It was hypothesised that kefir grains could be a rich source of 
bacteriocin-producing lactococci in that, while kefir grains contain a rich 
microbiota that is chiefly composed of yeast and lactobacilli, lactococci 
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predominate in kefir-fermented milk. Ultimately, a number of antimicrobial-
producing lactococci were isolated, including strain DPC 3147 which was 
ultimately found to be the producer of a two-peptide lantibiotic, named lacticin 
3147. This lantibiotic has since become one of the most extensively studied 
lantibiotics (Carroll et al., 2010, Cotter et al., 2006, Draper et al., 2009, Gardiner 
et al., 2007). The discovery of the lantibiotic butyrivibriocin AR10 stemmed from 
the study of bacteria isolated from the rumen of cattle (Kalmokoff and Teather, 
1997). The rumen is the primary site of microbial fermentation of ingested feed 
in cattle, and both the rumen and ruminal fluid are known to have an inhibitory 
effect on nonruminal bacteria. 49 isolates of Butyrivibrio fibrisolvens, and a 
single isolate of Butyrivibrio crossotus, were isolated from the rumen and their 
ability to produce antimicrobials was assessed using a deferred antagonism 
assay, using other Butyrivibrio as indicators. 25 isolates were shown to produce 
inhibitory agents, of which 18 were sensitive to protease digestion. The 
antimicrobial produced by one such isolate was chosen for purification and 
further analysis which culminated in the identification of butyrivibriocin AR10, 
the first ruminal anaerobe-associated bacteriocin (Kalmokoff and Teather, 
1997).  
Humans can also host many lantibiotic producers. Indeed, 
staphylococcin Au-26 was characterized from a vaginal isolate of Staphylococcus 
aureus after a study was initiated following the observation that vaginal S. 
aureus associated with toxic-shock syndrome (TSS) were producers of 
bacteriocins (Scott et al., 1992). It was postulated that this antimicrobial may 
confer a competitive advantage to the infectious bacteria over the indigenous 
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flora of lactobacilli and so a deferred antagonism test procedure was carried out 
using endocervical lactobacilli as indicators, which resulted in the isolation of S. 
aureus strain 26 and the associated lantibiotic, staphylococcin Au26 (Scott et al., 
1992). Interestingly, the same lantibiotic was also associated with many 
community-associated methicillin-resistant S. aureus (CA-MRSA) isolates (Daly 
et al., 2010). Finally, soil has also proven to be a rich repository for producers of 
lantibiotics and it is from this source that ancovenin, mersacidin and 
actagardine (Chatterjee et al., 1992, Kido et al., 1983, Parenti et al., 1976) were 
identified. Ancovenin was discovered while screening 5,200 samples for 
microbial enzyme inhibitors. Ancovenin was purified from the culture broth of 
Streptomyces sp. No. A647P-2, a strain isolated from a soil sample collected in 
Tokyo and was initially indentified on the basis of its specific inhibitory action 
against angiotensin I converting enzyme (ACE) rather than as a consequence of 
possessing antimicrobial activity (Kido et al., 1983).  
More recently, efforts have been made to scale up the processes 
involved in culture-based screening for antimicrobials. The lantibiotics 
planosporicin and microbisporicin were found as a direct result of a biological 
activity-guided high-throughput screening (HTS)-based strategy designed to 
target novel peptidoglycan biosynthesis inhibitors (Castiglione et al., 2007, 
Castiglione et al., 2008). This HTS approach relied on the use of robotics to 
investigate 40,000 actinomycetes isolated from the environment, which were 
then fermented to yield a library of 120,000 broth extracts. The initial step of 
the antimicrobial activity assay was to assess the ability of the extracts to inhibit 
the growth of S. aureus (in its cell wall-deficient state) in liquid microplate 
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assays. The next stage was to disregard those extracts likely to be antimicrobials 
that had already been characterised i.e. β-lactam antibiotics and glycopeptides. 
These were eliminated through assays with a β-lactamase cocktail or through 
use of a D-Ala-D-Ala affinity resin, respectively. This resulted in the identification 
of 5 novel lantibiotics, including the aforementioned planosporicin and 
microbisporicin (Castiglione et al., 2007, Castiglione et al., 2008). Notably, 
microbisporicin was subsequently found to have a wide antimicrobial spectrum, 
being active against many of the Gram-positive species of medical significance 
and against some Gram negative pathogens (Castiglione et al., 2008), making it 
one of the most potent lantibiotics identified to date.  
 
1.5 Molecular screening methods 
The second half of the 20th century saw the advent of molecular genetics, which 
had revolutionised many biological fields. Its relevance to the identification and 
creation of novel peptides lies in its ability to detect and manipulate genes and, 
consequently, gene products. Polymerase Chain Reaction (PCR) coupled with 
gene sequencing have been particularly valuable tools with respect to the 
detection of novel lantibiotic-encoding operons and will be discussed here. The 
manipulation of genes using PCR-mediated approaches is also relevant and will 
be discussed later in this review.   
A representative example of the use of PCR to identify a novel 
lantibiotic-encoding cluster was provided during the recent discovery of the 
type 2 lantibiotic Salivaricin 9 (Wescombe et al., 2011). During the course of 
previous studies it had been established that Streptocccus salivarius strain 9 
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produces the lantibiotic SalA4 (Wescombe et al., 2006). However, it was soon 
realized that this was not the only antimicrobial produced by the strain. Using 
degenerate primers designed to bind to and amplify regions conserved across 
all lanMs, the lanM associated with Salivaricin 9 biosynthesis was found to be 
present on the genome of S. salivarius strain 9. Inverse PCR was then used to 
amplify and sequence the region around lanM. Percentage similarities to 
previously sequenced genes/gene products were determined using Basic Local 
Alignment Search Tool (BLAST), an alignment program which compares base-
pair similarities of sequences against sequence databases. In this way, the 
sequenced 6277 bp region was shown to contain genes characteristic of a 
lantibiotic operon, including a structural gene and regulatory elements. It 
should be noted, however, that subsequent culture-based approaches were 
required to confirm that a novel antimicrobial was indeed produced (Wescombe 
et al., 2011) and to determine its antimicrobial spectrum.  
Similar, degenerate primer-based approaches have been employed to 
facilitate the identification of the gene clusters associated with the production 
of Smb (Yonezawa and Kuramitsu, 2005) and BHT-A (Hyink et al., 2005). It is also 
noteworthy that an alternative set of degenerate lanM primers has recently 
been designed to reflect the availability of an even larger collection of lanM 
sequences (O'Sullivan et al., 2011). A corresponding approach, using lanB and 
lanC degenerate primers pairs, led to the identification of the gene cluster 
associated with the type 1 lantibiotic, Nisin U (Wirawan et al., 2006). The 
degenerate primer pairs were designed on the basis of conserved amino acid 
sequences within the LanBs of streptin, pep5, nisin, epidermin, epicidin, and 
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subtilin, while the lanC primers were constructed on the basis of conserved 
regions within the corresponding LanC proteins as well as that associated with 
salivaricin A production (Wirawan et al., 2006). Despite the success of these 
approaches they have not, to date, been employed as part of high-throughput 
PCR-based approaches to identify novel lantibiotic-associated clusters from 
collections of strains.  
A quite different molecular tool has been employed in the past to 
identify novel producers of the lantibiotic nisin from human milk (Beasley and 
Saris, 2004). This took advantage of the fact that, in addition to being an 
antimicrobial peptide, nisin is also an auto-inducer of its own production 
(Chandrapati and O'Sullivan, 1999). The milk was initially screened using an agar 
diffusion test, where milk was spotted onto Luria-Bertani (LB) agar, and overlaid 
with a Micrococcus luteus indicator. 20 colonies producing zones of inhibition 
were selected and their identity was determined by partial 16S rRNA 
sequencing. It was found that the strains isolated were representatives of L. 
lactis subsp. lactis and, as a consequence of the identity of the microbes, it was 
suspected that they might be producers of nisin. However, characterisation of 
the strains revealed them to be quite different from nisin-producing strains 
previously isolated from cows’ milk. To establish that the antimicrobial activity 
observed was indeed due to nisin production, a microplate assay designed to 
detect nisin, on the basis of the fusion of a nisin-inducible promoter to a gene 
encoding a green fluorescent protein reporter (Reunanen and Saris, 2003), was 
used. Ultimately, these investigations indicated that approximately 30% of 
human breast milk contains nisin-producing bacteria.    
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1.6 Bioinformatic approaches 
As a consequence of the advent of next-generation sequencing technologies, 
the number of bacterial genome sequences available has increased 
dramatically. Many of these genome sequences are freely available and 
accessible via online databases and can be mined for particular genes, including 
bacteriocin-encoding gene clusters, and their predicted products. The benefits 
from this approach with respect to lantibiotic discovery have been highlighted 
on a number of occasions in recent years. Indeed, although approximately 60 
lantibiotics have been discovered to date, this number is greatly enhanced 
when in-silico identified lantibiotics are included in this estimate. 
Some of the first studies to use a bioinformatic approach to identify 
novel bacteriocin-associated genes led to the identification of a gene cluster 
encoding the two-peptide class 2 lantibiotic, haloduracin, within the genome of 
Bacillus halodurans C-125. These genes were identified on the basis of the 
homology between the predicted prepropeptides encoded and those of the 
prototypical two peptide lantibiotic, lacticin 3147, and the related one peptide 
lantibiotic, mersacidin (McClerren et al., 2006, Twomey et al., 2002). Analysis of 
the remainder of the gene cluster revealed the presence of two lanMs, a lanT 
(transporter-encodin gene) and two sets of lanEFG genes (encoding ABC 
transporters potentially involved in immunity). The lantibiotic encoded by these 
genes was accessed through the in vitro reconstitution of lantibiotic synthesis 
(McClerren et al., 2006) and through studies with the C-125 strain and 
associated cell-free supernatant (Lawton et al., 2007a). This approach has since 
been used on an even larger scale to reveal additional type 2 gene clusters 
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(Begley et al., 2009). In this case computational analyses was carried out to 
search bacterial genome sequences for genes potentially encoding homologs of 
the lacticin 3147 modification enzyme, LtnM1. This resulted in the generation of 
a list of 89 relevant genes. Notably, 61 of these were predicted to be produced 
by strains not previously thought to be lantibiotic producers and 5 
representatives were selected for detailed bioinformatic analysis. One 
associated strain, Bacillus licheniformis ATCC 14580, was selected for wet-lab 
investigations which led to the discovery of lichenicidin, a two-peptide 
lantibiotic which exhibits antimicrobial activity against Listeria monocytogenes, 
MRSA and vancomycin-resistant enterococcus.  
Inspired by the discovery of lichenicidin, a more recent in-silico search 
was undertaken to identify additional novel LanM homologs in DNA databases 
(O'Sullivan et al., 2011). LtnM1 was again used as a driver sequence to mine 
publically available microbial genomes and by this time the number of LanM-
encoding genes had increased to 124. In this instance 9 genes, and associated 
clusters, were subjected to an in-depth bioinformatic analysis. In addition, the 
metagenomic portal CAMERA (Seshadri et al., 2007) was used to search for 
LtnM1 homologs amongst all publicly available metagenomic datasets, which 
revealed a further 11 lanMs associated with lantibiotic gene clusters from a 
number of diverse environments (O'Sullivan et al., 2011).  
A corresponding study has utilized the nisin modification enzymes, NisB 
and NisC, as driver sequences to identify novel type 1 lantibiotics (Marsh et al., 
2010). In total, 49 previously unrecognised lantibiotics were uncovered in the 
genomes of microbes isolated from a variety of environments, such as deep sea 
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hydrothermal vents, the soil, the gastrointestinal tract and skin surfaces. 
Notably, the microbes in question included those from phyla (Bacteroidetes and 
Chylamydiae) not previously associated with the production of lantibiotics. The 
availability of this data again facilitated the identification of common motifs and 
residues while also permitting phylogenetic analysis and the construction of 
evolutionary trees which highlighted phylogenetic relatedness and diversity 
(Marsh et al., 2010).  
The mounting interest in the discovery of new bacteriocins utilizing the 
ever-expanding database of genomic information is also reflected by the 
development of the web-based bacteriocin genome mining tool, namely BAGEL 
(de Jong et al., 2006) and the updated BAGEL 2 (de Jong et al., 2010). BAGEL can 
identify novel bacteriocin clusters using knowledge-based bacteriocin databases 
and motif databases and also analyses the sequence surrounding the gene of 
interest for bacteriocin-associated proteins (transporters, immunity genes etc). 
Importantly, open reading frame detection acts independently of existing 
annotations and therefore can detect small structural peptides that may 
otherwise be overlooked. A theoretical drawback is that reliance on motifs will 
only uncover bacteriocins sharing homology with those already described. It 
should be noted that the association between gene clusters identified in-silico 
and lantibiotic production is putative until such time as antimicrobial activity is 
confirmed through analysis of the strain in question or heterologous expression 
of the relevant genes in an appropriate host (Majchrzykiewicz et al., 2010). 
However, the studies that have taken place to date indicate the usefulness of 
these approaches.  
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It is also notable that the popularity of bacteriocins is such that a 
database has been generated which is dedicated to the organization of 
bacteriocin-related data from the literature. This database, known as 
BACTIBASE, contains information relating to these bacteriocins, including 
calculated or predicted structural and physiochemical properties of bacteriocins 
produced by Gram positive and Gram negative bacteria (Hammami et al., 2010). 
 
1.7 Bioengineering of lantibiotics 
An alternative approach to the identification of novel lantibiotics involves the 
generation of peptides with enhanced antimicrobial activities. The fact that 
bacteriocins are gene-encoded facilitates the use of bioengineering to generate 
novel derivatives which are, in essence, novel bacteriocins. This contrasts with 
the situation with the majority of ‘classical’ antibiotics which are non-ribosomal 
and are synthesized by multi-enzyme complexes in the absence of a specific 
structural precursor, thus making genetic manipulation more challenging.  
The tolerance of lantibiotics to change is evident from nature in that 
natural variants of lantibiotics can exist. Nisin is a prime example in that the 
nisin family includes nisin A, nisin Z, nisin Q, nisin F, nisin U and nisin U2, 
although in the latter two cases the peptides differ more substantially from 
nisin A and their description as nisin variants is debatable (Piper et al., 2010). 
Over the past 20 years there have been several efforts to harness this tolerance 
of change to generate lantibiotic derivatives with enhanced functionalities. Site 
directed mutagenesis of lantibiotics was employed for the first time in 1992 
(Kuipers et al., 1992, Liu and Hansen, 1992) and has since produced a plethora 
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of information concerning residue function, composition and enzyme activity, 
which has been invaluable to advancements in lantibiotic engineering and, 
indeed, lantibiotic research in general. The first example of the bioengineering 
of a lantibiotic to enhance activity relates to the nisin-like lantibiotic, subtilin 
(Liu and Hansen, 1992). Subtilin is a type 1 lantibiotic produced by Bacillus 
subtilis and the bioengineering thereof was facilitated by the replacement of 
the spaS gene on the chromosome by an engineered version using double cross-
over homologous recombination. Using this approach, a mutant, in which the 
fourth residue, glutamate, was replaced with isoleucine, displayed enhanced 
activity with respect to preventing the spore outgrowth of Bacillus cereus T 
spores.  
Similar strategies have been employed on a number of occasions since 
this time which, although being a relatively time-consuming process, can result 
in a strain that can be regarded as being non-GM (genetically modified) once 
used in a contained manner (Sybesma et al., 2006; see http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:125:0075:0097:EN:PDF) 
In trans complementation and heterologous production approaches have also 
been frequently employed and can be more rapid but result in the strains losing 
their non-GM status. While these strategies have been employed to generate a 
considerable number of lantibiotic derivatives, many of which have been of 
considerable fundamental value (Cortes et al., 2009, Cotter et al., 2005a, Field 
et al., 2010), here we focus solely on those novel engineered peptides that 
exhibit enhanced functionalities. In this regard, a number of studies have 
highlighted the merits of manipulating a three amino acid stretch (Asn20-
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Met21-Lys22) located at the centre of the nisin propeptide (NisA), which 
functions as a hinge around which the receptor binding N-terminus and pore-
forming C-terminus rotate. Site-specific mutagenesis has shown that this hinge 
region plays a vital role in affording nisin the conformational plasticity required 
for antimicrobial activity (Yuan et al., 2004). Changes to this region conferred 
properties including improved stability at higher temperatures, and neutral or 
alkaline pH, in addition to greater solubility. Furthermore, two peptides with 
enhanced potency (N20K nisinZ and M21K nisinZ) against Gram negative targets 
Shigella, Pseudomonas and Salmonella, were identified. Unfortunately, 
however, these mutants displayed reduced activity compared to the wild type 
peptide against non-pathogenic Gram positive targets such as Micrococcus 
flavus and Streptococcus thermophilus, (Yuan et al., 2004) (Figure 3). Although 
the activity of these peptides is below that required for commercial and clinical 
use or is against non-pathogenic targets, these findings were nonetheless of 
great significance.  
The importance of these hinge residues has also been highlighted using 
a non-targeted approach, i.e., from screening of a large bank of producers 
(8,000) of randomly altered nisin peptides (altered to ensure a frequency of 1-3 
mutations within the gene; Field et al., 2008). Although a similar approach had 
been taken previously (Spee et al., 1993), the bank of strains created on that 
previous occasion was relatively small. Following extensive randomization 
(through use of a DNA polymerase that incorrectly incorporated nucleotides 
during PCR), Field and co-workers specifically looked for producers exhibiting 
enhanced activity against pathogens, and ultimately coupled this approach with 
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site-directed and site-specific saturation mutagenesis to uncover a number of 
peptides with improved activity against Gram positive pathogens of clinical or 
food relevance. More specifically, initial screening revealed that a strain 
producing a nisin variant in which a K22T change had occurred in the hinge 
region displayed increased activity against the mastitic pathogen Streptococcus 
agalactiae. This prompted further site-directed and site-saturation mutagenesis 
of the three hinge residues. Site-saturation mutagenesis is an approach 
whereby a bank of derivatives (or producers thereof) is created in which the 
amino acid located at a particular location in the antimicrobial is changed to 
each of the other 19 natural amino acids, typically through the use of 
degenerate PCR primers. The combined use of site-directed and site-saturation 
mutagenesis led to the identification of a number of additional ‘enhanced’ 
peptides including Nisin N20P, Nisin M21V and Nisin K22S (Field et al., 2008) 
(Figure 3).  
Similarly, Rink et al. showed that ring A mutants KFI and KSI were more 
potent than nisin A against Lactobacillus johnsonii and Leuconostoc 
mesenteroides, and L. lactis and L. johnsonii, respectively (Rink et al., 2007b). 
Interestingly, Kuipers and co-workers demonstrated how the substitution of 
threonine in a double mutation simultaneously generated two mutants, G18Thr 
and a dehydrated form, G18Dhb. The M17Q/G18Thr mutant displayed 
increased activity against Micrococcus flavus, while M17Q/G18Dhb showed 
similar activities to nisin Z. Additionally, it was shown that a T2S mutant had 
increased activity against M. flavus and Streptococcus thermophilus (Kuipers et 
al., 1996, Kuipers et al., 1992).  
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Figure 3 
Mutations of Nisin A/Nisin Z resulting in derivatives with enhanced antimicrobial activity. Nisin A 
and Nisin Z differ by one amino acid, where Nisin Z contains an asparagine residue instead of a 
histidine at position 27. Positions 20-23 are the “Hinge Region”. 
I = Triple mutation, ITL replaced with KFI. (Rink et al., 2007b)   
II = Triple mutation, ITL replaced with KSI.(Rink et al., 2007b) 
III = Double mutation, MG replaced with QT. Thr was also dehydrated to yield Dhb (Kuipers et 
al., 1996) 
 * Numerous other derivatives showed enhanced activity from mutations in this region, but 
were not investigated further (Field et al., 2008) 
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Site-saturation mutagenesis has also been successfully employed on a 
number of other occasions. Such an approach was applied to the bioengineering 
of the Staphylococcus warneri ISK-1-produced type 2 lantibiotic, nukacin ISK-1 
(Islam et al., 2009). During this process of mutagenesis, two variants, D13E and 
V22I, with twice the potency of the wild-type were identified via colony overlay 
assays, albeit against non-pathogenic strains (such as Lactobacillus sakei, 
Bacillus coagulans, Pediococcus pentococcus and Enterococcus faecalis). 
Important information regarding the importance of positive charges and ring 
structures was also obtained during this process. A similar strategy has been 
utilized in the case of another type 2 lantibiotic, mersacidin (Appleyard et al., 
2009). Although a system to facilitate the bioengineering of mersacidin had 
been previously identified (Szekat et al., 2003), this was improved upon to 
facilitate the generation of large numbers of variants (Appleyard et al., 2009). 
The trans complementation system in question utilizes an inactive mrsA 
(structural peptide-ending gene) mutant of the producing strain, which is 
complemented through the introduction of a shuttle plasmid carrying the mrsA 
gene, or a derivative thereof. A simplified transformation procedure to deliver 
the plasmid to the host by electroporation of demethylated DNA was developed 
to facilitate the process. It was noted that of the 228 mersacidin mutants in the 
saturation mutagenesis library, >80 mutants produced mature mersacidin at 
acceptable levels. 6 variants, G8H, G9S, G10A, G10N, G10V and G10Y, showed 
increased activity against both MRSA and vancomycin resistant enterococci 
(VRE), while another 9, P6H, G7A, G7N, G8N, G8Q, G9A, G9H, L14V and S16A, 
displayed increased activity against VRE only.  
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While the ‘novel’ lantibiotics described above differ quite subtly from 
the existing antimicrobials, the lantibiotic biosynthetic machinery can also be 
harnessed in vivo or in vitro to facilitate the creation of peptides which differ 
more significantly. In one case, Levengood et al. employed an approach 
whereby a biosynthetic enzyme was used to modify synthetic substrate 
analogues via a strategy termed in vitro mutasynthesis (IVM) (Levengood et al., 
2009). More specifically, they showed that LctM, the modification enzyme for 
the type 2 lantibiotic lacticin 481, continued to modify residues within the 
lacticin 481 propeptide even when residues (Trp19 and  Phe23) were 
substituted with nonproteinogenic amino acids (naphthyalanine and 
homophenylalanine, respectively). This resulted in the creation of two 
analogues with increased biological activity against L. lactis HP and Bacillus 
subtilis ATCC 6633, thereby demonstrating the value of this approach. Indeed, it 
has been established that many lantibiotic biosynthetic proteins can be 
harnessed (Kuipers et al., 2004, Li et al., 2006, van Saparoea et al., 2008, Rink et 
al., 2007a, Rink et al., 2005, Kluskens et al., 2005, Chatterjee et al., 2006, 
Kuipers et al., 2008), which will undoubtedly facilitate the synthesis of even 
greater numbers of novel antimicrobials in the future. Indeed, the application of 
modification proteins and in-silico screening have been nicely combined by 
Majchrzykiewicz and co-workers who successfully utilized the nisin 
expression/modification system to produce, modify, and secrete entirely 
unrelated putative lantibiotics identified using BAGEL (Majchrzykiewicz et al., 
2010). The two putative structural peptides of the potentially novel type 2 
lantibiotic pneumococcin, A1 and A2, from Streptocccus pneumoniae R6, were 
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chosen as the substrates for the nisin enzymes. Their propeptide regions (i.e. 
mature peptide region) were fused with nisin leader sequences and introduced 
into a Lactococcus lactis host that overproduces NisBTC. The peptides produced 
were shown to be modified and to exhibit biological activity against Micrococcus 
flavus. It is thus apparent that the nisin modification and transport machinery 
can be employed to harness a putative lantibiotic-encoding gene cluster 
corresponding to a different lantibiotic type and from a different genus and thus 
could potentially be employed to access the many other putatively lantibiotic-
encoding gene clusters referred to above. 
 
1.8 Non-lantibiotic, ribosomally synthesized, modified peptides 
As noted above, this review has focused specifically on lantibiotic-related 
research with a view to using the developments in this area to highlight the 
variety of different ways in which modified ribosomally synthesised 
antimicrobials in general can be identified. However, to highlight the relevance 
of these approaches to other gene-encoded peptides, a selection of recent 
examples of note is presented here. 
 
1.8.1 Sactibiotics 
Clostridium difficile is the causative agent of nosocomial diarrhea, and C. 
difficile-associated disease is increasing in both prevalence and severity. The 
main predisposing factor for this disease is antibiotic therapy, which often 
eradicates beneficial flora in the gut, allowing C. difficile to flourish. To this 
effect, a bio-screen was devised with the aim of isolating a narrow-spectrum 
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bacteriocin effective against C. difficile that would not impact on beneficial 
microbes in the intestine (Rea et al., 2010). It was hypothesised that spore-
forming, anaerobic bacteria would be a probable source of bacteriocins active 
against a related bacterium such as C. difficile. To select for such strains, human 
faecal samples from healthy and diseased adults were treated with ethanol for 
30 minutes to kill all vegetative cells. These were then plated on Wilkens 
Chagrin anaerobic agar (WCAA) and allowed to grow for 5 days at 37oC in an 
anaerobic chamber. Resulting colonies were overlaid with C. difficile-inoculated 
reinforced Clostridium agar and grown for another 18 hours, to produce a lawn 
of C. difficile growth. The plates were then inspected for zones of clearing, 
where the initial colony inhibited the growth of C. difficile. 30,000 colonies were 
screened, and only one colony showed potent antimicrobial activity against the 
overlaid C. difficle strain. Interestingly, other faecal bacteria growing in the 
bottom layer were not inhibited by this antimicrobial suggesting it could be a 
narrow spectrum antimicrobial. The producing colony in question was removed 
from the agar using a sterile scalpel and sub-cultured onto fresh WCAA. 
Proteinase tests were performed to confirm that the inhibitory substance was 
proteinaceous in nature and it was ultimately established to be a two peptide 
bacteriocin, designated thuricin CD, that underwent post-translational 
modification resulting in the formation of sulphur to α carbon linkages (from 
which the name sactibiotic is derived) (Rea et al., 2010). The thuricin CD gene 
cluster was identified through reverse genetics and inverse PCR and was found 
to contain two radicial SAM (S-adenosyl methyltransferase) encoding genes, 
trnC and trnD (Rea et al., 2010). An in-silico screen for novel sactibiotics, using 
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the radical SAM sequences as drivers, as uncovered a considerable number of 
additional gene clusters of note (Murphy et al., 2011).  
 
1.8.2 Labyrinthopeptins 
The labyrinthopeptins are a novel family of lantibiotic-like antimicrobials which 
contain an unprecedented carbacyclic, post-translationally modified amino acid 
named labionin (Meindl et al., 2010). These were identified when the culture 
extracts of a newly identified novel actinomycete Actinomadura namiensis DSM 
6313 (from Namibian desert soil) were shown to have moderate activity against 
the herpes simplex virus. The peptide was isolated using chromatographic 
methods and shown to have potential applications in the treatment of 
neuropathic pain.  
 
1.8.3 TOMMs 
The Thiazole/Oxazole-Modified Microcins (TOMMs) are a group of post-
translationally modified antimicrobial peptides, that includes assorted bacterial 
products such as microcins, thiopeptides, cyanobactins, putative Bacillus-
associated thiazole–containing heterocyclic bacteriocins, a nitrile hydrolase and 
Nifl 1 related precursor family, and which are grouped on the basis of containing 
thiazole and oxazole structures (Molloy et al., 2011). The culture-, in-silico- and 
bioengineering-based approaches described in this review can also be employed 
to identify novel such peptides. By way of example, we will focus on the 
thiopeptides.  
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Thiopeptides are another distinct group of ribsosomally, post-
translationally modified antimicrobials (Bagley et al., 2005). Thiopeptides are 
complex, highly modified sulfur-containing peptides which inhibit the initial 
steps of protein synthesis in Gram positive bacteria, including MRSA. They 
contain a macrocyclic framework consisting of modified heterocyclic residues, 
including indoles, oxazoles, thiazoles and dehydroamino acids. The 
development of screening programs has greatly expanded the number of 
known thiopeptide antibiotics in recent years. Although micrococcin P1 was the 
first thiopeptide antibiotic to be discovered (Su, 1948), thiostrepton has been 
the most extensively studied. Thiostrepton exhibits activity analogous to that of 
penicillin, but has not yet been developed for clinical use since bacterial 
resistance develops before a therapeutic dose can be reached, due to its low 
solubility (a problem common to many thiopeptide antibiotics).  
Targeted screening programs have isolated a number of thiopeptides 
from a variety of actinomycete sources. The chemical structure of several 
thiopeptides has been elucidated using X-ray crystallography and NMR 
techniques, and several, such as promothiocin A, amythiamicin D and 
thiostreptin have been synthesised chemically. These results offer a glimpse at a 
promising future in which chemical thiopeptide structures can be 
computationally and biologically optimised for antimicrobial activity. A high-
throughput screening strategy has been employed, using 96- and 384-well 
microtiter plates to screen a library of thiopeptide precursor compounds for 
their abilities to inhibit translation or reverse the inhibition of known 
thiopeptide antibiotics, to identify four distinct classes of precursor peptides 
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(Starosta et al., 2009), an in-silico screen was used to identify thiocillin, a 
thiopeptide that undergoes 13 post-translational modifications (Brown et al., 
2009) and TP-1161, a thiopeptide antibiotic from a marine Nocardiopsis species, 
was identified by PCR screening (Engelhardt et al., 2010).  
 
1.9 Conclusion 
There are numerous strategies available when targeting the 
identification/creation of novel post-translationally modified antimicrobials. 
Great advances have been made and today culture-based methods have 
evolved to encompass high-throughput screening, molecular tools to amplify 
and engineer DNA and in-silico databases and search tools enable bioinformatic 
mining for novel peptides. The continued evolution of these technologies will 
ensure that the rate of identification of novel modified antimicrobials will 
continue to increase at a considerable rate. 
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CHAPTER II 
Traditional fermented beverages with health-promoting potential: current 
and future perspectives 
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2.1 ABSTRACT 
Fermentation is an ancient form of food preservation and is also employed as a 
means of improving the nutritional content of foods. Many such foods, 
including fermented beverages, have become known for their health-promoting 
attributes including, in some cases, the treatment/prevention of gastrointestinal 
ailments. Today, most of the commercial fermented beverages that are 
regarded as health-promoting are dairy-based. As a consequence of the 
perception that these beverages contain health-promoting microbes, or 
because they can be used as a vehicle for specific probiotic strains, these bio-
active beverages are increasing in popularity. Examples include fermented 
dairy-based beverages such as kefir, koumiss, and a variety of African fermented 
milks, cereal-based beverages such as boza, togwa, kvass and amazake, and 
other forms of fermented beverages such as kombucha, water kefir and 
hardaliye. In addition to harnessing traditional beverages, there have recently 
been innovative efforts to develop non-dairy probiotic fermented beverages 
from a variety of substrates, including soy milk, whey, cereals and vegetable and 
fruit juices. Efforts have also been made to enhance these and other beverages 
through the addition of flavours, prebiotics and nutraceuticals. On the basis of 
recent developments, it is anticipated that fermented beverages will continue 
to be a growing sector within the functional food market.  
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2.2 Introduction 
Societies throughout the world independently discovered the value of 
fermenting food as a cheap means of preservation, improving nutritional quality 
and enhancing sensory characteristics. The fermentation of milk, cereals and 
other substrates to produce beverages with health-promoting properties is 
indigenous to many regions, including Asia, Africa, Europe, the Middle East and 
South America. Evidence from pottery vessels show that fermented rice, honey 
and fruit beverages date as far back as 7000 B.C. in China (McGovern et al., 
2004), cacao beverages have been dated to before 1000 B.C. from the Honduras 
region (Henderson et al., 2007), while it is known that kombucha was 
manufactured by approximately 220 B.C. (Dufresne and Farnworth, 2000).  
The global functional beverage market is a growing sector of the food 
industry as modern health-conscious consumers show an increasing desire for 
foods that can improve well-being and reduce the risk of disease (Landstrom et 
al., 2007). Fermented milks, especially yoghurt-style products, are the most 
popular functional beverages with kefir in western Europe and North America 
and ymer in Denmark being good examples. Notably, the global functional food 
and drink market increased 1.5 fold between 2003 and 2010, and is expected to 
grow a further 22.8% between 2010 and 2014 to be worth $29.8 billion 
(Leatherhead, 2011). It is also intriguing to note that a number of food 
companies that have been under pressure, due to the poor public perception 
regarding the ‘healthiness’ of the foods they produce, are now focusing on 
developing functional products (Hugenholtz, 2013). Here we review the 
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literature regarding traditional fermented beverages with reputed health 
benefits, and new developments in this field.  
 
2.3 Natural fermented beverages: sources and microbial composition  
2.3.1 Fermented milk beverages 
Many communities across the world produce fermented milks (most notably in 
Africa, Asia, Europe and the Middle East) with many of these products being of a 
yoghurt-style consistency. Fermented milk products can be made with milk (or 
skimmed milk) from various sources, including cow, camel, goat, sheep, yak, 
and even coconut, milk, and can be either pasteurised or unpasteurised. They 
can be produced through the use of defined starter cultures, back-slopping or 
allowed to ferment naturally. Although fermented milk beverages are 
predominantly composed of lactic acid bacteria (LAB) (Tillisch et al.), the exact 
microbial content may vary depending on the source of milk, treatment of the 
milk (e.g. pasteurisation), use of starters, the nature of the local environmental 
microbes present, temperatures, hygiene, the type and treatment of containers 
used, and the length of fermentation (Feresu and Muzondo, 1989, Mutukumira, 
1995). Many artisanal fermented milk beverages are produced as a result of 
back-slopping (Mutukumira, 1995), whereby a small portion of already-
fermented milk is used to begin a new fermentation. In this way, cultures from 
the LAB naturally present in the raw milk are passed from household to 
household and between generations. While the consumption of spontaneously 
fermented milk is common to many different regions, the exact microbial 
differences between these products has not been ascertained. Table 1 lists a 
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number of the most popular and best-studied fermented beverages from 
around the world, along with information with respect to their corresponding 
microbial compositions. From this, the domination of milk-based beverages 
fermented by LAB, mainly Leuconostoc, lactobacilli and lactococci, is clear. 
Fermentation in colder climates promotes the growth of mesophilic bacteria 
such as Lactococcus and Leuconostoc, whereas beverages produced at higher 
temperatures usually have greater counts of thermophillic bacteria such as 
Lactobacillus and Streptococcus (Tamime and Robinson, 1988). The 
contributions of slime-producing species (e.g. Leuconostoc spp.) or acetic acid 
producing species, generally present at low abundance relative to Lactobacillus 
or Lactococcus species, vary depending on abundance. There may also be 
significant numbers of coliforms present, depending on the level of hygiene 
employed during preparation. The quantity and types of yeasts involved can 
vary greatly, but Candida and Saccharomyces spp. are most commonly 
detected.  
Of the many fermented milk beverages, kefir has been a notable 
success, gaining worldwide popularity. This drink dates back over 2000 years to 
the shepherds of the Caucasian region who noticed that the spontaneous 
fermentation of milk carried in leather pouches preserved the milk over long 
periods of travel. Over time, kefir became known for its positive impact on the 
gastrointestinal tract of the consumer (Metchnikoff and Metchnikoff, 2004).
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Table 1 A compilation of various milk, cereal and other fermented beverages popular around the world, with their corresponding microbial 
populations and substrates. 
Product   Substrates Region Microflora  References  
Amasi  Milk (Cow, Various) Africa (Zimbabwe) Lactococus (L.lactis), Lactobacillus, 
Leuconostoc, Enterococcus. Uncharacterised 
fungal component  
(Osvik et al., 2013) 
Aryan Milk  (Cow, Various) Turkey  Lactobacillus bulgaricus, Streptococcus 
thermphilus  
(Altay et al., 2013) 
Garris  Milk (Camel) Africa (Sudan) LAB (Lactobacillus (L. parachesei, L. fermentum 
and L. plantarum), Lactococcus, Enterococcus, 
Leuconostoc). Uncharacterised fungal 
component 
(Sulieman et al., 
2006) 
Kefir  Milk (Cow, Various)  Eastern Europe 
(Caucasian 
region) 
Lactococcus, Lactobacillus, Leuconostoc, 
Acetobacter ; Naumovozyma, Kluyveromyces, 
Kazachstania 
(Marsh et al., 
2013c) 
Kivuguto Milk (Cow) Africa (Rwanda) LAB (Leuconostoc mesenteroides, Leuconostoc 
pseudomesenteroides and Lactococcus lactis).   
Uncharacterised  fungal component 
(Karenzi et al., 
2013) 
Koumiss/Airag Milk  (Cow, Camel, Goat) Asia/Russia LAB (predominantly Lactobacillus) and yeast 
(Kluyveromyces, Saccharomyces and 
Kazachstania) 
(Mu et al., 2012, 
Hao et al., 2010) 
Kumis Milk (Cow) South America 
(Columbia) 
LAB (Lactobacillus cremoris, Lactococcus lactis), 
Enterococcus (E. faecalis, E. faecium) Yeast 
(Galactomyces geotrichum, Pichia kudriavzevii, 
Clavispora lusitaniae, Candida tropicalis) 
(Chaves-Lopez et 
al., 2011, Chaves-
Lopez et al., 2012, 
Gaviria et al., 2010) 
Nyarmie Milk (Camel)  Africa (Ghana) LAB (Leuconostic mesenteroides, Lactoabcillus 
bulgaricus, Lactobacillus helveticus, 
Lactobacillus lactis, Lactococcus lactis); 
(Obodai and Dodd, 
2006) 
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Saccharomyces cerevisiae  
Rob  Milk (Unspecified) Africa (Sudan) LAB (Lactobacillus fermentum, Lactobacillus 
acidophilus, Lactococcus lactis, Streptococcus 
salivarius); Yeast (Saccharomyces cerevisiae, 
Candida kefyr) 
(Abdelgadir et al., 
2001) 
Suusac Milk (Unspecified) Africa (Kenya) LAB (Leucontostoc mesenteroides, L. plantarum, 
L. cruvatus, L. salivarius, L. raffinolactis); Yeasts 
(Candida krusei, Geotrichum penicillatum, 
Rhodotorula mucilaginosa) 
(Lore et al., 2005) 
Amazake  Rice  Japan  Fungi (Aspergillus spp)  (Saigusa and Ohba, 
2007, Yamamoto et 
al., 2011) 
Boza Various (Barley, Oats, 
Rye, Millet, Maize, 
Wheat or Rice) 
Balkans (Turkey, 
Bulgaria) 
Leuconostoc (L. paramesenteroides, L. 
sanfrancisco, L. mesenteroides), Lactobacullus 
(L. plantarum, L. acidophilus, L. fermentum); 
Saccharomyces (S. Uvarum, S. Cerevisiae), 
Pichia fermentans, Candida spp.  
(Botes et al., 2007, 
Gotcheva et al., 
2000, Hancioglu 
and Karapinar, 
1997, Caputo et al., 
2012) 
Bushera  Sorghum, Millet flour,  Africa (Uganda) Lactobacillus, Streptococcus, Enterococcus.  
Uncharacterised  fungal component 
(Muyanja et al., 
2003) 
Koko Sour Water Cereal (Pearl Millet) Africa (Ghana) LAB (Weisella confuse, Lactobacillus fermentum, 
Lactobacillus salivarius, Pediococcus spp.)   
Uncharacterised  fungal component 
(Lei and Jakobsen, 
2004) 
Kvass  Rye bread, rye and 
barley malt/flour,  
Russia  LAB (Lactobacillus casei, Leuconostic 
mesenteroides); Saccharomyces cerevisiae  
(Dlusskaya et al., 
2008) 
Mahewu  Maize, Sorghum/Millet Africa (Zimbabwe) Unknown  (Mugochi et al., 
2001, Gadaga et 
al., 1999) 
Pozol Maize Mexico 
(Southeast) 
LAB (Lactococcus lactis, Streptococcus suis, 
Lactobacillus (L. plantarum, L. casei, L. 
alimentarium, L. delbruekii), non-LAB 
(Bifidobacterium, Enterococcus).  
Uncharacterised  fungal component 
(Ampe et al., 1999, 
ben Omar and 
Ampe, 2000, 
Escalante et al., 
2001) 
Togwa Maize flour, Finger Millet Africa (Tanzania) Lactobacillus, Saccharomyces cerevisea, (Mugula et al., 
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Malt,  Candida spp.  2003, Kitabatake et 
al., 2003a) 
Hardaliye  Grapes/Mustard 
Seeds/Cherry Leaf 
Turkey  Lactobacillus. Uncharacterised  fungal 
component 
(Altay et al., 2013) 
Kombucha  Tea  China, Worldwide  Gluconacetobacter, Lactobacillus; 
Zygosaccharomyces  
(Marsh et al., 
2013a) 
Water Kefir  Water/Sucrose Mexico, Worldwide Lactobacillus, Zymomonas;  Dekkera, 
Hanseniaspora, Saccharomyces, 
Zygosaccharomyces 
(Marsh et al., 
2013b) 
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The microorganisms responsible for the fermentation are actually a symbiotic 
combination of bacteria and yeast, contained within a polysaccharide matrix, 
known as kefir ‘grains’ (Farnworth, 2006). So complex is the symbiotic 
relationship, that in vitro synthesis of kefir grains has yet to be replicated. 
Therefore, commercial kefir is produced by defined starters, and probiotic 
strains are also added to some products.  
 Koumiss, sometimes known as airag (a name usually indicating it is 
produced from mare’s milk), is a popular beverage of nomadic cattle breeders 
in Asia and some regions of Russia. Like kefir, it is fermented by a symbiotic 
combination of microbes to produce a sour, sparkling beverage. However, 
unlike kefir, there is no solid inoculation matrix, and this milk is fermented by 
back-slopping or by allowing the milk to ferment naturally. The microorganisms 
responsible for both products are alike, but for the fact that koumiss has been 
reported to contain fewer lactococci. Both kefir and koumiss have become 
popular worldwide due to their reputed ability to improve gastrointestinal 
health (Jagielski, 1877, Saijirahu, 2008, Metchnikoff and Metchnikoff, 2004). 
Kumis is a similarly prepared beverage that is found in Colombia, which has 
been shown to contain significant proportions of enterococci, an observation 
which has been attributed to poor hygiene (Chaves-Lopez et al., 2011).  
In Africa, fermented milk beverages are quite popular, and the art of 
making fermented products is passed down through generations (Caplice and 
Fitzgerald, 1999). Examples of such beverages include amasi from Zimbabwe, 
kivuguto from Rwanda, suusac from Kenya, nyarmie from Ghana and rob and 
garris from Sudan (Obodai and Dodd, 2006, Lore et al., 2005, Osvik et al., 2013, 
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Karenzi et al., 2013, Abdelgadir et al., 2001, Sulieman et al., 2006). Considering 
that most of these are derived from the spontaneous fermentation of milk by its 
innate flora, it is likely that the fermented milks, although known by different 
names are actually quite similar (in the same way airag and koumiss may be 
considered similar), and have, in combination, been referred to as naturally 
fermented milk (NFM) (Narvhusa and Gadaga, 2003). Exceptions exist in that 
amasi, the Zimbabwean fermented milk has a distinct sensory profile (Narvhusa 
and Gadaga, 2003). Nonetheless, accurate categorization remains difficult in the 
absence of more detailed microbiological and biochemical analyses.  
The aforementioned amasi is fermented in a smoked, calabash container 
for 3-5 days. Whey is removed until the beverage reaches the desired viscous 
consistency (Osvik et al., 2013). For nyarmie, the milk is pasteurised and 
fermented in an aluminium container for 24-48 hours (Obodai and Dodd, 2006). 
Suusac is prepared by the natural fermentation of camel milk in smoke-treated 
gourds for 24-48 hours, producing a beverage with low viscosity and distinct 
smoky taste. The dominant microorganisms in this beverage were found to be 
Leuconostoc mesenteroides and Candida krusei, with Lactobacillus plantarum 
also present (Lore et al., 2005). Garris is another fermented camels milk, that is 
produced by a continuous batch fermentation in large leather pouches and 
agitated by the movement of the camel (Sulieman et al., 2006). Kivugoto is a 
naturally fermented beverage produced from unpasteurised cows milk, which 
takes 2-3 days to produce (Karenzi et al., 2013). Fermentation of rob is started 
through the transfer of cultures from the previous day’s fermentation, and is 
made in either a goatskin container or gourd made from hollowed dried fruit 
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(Abdelgadir et al., 2001). Depending on the level of hygiene used in production, 
contamination with non-milk microbes is frequent. This has been particularly 
evident in African beverages (Gran et al., 2003). 
Finally, in many countries, yoghurts are diluted with water to form 
drinkable fermented milk. In the Middle East, doogh is very popular and 
seasoned with mint (Shab-Bidar et al., 2011), while ayran is popular in Turkey 
(Caglayan et al., 1989). Other examples include chaas and lassi, Indian yoghurt-
beverages that are mixed with spices and, on occasion, fruit. The microbial 
comparison of these beverages is generally quite similar to that of yoghurts.  
 
2.3.2 Cereal and other fermented beverages  
Another important class of fermented beverages are those made from cereals, 
which are popular in tropical regions and on the continent of Africa in 
particular. As with many milk-based products, the natural microbial component 
is used to ferment grains including maize, millet, barley, oats, rye, wheat, rice or 
sorghum. The grains are often heated, mashed and sometimes filtered. Back-
slopping is again quite common, but the microbial populations responsible for 
the fermentation of these beverages are not as well characterised.  
Boza, consumed in Bulgaria and Turkey, is generated through the 
fermentation of a variety of cereals including barley, oats, rye, millet, maize, 
wheat or rice, with the specific composition affecting the viscosity, 
fermentability and content of the final beverage (Akpinar-Bayizit et al., 2010). 
The cereal is boiled and filtered, a carbohydrate source is added, and the 
mixture can be left to ferment independently or with the use of back-slop. Boza 
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has yet to be commercialised and studies have revealed that the microbial 
population varies (Botes et al., 2007, Gotcheva et al., 2000, Hancioglu and 
Karapinar, 1997). The function of the yeast present, which are only sometimes 
detected, remains unknown. Of several combinations, fermentation by S. 
cerevisiae, Leuconostoc mesenteroides and Lactobacillus confusus was shown to 
produce the most palatable beverage (Zorba et al., 2003). 
Togwa, a sweet and sour, non-alcoholic beverage, is one of the better 
studied African cereal beverages. Produced from the flour of maize, sorghum 
and finger millet and sometimes, cassava root, the chosen substrates are boiled, 
cooled and fermented for approx. 12 hours to form a porridge, which is then 
diluted to drink (Kitabatake et al., 2003b). Mahewu is similar in that maize or 
sorghum meal is fermented with millet or sorghum malt, and is available 
commercially (Mugochi et al., 2001). Bushera is generally prepared from 
germinated or non-germinated sorghum grains, and fermented for 1-6 days 
(Muyanja et al., 2003). These beverages are often used to wean children, and as 
a high-energy diet supplement. Koko sour water is the fermented liquid water 
created in the production of the fermented porridge, koko. This contains a high 
portion of LAB and is used by locals to treat stomach aches and as a refreshing 
beverage (Lei and Jakobsen, 2004).  
Kvass is a fermented rye bread beverage common in Russia, which has 
seen much commercial success (Dlusskaya et al., 2008). The beverage can have 
a sparkling, sweet or sour, rye bread flavour. Its alcohol content, though usually 
low, can vary, and has been suggested as a contributor to alcoholism (Jargin, 
2009). Amazake is a sweet fermented rice beverage that is the non-alcoholic 
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precursor to sake, produced in Japan. Steamed rice is mixed with rice-koji 
(Aspergillus-mycelia and rice) and water, and is heated to 55-60°C for 15-18 
hours. Enzymes break down the rice and form glucose content of approximately 
20%. Amazake is highly nutritious and is consumed for its purported health 
benefits (Yamamoto et al., 2011, Saigusa and Ohba, 2007). Pozol, which is 
common to south-eastern Mexico, has a quite different method of production, 
in that maize grains are heat-treated in an acid solution, ground and shaped into 
dough balls. These are then wrapped in banana leaves and fermented for 2-7 
days, after which they are resuspended in water and consumed as beverages. 
Pozol is composed of a variety of microorganisms including LAB, non-LAB, yeasts 
and other fungi (Ampe et al., 1999, ben Omar and Ampe, 2000, Escalante et al., 
2001).  
In addition to milk and cereal-based fermentations, there are also other 
forms of fermented beverages. One example is kombucha, which is a fermented 
sweetened tea that was originally popular in China but is now enjoyed 
worldwide. It is fermented by a symbiotic mixture of bacteria (typically acetic 
acid bacteria, with small quantities of LAB) and yeast, which are embedded 
within a cellulosic matrix that floats above the fermentate, similar to the 
mother cultures of vinegar. Due to the high acid content (as low as pH2), the 
functionality of kombucha is predominantly due to its physiochemical 
properties (Greenwalt et al., 2000). As a result of the tea content, it also 
contains a number of phenols and vitamins (Dufresne and Farnworth, 2000). 
Water kefir is similar in concept to milk kefir in that it is fermented by a 
symbiosis of bacteria and yeast contained within grains. However, these grains 
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are composed of dextran, are translucent and crystal-like in appearance, and 
are thought to have originated in Mexico where they formed as hard granules 
fermented from sap on the pads of the Opuntia cactus. They ferment 
sweetened water, to which figs and lemon are traditionally added for additional 
flavour and nutrients. The composition of water kefir can vary, but is known to 
contain LAB, including Lactobacillus, and Bifidobacterium (Gulitz et al., 2013, 
Marsh et al., 2013b). Hardaliye is a non-alcoholic, Turkish, fermented beverage 
made from red grapes, black mustard seeds, cherry leaf and benzoic acid. 
Ingredients are pressed and fermented for 5-10 days at room temperature. 
Again, the microbial population has been reported to be predominantly 
composed of Lactobacillus and unknown fungal components (Altay et al., 2013), 
and this beverage is thought to have antioxidant properties (Amoutzopoulos et 
al., 2013).  
 
2.4 Beyond physiochemical advantages: from microbial content to 
functionality  
2.4.1 Molecular-based microbial characterisation 
Despite the data presented above, many of these beverages have not been the 
focus of detailed microbiological analyses. Some molecular-based microbial 
characterisation of these beverages have taken place and have mostly relied on 
low-throughput approaches, employing techniques such as DGGE, which can 
only assess 1-2% of a population (Muyzer et al., 1993).  
Moving forward, the availability of molecular technologies such as 
culture-independent high-throughput sequencing based microbial analyses, 
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metabolomics and bioinformatics will prove particularly useful, and will provide 
a more accurate picture of these populations, surmounting problems associated 
with relying on phenotypic-based approaches (Giraffa and Neviani, 2001). In-
depth molecular studies have the potential to be particularly useful when 
carrying out analyses across different beverages with a view to attributing 
specific desirable or non-desirable sensory characteristics with specific 
microorganisms present (Marsh et al., 2013c, Marsh et al., 2013b). Such 
approaches will also ultimately facilitate accurate species identification, leading 
to novel starter design, and the development of beverages with different and 
complex flavour profiles. It will also be possible to more effectively monitor the 
change of proportions of different species throughout fermentation and storage 
(Cocolin et al., 2013). 
 
2.4.2 Health-promoting microbes  
It is widely believed that the primary reason for the functionality of these 
beverages is due to the presence of specific live microorganisms. To the 
consumer, health claims are more important than nutritional claims (Verbeke et 
al., 2009), so there has and will be a desire to augment the health-promoting 
potential of these beverages through the addition of certified probiotics. The 
WHO/FAO defines probiotics as “live microorganisms, which when administered 
in adequate amounts confer a health benefit on the host” (Araya et al., 2002), 
and the probiotic sector is the largest component of the functional food market. 
The physiology of certain strains of lactobacilli and bifidobacteria make them 
well-suited to both the gastrointestinal and milk environments, and thus lactic 
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acid bacteria and bifidobacteria are the most studied and utilised probiotic 
organisms. It is generally considered that a minimum of 109 cells per daily dose 
are required for probiotics to be effective (Forssten et al., 2011). Within the EU, 
the term “probiotic” is now considered a health claim, and most applications 
submitted to the European Food Safety Authority (EFSA) have been rejected 
(Guarner et al., 2011, Schmidt, 2013). In Europe, boosting numbers of 
Lactobacillus and Bifidobacterium in the gut is not deemed to be of sufficient 
merit to be considered a health benefit; the link must be made to a 
physiological (e.g. strengthening the immune system or resistance to infections) 
benefit to the host. Proving such health claims is expensive, and in the midst of 
unclear definitions and guidelines, industries are currently more likely to 
develop and market probiotic products in other parts of the world (Katan, 
2012). In situations where probiotic strains are added during a fermentation, 
they must not interact antagonistically with starter strains. This becomes less of 
an issue if strains are added after fermentation is complete, due to the low 
metabolic rates at refrigerated temperatures (Heller, 2001). Additionally, 
microencapsulation technology may aid in the delivery of probiotic strains by 
protecting them in non-native environments. Microencapsulation of 
Bifidobacterium increased viable numbers when added to mahewu, without 
significantly impacting on flavour, suggesting it could be an effective probiotic 
delivery system (McMaster et al., 2005).  
Many traditional beverages are themselves capable of conferring health 
benefits, given their historical and frequent use to treat gastrointestinal 
ailments (Jagielski, 1877, Saijirahu, 2008, Metchnikoff and Metchnikoff, 2004). 
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However, in most cases, there is insufficient scientific evidence to substantiate 
the associated health claims. Nonetheless, natural fermented milks have been 
shown to have antihypertensive effects, enhance systemic immunity, help lower 
cholesterol and to help lower blood pressure (Gonzalez-Gonzalez et al., 2011, 
Dong et al., 2013, Galdeano et al., 2011, Wang et al., 2010). In recent human 
trials, they have been shown to aid in the treatment of IBS and to help alleviate 
constipation (Simren et al., 2010, Agrawal et al., 2009, Tabbers et al., 2011, 
Marteau et al., 2013, Matsumoto et al., 2010). Additionally, they have been 
shown to have modulatory effects on the brain, and demonstrate anti-cancer 
potential (Kumar et al., 2012, Tillisch et al., 2013). Furthermore, traditional 
beverages are often reported to contain health-promoting strains, usually in 
reference to the presence of lactic acid bacteria such as lactobacilli, but this 
again requires validation. Notably, there are some fermented beverage isolates 
that have shown promise due to their in vitro gastric survival and cell adhesion, 
such as lactobacilli from boza (Todorov et al., 2008), Lactobacillus rhamnosus 
strains from fermented mare’s milk (Shi et al., 2012) and bacterial isolates from 
koumiss and other dairy products (Pan et al., 2011, Zhang et al., 2010, Wu et al., 
2009). Additionally, the ability to produce antimicrobial substances, believed to 
contribute to probiotic activity (Dobson et al., 2012), has been demonstrated by 
various fermented beverage isolates (Powell et al., 2007, Todorov, 2008, 
Todorov, 2010, von Mollendorff et al., 2006, Batdorj et al., 2006).  
The health-related role of yeast in fermented beverages has yet to be 
fully elucidated. The volume of studies reporting significant numbers of yeast in 
traditional fermented beverages indicates their importance in these 
- 67 - 
 
fermentations. Yeasts in dairy produce contribute desirable aromatic 
compounds, proteolytic and lipolytic activities and can aid bacterial growth by 
producing amino acids, vitamins and other metabolites, and contribute to the 
final composition of the product by producing ethanol and carbon dioxide 
(Viljoen, 2001). In particular, studies have demonstrated that yeast can exert a 
positive effect on the abundance of Lactobacillus in fermented environments 
(Karaolis et al., 2013, Gadaga et al., 2001), and this might be a key function in 
such symbioses. Yeast might also play a role in preventing the proliferation of 
undesirable species such as Enterobacteriaceae (Mathara et al., 2004). Success 
has been made in incorporating them in commercial fermented milk products, 
but excessive gas production during storage can be an issue (Lourens-Hattingh 
and Viljoen, 2001, Karaolis et al., 2013). Saccharomyces boulardii is currently the 
only recognised probiotic yeast. While yeast only comprise <0.1% of the gut 
microbiota, they are 10 times larger than prokaryotes and can thus impede 
colonisation of pathogenic bacteria (Czerucka et al., 2007). Some species of 
yeasts are common to both fermented beverages and the gut microbiota, such 
as Saccharomyces and Candida species, and could be investigated with a view to 
their contribution to fermentations and optimising health-promoting potential.  
 
2.4.3 Rational design of starter cultures 
The selection of appropriate starter strains will be key in efforts to accurately 
reproduce the desirable characteristics of traditional health-promoting 
beverages for mass production. To faithfully reproduce these beverages and 
traits, microbes should be sourced from the traditional fermented beverages, 
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given that these microbes have adapted over thousands of years to their 
respective environments, and are more likely to function at the appropriate pH, 
salt concentration, temperature etc. For instance, amylolytic digestion of starch 
could be considered desirable for fermented cereal production, and isolates 
from boza and pozol have shown to be capable of this metabolic trait (Petrova 
et al., 2010, Diaz-Ruiz et al., 2003). Such populations also have a history of safe 
human consumption. Rational strain selection to produce the correct balance of 
flavour, aroma, texture, acidification, bitterness, speed of fermentation, and the 
optimum quantity of organic acid, vitamins and minerals is essential (Di Cagno 
et al., 2013), as beverages that are too sour or bitter, or contain too much 
ethanol, will not meet consumers’ approval. Over recent years, genetic tools 
have become available to engineer and select superior starter strains, but 
legislation currently hinders their industrial use (Hansen, 2002). The inclusion of 
strains producing antimicrobials, such as bacteriocins, could serve as natual 
preservatives and help produce a more natural product (Cleveland et al., 2001), 
while sequential fermentation with yeast, followed by bacteria, could produce a 
beverage with the desired physiochemical effects, but without biostabilisation 
issues created by excessive gas production (Kwak et al., 1996).  
As stated above, the natural fermentation of beverages involves many 
different strains of bacteria, and sometimes, yeast. There is an understandable 
tendency to keep starter cocktails simple but, as traditional beverages show, 
there are often multiple strains involved, including different species or even 
microorganisms. From a health perspective, multistrain or multispecies 
probiotic beverages display greater beneficial effects than monostrain cultures 
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(Timmerman et al., 2004). Incidentally, there is a lack of studies assessing the 
effects of combining several natural strains on the physiochemical and sensory 
characteristics of milk or other functional beverages. Without such information, 
it is difficult to accurately reproduce the characteristics of the organic beverage 
with one produced by a defined combination of starters, to match the flavour 
and properties of the original beverage. This is crucial when marketing 
beverages to consumers already familiar with the artisanally produced variant 
of the product, and if wishing to retain the health-promoting characteristics 
attributed to the original product.  
 
2.5 Development of novel functional beverages 
Expanding technological capabilities, especially ingredient exploration and 
development, has led to increased functional product innovation. The number 
of new products with functional claims has been growing by approximately 28% 
per year (Leatherhead, 2011). Consumers’ willingness to pay a premium price 
for fortified products is also a key driver for innovation. While most current 
functional beverages are aimed at the high-income consumer, there is an 
argument to be made that those who would benefit most from fermented 
beverages are from underdeveloped nations, where such beverages could 
provide a cost-effective means of delivering much-needed nutrition (Van Wyk et 
al., 2002). Fermented foods are particularly common in Africa, where palates 
are accustomed to sour foods. Incorporation of reliable probiotic cultures into 
beverages that are already familiar to Africans could be a way of preventing or 
treating diarrhoea, which claims the lives of many African children. Additionally, 
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providing a safe, fermented cereal beverage could help reduce diarrhoea and 
malnutrition caused by contaminated traditional beverages used in weaning 
children (Motarjemi et al., 1993). Trends in the developments of fermented 
milks have been covered elsewhere (Khurana and Kanawjia, 2007, Shiby and 
Mishra, 2013), so here we will focus primarily on the further development of 
non-dairy functional beverages.   
 
2.5.1 New substrates  
The US, Europe and Japan markets account for over 90% of total functional 
foods, with the majority being functional dairy products. However, non-dairy 
probiotic delivery has been attracting more attention in recent years, partly due 
to the success of bio-functional foods and the desire to expand and provide an 
alternative probiotic choice to conventional dairy-based beverages. Non-dairy 
probiotic beverages are particularly attractive due to their lack of dairy 
allergens, low cholesterol content and vegetarian-friendly status (Prado et al., 
2008, Rivera-Espinoza and Gallardo-Navarro, 2010). Furthermore, they can be 
rich in antioxidants, dietary fibre, minerals and vitamins.  
To this end, cereal-based beverages could be marketed in response to 
consumers’ awareness of the benefits of high fibre diets. They contain natural 
prebiotic traits due to the presence of indigestible fibres (Kedia et al., 2007) and 
the presence of diacetyl acetic acid and butyric acid make them palatable, and 
furthermore, could be cheaper to produce. Oats, a major source of beta-glucan, 
which can reduce LDL-cholesterol, are known to function as a prebiotic by 
boosting bifidobacteria numbers in the gut (Martensson et al., 2005), and have 
- 71 - 
 
been investigated with a view to producing synbiotic beverages (Gupta et al., 
2010, Guo et al., 2003). A fermented oat drink with two Bifidobacterium longum 
strains was shown to normalise bowel movements in elderly patients (Pitkala et 
al., 2007). Malt and barley have also been used as beverage substrates (Rathore 
et al., 2012), with malt proving in that instance to be the better of the two 
cereals, and also demonstrating better growth of health-promoting strains 
(Charalampopoulos et al., 2002). Emmer, an ancient European cereal has also 
shown potential as a functional cereal beverage (Coda et al., 2011).  
Soy-based beverages also have the possibility to become more popular 
due to the fact they contain low cholesterol and saturated fats, and are lactose-
free (Wagar et al., 2009, Champagne et al., 2010). They have also been shown 
to be capable of fermentation by Bifidobacterium, which in combination with 
Lactobacillus, can have a positive impact on the ecosystem of the intestinal tract 
(Cheng et al., 2005). Some varieties are already available commercially 
(Haelan951®, Rcircle, Jiva™) and have been shown to have beneficial effects on 
the host (Klein et al., 2006). 
 Whey is a by-product of the cheese industry which retains 55% of milk 
nutrients and contains only 0.36% fat, and has the potential for further use in 
the human diet. In an effort to add value to this waste product, numerous 
studies have investigated its fermentation by lactic acid bacteria (Streptococcus 
and Lactobacillus) to produce a lactic probiotic beverage (Pescuma et al., 2008, 
Pescuma et al., 2010), and probiotic bacteria have already demonstrated good 
survival in whey (Drgalic et al., 2005, Ying et al., 2013). Prebiotics have also been 
successfully incorporated, including oligofructose and inulin (de Castro et al., 
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2009b, Drgalic et al., 2005), and hydrocolloid thickening agents added to 
improve viscosity and mouthfeel (Gallardo-Escamilla et al., 2007). 
 
2.5.2 Fermented juices  
Fruit juices have considerable market value and consumer acceptance (Sun-
Waterhouse, 2011). Already considered a healthy food product, fruit juices are 
often fortified with vitamins and minerals, in addition to having a high nutrient 
and antioxidant content, and represent a new method of nutrient and probiotic 
delivery (Sheehan et al., 2007). Indications show that consumers have a 
preference for the “healthiest” product over taste (Luckow and Delahunty, 
2004). As an increasing number of studies are demonstrating, sugars naturally 
present in juices can facilitate the growth of cultures with appealing taste 
profiles. This is true of tomato, pomegranate, pineapple, orange and cashew-
apple juice (Yoon et al., 2004, Pereira et al., 2011, Costa et al., 2013, Escudero-
Lopez et al., 2013, Filannino et al., 2013). These microbes can impact on 
physiochemical aspects, such increasing concentrations of flavanones and 
carotenoids in orange juice (Escudero-Lopez et al., 2013), and have shown good 
survival rates during storage of the beverages. While the final content of such 
beverages are quite acidic and best suited to fermentation by probiotic 
Lactobacillus species (L. casei, L. acidophilus, L. plantarum, L. parachesei and L. 
delbrueckii), the use of microencapsulation technology could aid in the delivery 
of other viable probiotic microorganisms (Champagne and Fustier, 2007). The 
enrichment of juices with brewer’s yeast autolysate before fermentation 
positively impacts on the nutritional content of the final beverage (Rakin et al., 
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2004, Rakin et al., 2007), raising the feasibility of co-fermentation by the right 
combination of bacteria and yeast (Priya and Munishamanna, 2013). Similar 
microorganisms have also been shown to successfully ferment various 
vegetable juices including cabbage, beet, pumpkin, courgette and carrot juices 
supplemented with prebiotics (Yoon et al., 2005, Yoon et al., 2006, Kohajdova et 
al., 2006, Nazzaro et al., 2008). This topic has been recently reviewed (Martins 
et al., 2013). Moreover, there is also an option of combining fruit and vegetable 
juices with fermented milks (Shiby and Mishra, 2013, Daneshi et al., 2013).  
 
2.5.3 Application of traditional cultures  
In spite of the wide range of options available when designing novel health-
promoting fermented beverages, there will always be an attraction for healthy 
foods derived from natural processes. Applying the solid inoculation matrices of 
traditional fermented beverages to new substrates provides a means of 
generating new beverages while retaining natural microbial populations. The 
use of kefir grains to continuously ferment whey to produce high quality alcohol 
has been investigated, and they have also been employed to produce whey and 
cocoa pulp beverages containing health-promoting strains (Magalhaes et al., 
2010, Koutinas et al., 2007, Londero et al., 2012, Puerari et al., 2012). Similarly, 
the cellulosic pellicle of kombucha has been successfully used to ferment malt, 
milk and cheese whey (Belloso-Morales and Hernández-Sánchez, 2003, Ilicic et 
al., 2012, Malbasa et al., 2009, Belloso-Morales and Hernandez-Sanchez, 2003, 
Cvetković and Markov, 2002).  
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2.5.4 Enhancing beverage impact  
Most of the beverages described in this review are still in the early stages of 
commercial development, and require further extensive sensory, physical and 
chemical characterisation to develop a palatable flavour profile and viable 
product before commercialisation. Experiments have shown that the addition to 
fermented milks of flavour enhancers such as spearmint and oregano had a 
positive impact on the growth of Lactobacillus and Bifidobacterium 
(Marhamatizadeh et al., 2012, Marhamatizadeh et al., 2011), whereas citrus 
fibres had a positive effect on Lactobacillus only (Sendra et al., 2008). Artificial 
sweeteners were demonstrated to have positive effects on the flavours of an 
oat-based beverage (Angelov et al., 2006). Prebiotics, including 
fructooligosaccharides, inulin and galactooligosaccharides, are added 
commercially to fermented milks to promote the growth of favourable bacteria 
(Huebner et al., 2007), while investigations of other prebiotics such as 
oligofructose and polydextrose have also yielded positive results (Oliveira et al., 
2009, De Castro et al., 2009a). Enrichment of fermented milk and soy beverages 
with plant sterols can contribute to controlling hypercholesterolemia (Weidner 
et al., 2008, Hansel et al., 2007), while fortification of fermented milks with iron 
improved the growth of preschool children (Silva et al., 2008). In addition to 
preventing and treating intestinal-associated diseases, the incorporation of 
nutraceuticals such as ω-3 fatty acids, isoflavones and phytosterols in 
fermented milks also have potential applications (Awaisheh et al., 2005).  
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2.6 Conclusion 
Fermentation of products is an ancient form of bio-preservation that is common 
to all regions of the world. With traditional milk-fermented products currently 
enjoying great success in many markets, there is an increasing interest in 
functional beverages from a scientific, consumer and commercial perspective. In 
addition to the many forms of traditional milk-based beverages, there are also 
other varieties of traditional beverages that could be utilised as alternative 
methods for probiotic delivery and simply as alternatives to milk-based 
functional drinks.  
These beverages also represent an excellent source for starter strains in 
industrial fermentations, and for potential probiotic/health-promoting strains. 
One obvious hurdle is consumers’ willingness to accept an unfamiliar product, 
but with the right combination of starters and substrates, optimum nutrition 
and flavour development and with scientifically-supported health benefits, the 
market exists for such products. Indeed, with the availability and improvements 
in technology, and consumers’ increasing interest in functional foods, the 
outlook for fermented beverages is as promising as it has ever been. 
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3.1 ABSTRACT 
Lantibiotics are lanthionine-containing, post-translationally modified 
antimicrobial peptides. These peptides have significant, but largely untapped, 
potential as preservatives and chemotherapeutic agents. Type 1 lantibiotics are 
those in which lanthionine residues are introduced into the structural peptide 
(LanA) through the activity of separate lanthionine dehydratase (LanB) and 
lanthionine synthetase (LanC) enzymes. Here we take advantage of the 
conserved nature of LanC enzymes to devise an in-silico approach to identify 
potential lantibiotic-encoding gene clusters in genome sequenced bacteria. In 
total 49 novel type 1 lantibiotic clusters were identified which unexpectedly 
were associated with species, genera and even phyla of bacteria which have not 
previously been associated with lantibiotic production. Multiple type 1 
lantibiotic gene clusters were identified at a frequency that suggests that these 
antimicrobials are much more widespread than previously thought. These 
clusters represent a rich repository which can yield a large number of valuable 
novel antimicrobials and biosynthetic enzymes.  
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3.2 INTRODUCTION 
Bacteriocins are bacterially produced peptide antibiotics. Two major classes of 
gram-positive bacteriocins have been recognised, Class I undergo significant 
post-translationally modifications while the Class II are unmodified (Cotter et 
al., 2005, Rea, 2010). The majority of the class I bacteriocins are lantibiotics; 
small peptides containing internal bridges resulting from the formation of (β-
methyl)lanthionine residues. The structural gene encodes a ribosomally 
synthesised precursor prepeptide which is generically named LanA. This 
prepeptide contains a leader sequence at the N-terminus, which is ultimately 
cleaved, and a propeptide at the C-terminus. Many or all of the serine and 
threonine residues within the propeptide are dehydrated to form 
dehydroalanine (Dha) and dehydrobutyrine (Dhb), respectively. When these 
modified residues interact with an intrapeptide cysteine, a thioether bond is 
formed resulting in the formation of lanthionine (Lan, from Dha) or β-methyl 
lanthionine (meLan, from Dhb).  
The lantibiotics and lantipeptides (lanthionine containing peptides which 
lack antimicrobial activity) can be divided into four groups according to the 
nature of the enzymes which catalyse (me)Lan formation (Willey and van der 
Donk, 2007). In the case of type 1 lantibiotics two enzymes are involved; LanB, 
the lanthionine dehydratase which catalyses the dehydration of the amino 
acids, and LanC, the lanthionine synthetase which catalyses thioether 
formation. Type 2 lantibiotics contain a single LanM enzyme which performs 
both functions. Type 3 and 4 are lantipeptides which are also catalysed by 
distinct enzymes such as the RamC-like and LanL enzymes (Kodani et al., 2004 , 
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Goto et al., 2010). The type 1 and 2 lantibiotics can also be further subdivided 
on the basis of the amino acid sequence of the unmodified propeptide. In the 
case of the type 1 lantibiotics, five such subgroups have been identified, each of 
which is named after the corresponding prototypical lantibiotic; the nisin-like, 
epidermin-like, Pep5-like, streptin-like and planosporocin-like lantibiotic 
subgroups (Rea et al., 2010; Piper et al., 2009). The nisin-like group is named for 
nisin A, which is the most extensively studied bacteriocin and is currently sold in 
more than 50 countries as a food preservative (Delves-Broughton, 2005). In 
addition to LanA, B and C, other proteins involved in the production of nisin A 
and other type 1 lantibiotics include LanP, a serine protease that cleaves the 
leader from the propeptide; LanT, an ABC transporter responsible for the 
transport of the lantibiotic precursor across the cell membrane; LanIEFG encode 
proteins involved in immunity; and LanK, a histidine kinase and LanR, a response 
regulator, that together operate as a two-component regulatory system. LanD 
enzymes, such as that responsible for the oxidative decarboxylation of C-
terminal cysteines in epidermin (Kupke et al., 1992), are less common. 
Given the broad antimicrobial spectrum of many lantibiotics, the 
possibility of applying lantibiotics in a medicinal capacity has become the 
subject of much attention. This is supported by an enhanced understanding of 
their mechanisms of action (Bierbaum and Sahl, 2009) and the dearth of novel 
antibiotics. Of the type 1 lantibiotics, nisin, mutacin and planosporicin have 
been shown to be active against multi-drug resistant gram-positive pathogens 
(Severina et al., 1998, Parrot et al., 1989, Castiglione et al., 2007), Pep5 and 
epidermin inhibit Staphylococcus epidermidis adhesion to catheters (Fontana et 
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al., 2006) and epidermin and gallidermin are active against Propionibacterium 
acnes (Kellner et al., 1988). Other lantibiotics, or their producer strains, have 
been used as food preservatives and as oral and gastrointestinal 
antimicrobials/probiotics (Cleveland et al., 2001, Wescombe et al., 2006, 
Wescombe et al., 2009). As a consequence of this increased interest in 
lantibiotics, a concerted effort has taken place to identify new and improved 
forms of these peptides. Culture-based screening strategies have in the past 
been responsible for the identification of lantibiotics produced by bacteria 
isolated from diverse microbial niches including the oral cavity, intestine, soil, 
kefir grains and milk (Dabard et al., 2001, Castiglione et al., 2007, Ryan et al., 
1996, Beasley and Saris, 2004, Hillman et al., 1998). Recently, an alternative 
means of identifying novel lantibiotics has emerged as a consequence of the 
increasing generation and availability of genomic and metagenomic sequence 
data. The availability of such information has recently led to the identification of 
the type 1 epidermin-like lantibiotic, Bsa (Daly et al., 2010) as well as type 2 
lantibiotics such as haloduracin (McClerren et al., 2006, Lawton et al., 2007), 
licheniciden (Begley et al., 2009, Dischinger et al., 2009), as well as a range of 
cyanobacteria-associated lantipeptides (Li et al., 2010). This has prompted the 
development of on-line tools and repositories such as BAGEL and BACTIBASE to 
facilitate such screening strategies (de Jong et al., 2006, de Jong et al., 2010, 
Hammami et al., 2007, Hammami et al., 2010). Notably, although an in-silico 
screen for lanM genes has recently resulted in the identification of 61 novel 
type 2 lantibiotic-like gene clusters (Begley et al., 2009), a corresponding screen 
for type 1 lantibiotics has not yet been described. Here we address this issue by 
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screening for clusters containing genes homologous to the nisin A biosynthetic 
genes nisB (representing lanB) and nisC (representing lanC). In each case, the 
regions flanking the newly identified lanB/lanC genes were subjected to further 
in-silico analysis to determine if they are potential lantibiotic/lantipeptide-
associated gene clusters. This included a search of nearby open reading frames 
(orfs) which might encode a corresponding LanA, defined as being of relatively 
short length (approx 60 amino acids) and containing an uneven distribution of 
cysteine, threonine and serine amino acids within the propeptide region. Using 
this approach, 27 novel type 1 lantibiotic/lantipeptide-encoding clusters were 
identified. Subsequent screening using the newly identified LanA, B and C 
homologs as driver sequences revealed a further 22 gene clusters, resulting in a 
total of 49 putative novel type 1 lantibiotic clusters. Significantly, many of these 
clusters are present in species, genera and phyla not previously associated with 
lantibiotic/lantipeptide production and are predicted to encode peptides which 
represent completely new type 1 subclasses.  
 
3.3 MATERIALS AND METHODS  
3.3.1 Screening of genomic databases 
Using the nisin modification enzyme NisC (GenBank accession number 
CAA79470) as a driver sequence, all fully sequenced genomic sequences 
(approx. 1178 at time of study; Dec 2009) were mined for homologs using 
Genomic-BLAST (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi). BLASTs 
were carried out with default parameters; criteria for homolog detection were a 
threshold of 1e-7 and greater than 20% identity.  
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3.3.2 Bioinformatic analysis of lanC-containing gene clusters 
In cases where novel lanC-like genes encoding enzymes were identified, the 
arrangement of adjacent genes was visualised using the genome viewer on 
NCBI, and individual orfs were subjected to BLAST analysis to identify those 
potentially involved in lantibiotic production or immunity. The predicted LanA, 
LanB and LanC proteins from these operons were each in turn used for further 
in-silico screens to determine their similarities to corresponding proteins 
associated with known lantibiotics and to identify additional novel clusters. In 
instances where a LanC- and LanB-, but not a LanA-, encoding gene were 
annotated, intergenic regions were inspected following translation by the 
Seqbuilder program of the DNASTAR Lasergene 8 software package to 
investigate the presence of potentially unidentified lanA genes. The tblastn 
program was then used to search all sequenced DNA for related peptides. 
 
3.2.3 Phylogenetic analysis 
Protein alignments were generated by MUSCLE (Edgar, 2004). Sequence 
alignment were viewed and edited for publication with Jalview alignment editor 
(Waterhouse et al., 2009). These alignments were used to establish 
phylogenetic trees in Phylip (Felsenstein, 1989) which were subsequently 
visualised using the Dendroscope package (Huson et al., 2007). 
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3.4 RESULTS AND DISCUSSION 
3.4.1 In-silico screen for lanC genes 
An in-silico screen for LanC homologues, using the NisC sequence as a driver, 
resulted in the identification of 56 homologues. Of these 7 have previously been 
associated with lantibiotic production, 11 were orphan homologs (in that no 
other lantibiotic-associated genes were identified in close association) (Table 1), 
9 were encoded within a cluster in which no lanA could be detected (Table 2) 
and one cluster contained two LanCs (but no structural peptide). The remaining 
27 potential lantibiotic/lantipeptide-encoding gene clusters all contained 
putative lanA, B and C genes (Table 3). The genes flanking the 27 novel lanC-like 
genes were subjected to further bioinformatic analysis to determine the 
presence of other orfs that share homology with genes linked to lantibiotic 
production or immunity. While these 27 clusters are the primary focus of this in-
silico analysis, the sequences of the newly identified LanA, B and C proteins 
associated with these clusters were in turn used for further in-silico screens. 
This approach uncovered an additional 22 clusters (Table 4) that were also 
predicted to be novel lantibiotic/lantipeptide-encoding clusters, thereby 
yielding a total of 49 novel type 1 clusters. 
All except one of the 27 gene clusters revealed following the initial 
screen were located within the genomes of Firmicutes and Actinobacteria. The 
exception was Chitinophaga pinensis DSM 2588 of the phylum Bacteroidetes. Of 
the other 26, the genera most commonly associated with lantibiotic production 
were Bacillus, Geobacillus, Clostridium, Enterococcus, Streptococcus, Frankia 
and Streptomyces. In many cases the novel clusters associated with a specific  
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Table 1. A selection of bacterial genomes in which isolated genes encoding 
LanA, LanB or LanC homologs were identified. 
 
Clusterless Homologs Accession No. LanA only LanB only LanC only 
Anoxybacillus flavithermus 
WK1 
NC_011567  Aflv_2440  
Bacillus sp. B14905 NZ_AAXV00000000  BB14905_21668  
Paenibacillus larvae subsp. 
larvae BRL-230010 
NZ_AARF00000000   Plarl_010100024193 
Lactobacillus crispatus MV-1A-
US 
NZ_ACOG00000000   HMPREF0507_00422 
Lactobacillus crispatus JV-V01 NZ_ACKR00000000   HMPREF0506_0642 
Haliangium ochraceum DSM 
14365 
NC_013440   Hoch_3102 
Haliangium ochraceum DSM 
14365 
NC_013440   Hoch_4144 
Haliangium ochraceum DSM 
14365 
NC_013440  Hoch_0066  
Pedobacter sp. BAL39 NZ_ABCM00000000  PBAL39_02527  
Peptoniphilus lacrimalis 315-B NZ_ADDO00000000  HMPREF0628_0526  
Peptoniphilus lacrimalis 315-B NZ_ADDO00000000  HMPREF0628_0527  
Lactococcus lactis subsp. lactis 
KF147 
NC_013656    
Frankia alni ACN14a NC_008278  FRAAL2701  
Frankia sp. CcI3 NC_007777   Francci3_0205 
Frankia sp. CcI3 NC_007777   Francci3_3997 
Peptoniphilus lacrimalis 315-B NZ_ADDO00000000  HMPREF0628_0527  
Bifidobacterium longum subsp. 
infantis ATCC 15697 
NC_011593    
Streptomyces sp. AA4 NZ_ACEV00000000    
Streptococcus pneumoniae 
CGSP14 
NC_010582    
Saccharopolyspora erythraea 
NRRL 2338 
NZ_ABFV00000000   SACE_4959 
Kordia algicida OT-1 NZ_ABIB00000000   KAOT1_07113 
Streptococcus dysgalactiae 
GGS_124 
NC_012891   SDEG_0295 
Microscilla marina ATCC 
23134 
NZ_AAWS00000000  M23134_07394  
Microscilla marina ATCC 
23134 
NZ_AAWS00000000  M23134_05752  
Microscilla marina ATCC 
23134 
NZ_AAWS00000000  M23134_07275  
Microscilla marina ATCC 
23134 
NZ_AAWS00000000  M23134_01545  
Microscilla marina ATCC 
23134 
NZ_AAWS00000000   M23134_07404 
Streptomyces sp. Mg1 NZ_ABJF00000000  SSAG_05771  
Frankia sp. EuI1c NZ_ADDL00000000 FraEuI1cDRAFT_6351   
Geobacillus sp. Y412MC52 NZ_ACNM00000000 GYMC52DRAFT_3129   
Geobacillus sp. Y412MC61 NC_013411 GYMC61_1158   
Streptococcus pyogenes M1 
GAS 
NC_002737 SPy_1083   
Streptomyces griseus subsp. 
griseus NBRC 13350 
NC_010572   SGR_6574 
Clostridium kluyveri DSM 555 NC_009706   CKL_3505 
Spirosoma linguale DSM 74 NC_013730  Slin_0903  
Spirosoma linguale DSM 74 NC_013730   Slin_2131   
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Table 2. Gene clusters encoding LanB and LanC, but not LanA, homologs 
 
Species (Cluster No.) Accession No. LanB LanC 
Frankia alni ACN14a I NC_008278 FRAAL2701  FRAAL2700 
Frankia sp. CcI3 IV NC_007777 Francci3_2033 Francci3_2032  
Frankia EAN1pec II NC_009921 Franean1_2799 Franean1_2800 
Frankia sp. EuI1c II NZ_ADDL00000000 FraEuI1cDRAFT_6786 FraEuI1cDRAFT_6785 
Bacillus clausii KSM-K16 NC_006582 ABC3559 ABC3558 
Clostridium cellulovorans 743B  NZ_ACPD00000000 ClocelDRAFT_0447 ClocelDRAFT_0445 / _0452 
Bacillus cereus AH1273 NZ_ACMT00000000 bcere0030_58380 bcere0030_58400 
Bacillus thuringiensis serovar berliner 
ATCC 10792 
NZ_ACNF00000000 bthur0008_53920 bthur0008_53930 
Bacillus thuringiensis IBL 200 NZ_ACNK00000000 bthur0013_59170 bthur0013_59180 
Streptococcus  pyogenes MGAS9429 NC_008021 MGAS9429_Spy0926 MGAS9429_Spy0924 
Catenulispora acidiphila DSM 44928  NC_013131 Mentioned; Caci_4205 Caci_4204 
Frankia sp Cc13 V NC_007777 Francci3_3530 Francci3_3531 
Microscilla marina ATCC 23134  NZ_AAWS00000000 M23134_05752   M23134_05756  
Staphylococcus capitis SK14 NZ_ACFR00000000 STACA0001_2327 STACA0001_2326  
Streptomyces sp. Mg1 I NZ_ABJF00000000 SSAG_03540 SSAG_03541 
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Table 3. Bacterial genomes in which 27 uncharacterised type 1 lantibiotic 
clusters were identified following a NisC-led in-silico screen  
 
Species (Cluster No.) Accession No.  
Frankia alni ACN14a (II) NC_008278 
Frankia sp Cc13 (I) NC_007777 
Frankia sp Cc13 (II) NC_007777 
Frankia sp Cc13 (III) NC_007777 
Frankia EAN1pec (I) NC_009921 
Frankia EAN1pec (III) NC_009921 
Frankia sp. EuI1c (I) NZ_ADDL00000000 
Salinispora arenicola CNS-205* NC_009953 
Stackebrandtia nassauensis DSM 44728 (I) NC_013947 
Stackebrandtia nassauensis DSM 44728 (II) NC_013947 
Streptomyces clavuligerus ATCC 27064 (I) NZ_ADGD00000000 
Streptomyces clavuligerus ATCC 27064 (II) NZ_ADGD00000000 
Streptomyces coelicolor A3(2) (I) NC_003888 
Streptomyces coelicolor A3(2) (II) NC_003888 
Streptomyces sp. Mg1 (II) NZ_ABJF00000000 
Streptomyces griseoflavus Tu4000 (I) NZ_ACFA00000000 
Streptomyces griseoflavus Tu4000 (II) NZ_ACFA00000000 
Streptomyces griseoflavus Tu4000 (III) NZ_ACFA00000000 
Bacillus cereus F65185  NZ_ACMO00000000 
Bacillus mycoides DSM 2048 NZ_ACMU00000000 
Clostridium perfringens CPE str. F4969 NZ_ABDX00000000 
Enterococcus faecalis Fly1 NZ_ACAR00000000 
Geobacillus kaustophilus HTA426 NC_006510 
Geobacillus thermodenitrificans NG80-2  NC_009328 
Geobacillus sp. G11MC16 NZ_ABVH00000000 
Streptococcus thermophilus LMG 18311*  NC_006448 
Chitinophaga pinensis DSM 2588 I NC_013132 
 
*The existence of a lantibiotic gene cluster within these strains has been referred to briefly, (Penn 
et al., 2009) and (Bolotin et al., 2004, Liu et al., 2009) respectively, but these clusters have not 
been the focus of a detailed bioinformatic analysis.  
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Table 4. Bacterial genomes in which 22 additional type 1 lantibiotic gene 
clusters were identified following an in-silico screen using the LanA, B, and C 
homologs, corresponding to the clusters referred to in Table 3, as leader 
sequences. 
 
Species (Cluster No.) Accession No. 
Thermomonospora curvata DSM 43183 NC_013510 
Frankia EAN1pec (IV) NC_009921 
Streptomyces viridochromogenes DSM 40736 NZ_ACEZ00000000 
Streptomyces sp. SPB74  NZ_ABJG00000000 
Streptomyces lividans TK24  NZ_ACEY00000000 
Catenulispora acidiphila DSM 44928 NC_013131 
Streptomyces sp. Mg1 (III) NZ_ABJF00000000 
Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111  NZ_ABUI00000000 
Micromonospora aurantiaca ATCC 27029 (I) NZ_ADBZ00000000 
Micromonospora aurantiaca ATCC 27029 (II) NZ_ADBZ00000000 
Bacillus cereus AH1272 NZ_ACMS00000000 
Staphylococcus aureus subsp. aureus D139  NZ_ACSR00000000 
Staphylococcus aureus subsp. aureus H19 NZ_ACSS00000000 
Actinomyces sp. oral taxon 848 NZ_ACUY00000000 
Parachlamydia acanthamoebae str. Hall's coccus NZ_ACZE00000000 
Corynebacterium lipophiloflavum DSM 44291 NZ_ACHJ00000000 
Staphylococcus aureus A9765  NZ_ACSN00000000 
Chitinophaga pinensis DSM 2588 (II) NC_013132 
Spirosoma linguale DSM 74 NC_013730 
Pedobacter heparinus DSM 2366  NC_013061 
Kordia algicida OT-1  NZ_ABIB00000000 
Microscilla marina ATCC 23134 NZ_AAWS00000000 
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genus, such as those found on the Streptomyces and Frankia genomes, showed 
at least some similarity to each other. It was also noted that several of the 
genomes in which a cluster was located also contained an additional cluster(s) 
(Table 3), or other genes predicted to encode additional LanA, B or C proteins 
(Table 2), elsewhere in the genome. The 27 clusters are described below and 
are grouped according to the phylum and genus of the associated strain. 
 
3.4.2 Type 1 lantibiotic gene clusters in Actinobacteria  
3.4.2.1 Identification of novel Frankia-associated lantibiotic gene clusters 
The Frankia are nitrogen-fixing, root nodule-forming filamentous Actinobacteria 
that live in symbiosis with actinorhizal plants. All species of Frankia are closely 
related (Normand et al., 2007). To date, four Frankia genomes have been 
sequenced, i.e. Frankia alni ACN14a, Frankia sp. EAN1pec, Frankia sp. Cc13 and 
Frankia sp. EUI1c, and although no Frankia-associated bacteriocins have 
previously been reported, a number of predicted lantibiotic clusters can be 
found in each case (Figure 1) in addition to a number of apparently LanB- and 
LanC-encoding genes which do not have an accompanying lanA (Table 2). This 
latter phenomenon could be a result of the frequent rearrangements which 
occur in Frankia strains (Normand et al., 2007). Of the clusters identified, many 
resemble clusters associated with another genus of Actinobacteria, the 
Streptomyces.  
 
Frankia alni ACN14a: The genome sequence of F. alni ACN14a (Normand et al., 
2007) contains one complete cluster, F. alni ACN14a II which includes the  
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Figure 1 
Diagrammatic representation of the non-Streptomyces Actinobacteria type 1 
lantibiotic operons, identified in the first round of screening, which contain 
genes predicted to encode a structural peptide LanA, and the modification 
enzymes LanB and LanC. Structural peptides are coloured in black, dehydratases 
in red, synthetases in green and other ORFs in blue.  
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predicted LanA prepropeptide, FRAAL6345, FRAAL6344 and FRAAL6343 
(encoding a putative LanB and LanC, respectively). The LanA peptide does not 
resemble any of the previously characterised type 1 lantibiotic propeptides but 
is 79% identical to Franean1_0057 of Frankia sp. EAN1pec (see below). The LanB 
and LanC proteins resemble those associated with other Frankia, as well as 
Streptomyces, clusters. The LanC protein is also 62% identical to Tcur_4648 of 
Thermomonospora curvata DSM 43183 (NC_013510), which itself appears to be 
encoded by an orf within a novel lantibiotic gene cluster. The ACN14a II cluster 
is also predicted to encode two proteins which share homology with O-
methyltransferases (FRAAL6342 and FRAAL6346). O-methyltransferases 
contribute to the production of a number of non-ribosomal antibiotics (Li et al., 
2009, Tsukada et al., 2010) and catalyse the methylation of hydroxyl group(s) on 
deoxysugar rings to protect the reactive hydroxyl group from undesired 
modifications and can alter the solubility and pharmacokinetic properties of the 
resulting molecule (Zubieta et al., 2001). Although O-methyltransferases have 
not previously been associated with lantibiotic production, this study reveals 
that many Actinobacteria-associated type 1 clusters possess genes predicted to 
encode these enzymes.  
 
Frankia sp. Cc13: The Frankia sp. Cc13 genome (Normand et al., 2007) contains 
three gene clusters of interest (Frankia sp. Cc13 I, Frankia sp. Cc13 II and 
Frankia sp. Cc13 III). Two O-methyltransferase-encoding genes were identified 
in each case and it was noted that the associated LanB and LanC proteins are 
similar to one another and to numerous others predicted to be produced by 
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Frankia and Streptomyces species. In contrast, there is a lack of homology 
between the three lanA genes. The lanA gene from cluster I was not previously 
annotated and was only identified following closer inspection of the DNA 
sequence. The cluster II-associated LanA, Francci3_1820, most closely 
resembles Frankia sp. EuI1c FraEuI1cDRAFT_6351 (69% identity) while the third, 
and also previously unannotated LanA appears to be one of an extended group 
of Frankia- and Streptomyces-associated LanAs that includes Frankia sp. EuI1c 
FraEuI1cDRAFT_1582 (56% identity). 
 
Frankia EAN1pec: The Frankia EAN1pec genome (Normand et al., 2007) 
contains 4 putative LanB-encoding genes three of which correspond to potential 
lantibiotic/lantipeptide-associated gene clusters (Frankia EAN1pec I, Frankia 
EAN1pec III and Frankia EAN1pec IV) which again resemble those of 
Streptomyces and other Frankia species, and contain O-methyltransferase-
encoding genes. Within the first cluster, a putative LanA prepropeptide, 
encoded by a previously unannotated orf located between Franean1_1331 and 
the LanB determinant, is homologous to a number of other LanAs, including 
Sare_0601 of Salinispora arenicola CNS-205 (55% identity). The cluster is also 
noteworthy be virtue of the presence of two LanC-encoding genes, 
Franean1_1333 and Franean1_1336. Within Frankia EAN1pec III, the LanA 
peptide, encoded by Franean1_6756 is 42% identical to FraEuI1cDRAFT_6351 of 
Frankia sp. EuI1c while finally, a screen using F. alni ACN14a FRAAL6345 as a 
driver led to the identification of yet another cluster (consisting of at least 
Franean1_0057-0055) which closely resembles cluster II of F. alni ACN14a II. 
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Frankia sp. EuI1c: Frankia sp. EuI1c contains a single putative 
lantibiotic/lantipeptide gene cluster (Frankia sp. EuI1c I) which again contains 
LanB, C and O-methyltransferase genes typical of Frankia and Streptomyces 
clusters. The associated LanA homolog (FraEuI1cDRAFT_1582) is notable by 
virtue of being 46% identical to SSCG_03316, a known LanA of Streptomyces 
clavuligerus ATCC 27064 while a gene encoding an ABC transporter related 
protein (FraEuI1cDRAFT_1578) is also present.  
 
3.4.2.2 Identification of novel Salinispora -associated lantibiotic gene clusters 
Salinispora are marine Actinobacteria. There are two recognised species, S. 
tropicalis and S. arenicola. Representatives have been sequenced in each case 
and genes predicted to encode non-lantibiotic bacteriocins have been identified 
in both cases (Penn et al., 2009). The existence of a putative 
lantibiotic/lantipeptide cluster, between Sare_0602 and Sare_0623, in the 
genome of S. arenicola CNS-205 was noted previously (Penn et al., 2009). 
However, this cluster has not been the subject of a detailed bioinformatic 
characterisation. Our analysis reveals that Sare_0601 apparently encodes a 
LanA peptide which is 88% identical to that encoded by MicauDRAFT_5818 of 
Micromonospora aurantiaca ATCC 27029. The proteins encoded by Sare_0602 
(LanB) and Sare_0603 (LanC) also resemble other ATCC 27029-associated 
proteins (encoded by MicauDRAFT_5819 (71% identity) and MicauDRAFT_5820 
(75% identity)), thereby revealing an additional novel cluster in 
 - 111 - 
Micromonospora, a genus better known for its production of non-ribosomal 
antibiotics such gentamycin and netamycin (Berdy, 2005)  (Table 4).  
 
3.4.2.3 Identification of novel Stackebrandtia-associated lantibiotic gene 
clusters 
Stackebrandtia are aerobic, non-motile Actinobacteria which have been isolated 
from soil (Labeda and Kroppenstedt, 2005). There are only 2 associated species 
i.e. S.  albiflava and S. nassauensis and in-silico analysis of S. nassauensis DSM 
44728 (NC_013947) reveals the presence of two similar clusters (S. nassauensis 
DSM 44728 I and S. nassauensis DSM 44728 II) (Figure 1). The hypothetical 
LanA, encoded by Snas_5416, of the first cluster showed a singular homology of 
78% identity to Snas_3601 of the second cluster. The corresponding LanBs 
(Snas_5417 and Snas_3602) are 62% identical while the LanCs (Snas_5418 and 
Snas_3603) are 68% identical.  
 
3.4.2.4 Identification of novel Streptomyces-associated lantibiotic gene 
clusters 
Bacteria from the genus Streptomyces, comprising over 500 species, are 
filamentous, high G-C bacteria found frequently in soil and rotting vegetation. 
They are the most numerous and ubiquitous soil bacteria (Hodgson, 2000). 
Streptomyces are also responsible for the production of over two-thirds of the 
clinically useful antibiotics of natural origin (e.g., neomycin, chloramphenicol) 
(Watve et al., 2001). Although a number of Streptomyces-associated 
bacteriocins, such as ancovenin (Kido et al., 1983) and cinnamycin (Widdick et 
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al., 2003), have been identified, this number is relatively small considering the 
size of the genus. As was apparent above, our in-silico analysis has revealed that 
many Streptomyces possess potentially lantibiotic-encoding gene clusters which 
resemble those found in Frankia. Once again, the majority of these clusters 
contain O-methyltransferases (Figure 2). 
 
Streptomyces clavuligerus ATCC 27064: S. clavuligerus is an aerobic, mesophillic 
Streptomyces sp.. While there have been no previous reports of bacteriocin 
production by this species, two lantibiotic clusters were found to be present on 
the genome of S. clavuligerus ATCC 27064. In the first of these clusters, the 
associated hypothetical LanA, B and C proteins (SSCG_01498-01496) are 63%, 
42% and 50% identical to the corresponding proteins of Frankia sp. CcI3 II. 
BLAST analysis of these proteins also revealed another novel cluster in 
Streptomyces viridochromogenes DSM 40736 corresponding to SvirD4_23440 
(LanA; 50% identity), SvirD4_23449 (LanB; 36% identity) and SvirD4_23454 
(LanB; 45% identity) (Table 4). The second S. clavuligerus cluster, which contains 
SSCG_03316 (LanA), SSCG_03317 (LanB) and SSCG_03318 (LanC), resembled 
clusters present in a number of other strains such as that of Streptomyces 
griseus subsp. griseus NBRC 13350 (Ohnishi et al., 2008) (73%, 56% and 64% 
identity, respectively). BLAST analysis of these sequences also led to the 
identification of yet another novel cluster in Streptomyces sp. SPB74 
(SSBG_01041 [LanA] 69% identity and SSBG_01042 [LanB] 58% identity).  
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Figure 2 
Diagrammatic representation of the Streptomyces type 1 lantibiotic operons, 
found in the original NisC screen, which contain genes predicted to encode a 
structural peptide LanA, and the modification enzymes LanB and LanC. 
Structural peptides are coloured in black, dehydratases in red, synthetases in 
green and other ORFs in blue. 
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Streptomyces coelicolor A3(2): Streptomyces coelicolor A3(2) (NC_003888) is the 
best characterised representive of its genus (Hopwood, 1999) and was the first 
Streptomyces strain to have its genome sequenced (Bentley et al., 2002). 
Although bacteriocins/bacteriocin-like peptides are known to be produced by 
this species (e.g. the class III morphogenic peptide SapB (Kodani et al., 2004)), 
such peptides have not previously been associated with this strain. Here BLAST 
analysis revealed the presence of two lantibiotic/lantipeptide clusters (S. 
coelicolor A3(2) I and S. coelicolor A3(2) II). The first of these clusters, containing 
SCO0268 (LanA), SCO0269 (LanB) and SCO0270 (LanC), very closely resembles 
Streptomyces griseoflavus Tu4000 cluster II (see below). Subsequent BLAST 
searches with the A3(2) cluster I-associated proteins led in turn to the discovery 
of an almost identical cluster in Streptomyces lividans TK24 which contains 
SSPG_07329 (LanA; 100% identity), SSPG_07328 (LanB; 99% identity) and 
SSPG_07327  (LanC; 100% identity) (Table 4). The second cluster, Streptomyces 
coelicolor A3(2) II, is predicted to encode two LanA peptides, (SCO6932 [43aa] 
and SCO6931 [59aa]) which are 97% identical to each other, as well as LanB 
(SCO6930) and LanC (SCO6929) proteins with homology (39-46% identity) with 
corresponding proteins associated with Frankia sp. CcI3. Such analysis also 
revealed another cluster of interest in the actinomycete, Catenulispora 
acidiphila DSM 44928 (NC_013131; [Table 4]). 
 
Streptomyces griseoflavus Tu4000: Three lantibiotic/lantipeptide clusters were 
identified on the genome of this anaerobic, terrestrial Streptomyces. Although 
the LanA encoded within the first cluster (SgriT_010100000925) does not 
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significantly resemble any other protein, the associated LanB 
(SgriT_010100000920) and LanC (SgriT_010100000915) proteins are 
homologous to the corresponding proteins of S. coelicolor A3(2) cluster I and 
Tu4000 cluster II. BLAST searches using the cluster I proteins as drivers also 
resulted in the identification of several additional clusters in Nocardiopsis 
dassonvillei DSM 43111 (NdasDRAFT_3161 [LanB] 30% identity), Streptomyces 
sp. Mg1 (SSAG_05771 [LanB] 37% identity) and two clusters on the genome of 
M. aurantiaca ATCC 27029 (NZ_ADBZ00000000; MicauDRAFT_5820 and 
MicauDRAFT_3008 [both LanBs] 35% identity). In addition to the components of 
the second cluster referred to above, an associated LanA (SgriT_010100036309) 
was also noted. In addition to the Tu4000 I and A3(2) I clusters, this cluster is 
also highly identical to that of S. lividans TK24 (SSPG_07329 [LanA] 97% identity; 
SSPG_07328 [LanB] 87% identity and SSPG_07327 [LanC] 89% identity). The 
LanA associated with the final cluster (SgriT_010100029766) again bears no 
homology with any other known peptides whereas the LanB 
(SgriT_010100029771) and LanC (SgriT_010100029776) corresponded to those 
of Frankia sp. EAN1pec II (39% and 44% identity, respectively).  
 
3.4.3 Type 1 lantibiotic gene clusters in Firmicutes 
3.4.3.1 Identification of novel Bacillus-associated lantibiotic gene clusters 
Bacillus is a large and diverse genus of rod-shaped, sporulating, facultative 
aerobes which contains some pathogenic species. A number of type 1 
lantibiotics have previously been characterized in this genus (e.g. subtilin (Nishio 
et al., 1983) and ericin (Stein et al., 2002)). The NisC-driven screen highlighted 
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the presence of a type 1 lantibiotic cluster in the genomes of two Bacillus 
strains i.e. Bacillus cereus F65185 and Bacillus mycoides DSM 2048 (Figure 3). 
Bioinformatic analysis of these clusters revealed two further clusters in B. 
cereus ATCC 14579 and B. cereus AH1272.  
 
Bacillus cereus F65185: B. cereus F65185 is a mesophilic bacterium sourced 
from a human wound containing one lantibiotic/lantipeptide cluster which is 
unusual in that 3 orfs separate the putative LanB and C genes and the two have 
a divergent orientation. The predicted LanA (bcere0025_48310) does not 
resemble any other known lantibiotic prepropeptides. The LanB homolog 
(bcere0025_48320) resembles a putative LanB associated with Clostridium 
cellulovorans 743B (ClocelDRAFT_0452, 30% identity) while the predicted LanC 
(bcere0025_48280) most closely resembles two further 743B proteins 
(ClocelDRAFT_0452, 34% identity and ClocelDRAFT_0446, 28% identity). 
However the 743B strain lacks an associated LanA. Further BLAST analysis with 
the F65185-associated LanB highlighted the presence of a related protein within 
thiocillin-encoding gene cluster in B. cereus ATCC 14579 (Brown et al., 2009).  
 
Bacillus mycoides DSM 2048: B. mycoides is a non-motile, non-pathogenic, 
saprophytic Bacillus, strains of which have been investigated with a view to 
their application as biological pesticides. Although representatives of this 
species have been associated with bacteriocin production (Sharma and Gautam, 
2008), there are no published reports of lantibiotic-producing B. mycoides. The 
DSM 2048 genome contains a lantibiotic/lantipeptide cluster that contains  
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Figure 3 
Diagrammatic representation of the Firmicutes type 1 lantibiotic operons, found 
in the original NisC screen, which contain genes predicted to encode a structural 
peptide LanA, and the modification enzymes LanB and LanC. Structural peptides 
are coloured in black, dehydratases in red, synthetases in green and other ORFs 
in blue. 
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putative lanA, B, C and other lantibiotic-associated genes which is very similar to 
other novel clusters in B. cereus AH1272 and B. cereus AH1273. 
Bmyco0001_53830 is the predicted prepropeptide and is 100% identical to the 
products of the B. cereus AH1272-associated bcere0029_28240 and 
bcere0029_28250. It is also 58% identical to prepropeptides associated with 
several Staphylococcus-associated Bsa lantibiotics, such as BsaA2RF122 of S. 
aureus RF122 (Daly et al., 2010). It is thus apparent that the LanA is a member 
of the epidermin-like peptides. In addition to homologues in B. cereus AH1273 
and AH1272, use of the DSM 2048-associated LanB and LanC sequences as 
drivers also surprisingly highlighted a gene cluster present in Actinomyces sp. 
oral taxon 848 (Table 4). In addition to homology with respect to LanB and LanC 
proteins (HMPREF0972_00932 and HMPREF0972_00933, respectively), the 
proposed LanA (HMPREF0972_00931; 86aa) is 43% identical to 
bmyco0001_53830 and bcere0029_28240 and bcere0029_28250 of Bacillus 
mycoides DSM 2048 and Bacillus cereus AH1272, respectively. 
 
3.4.3.2 Identification of novel Clostridium-associated lantibiotic gene clusters 
The Clostridia are gram postitive anaerobic, endospore-forming Firmicutes of 
which there are approximately 100 species. These include important pathogens 
such as Clostridium difficile, Clostridium perfingens and Clostridium tetani. 
Several Clostridium-associated bacteriocins have been characterised from this 
genus (Dineen et al., 2000, Li et al., 1982, Nieves and Castillo, 1982), but no type 
1 lantibiotic producers have been identified to date. Here, bioinformatic 
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analysis revealed one Clostridium-associated lantibiotic/lantipeptide cluster, 
located on the genome of C. perfringens CPE str. F4969 (Figure 3).  
 
C. perfringens CPE str. F4969: C. perfringens is one of the leading causes of food-
borne illness in the developed world. It can also be responsible for wound and 
surgical infections (Narayan, 1982, Pearson et al., 1980). The predicted LanA 
(AC5_A0201) of strain F4969 is most closely related to the LanAs of B. mycoides 
DSM 2048 and B. cereus AH1272 (51% identity) while the proteins encoded by 
AC5_A0200 (LanB) and AC5_A0198 (LanC) most closely resemble proteins 
associated with Geobacillus sp. G11MC16 (G11MC16DRAFT_2954 and 
G11MC16DRAFT_2952; 34% and 35% identity respectively). Surprisingly, BLAST 
analysis also highlighted the presence of a related LanB homolog encoded 
within a lantibiotic/lantipeptide-like gene cluster in the genome of 
Parachlamydia acanthamoebae (phlylum Chlamydiae) str. Hall's coccus 
(pah_c028o031; 25% identity). Adjacent genes of note within the P. 
acanthamoebae cluster include pah_c028o029 (LanA) and pah_c028o030 
(LanC).  
 
3.4.3.3 Identification of novel Enterococcus-associated lantibiotic gene clusters 
The enterococci are gram positive lactic acid bacteria which are common 
commensal organisms in the intestines of humans but can also be pathogens. 
Many Enterococcus-associated bacteriocins (enterocins) have been identified 
(Franz et al., 2007). Only one Enterococcus-associated lantibiotic, the type 2 
peptide cytolysin, has been identified to date (Booth et al., 1996). Here we 
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describe genes which potentially encode the first type 1 Enterococcus-
associated lantibiotic (Figure 3). 
 
Enterococcus faecalis Fly1: E. faecalis Fly1 (NZ_ACAR00000000) is a non-motile, 
facultative anaerobe. Within its genome we identified a previously unannotated 
LanA determinant, through analysis of raw sequence data. The corresponding 
peptide is homologous to C. perfringens CPE str. F4969 (AC5_A0201; 68% 
identity), as well as a number of epidermin-like LanAs in other bacilli. The 
putative LanB protein is split across two orfs, EFKG_00402 (80 amino acids) and 
EFKG_0403 (942 amino acids), with both components most closely resembling 
the N-terminus of the dehydratase of Streptococcus pyogenes MGAS10270, 
MGAS10270_Spy0922. It is unclear whether the apparent frameshift in the Fly1 
lanB is genuine or the result of a sequencing error. The LanC-like EFKG_00405, 
was most closely related to the corresponding protein in G. thermodenitrificans 
NG80-2 (SpaC GTNG_0268; 35% identity).  
 
3.4.3.4 Identification of novel Geobacillus-associated lantibiotic gene clusters 
Geobacilli are thermophillic (45-70oC), aerobic, spore-forming Firmicutes. They 
have been isolated from various terrestrial and marine environments, in 
geothermal, temperate and permanently cold habitats. Reclassified in 2001 
(Nazina et al., 2001), these bacteria are of industrial interest as sources of 
thermostable enzymes. Bacteriocins have been identified in Geobacillus 
stearothermophilus (Pokusaeva et al., 2009) and Geobacillus thermoleovorans 
(Novotny and Perry, 1992), and while screening for LanM-producing gene 
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clusters has highlighted the potential existence of a number of type 2 
lantibiotics (Begley et al., 2009), associated type 1 lantibiotics have not 
previously been described. Here, three putative type 1 lantibiotic/lantipeptide-
encoding clusters within the genomes of Geobacillus kaustophilus HTA426, 
Geobacillus thermodenitrificans NG80-2 and Geobacillus sp. G11MC16 (Figure 3) 
are described. 
 
Geobacillus kaustophilus HTA426: G. kaustophilus grows optimally in aquatic 
environments at 60°C with an upper temperature limit of 74°C. From a 
lantibiotic persepective, genome sequencing of HTA426 revealed a hypothetical 
protein annotated as a ‘lantibiotic precursor’ GK0294. Our analysis revealed 
that this putative LanA is 91% identical to another prepropeptide encoded by 
the closely located GK0286 gene. It is also 100% identical to orphan ‘lantibiotic 
precursor’ homologs (GYMC52DRAFT_3129 and GYMC61_1158) in Geobacillus 
sp. Y412MC52 and Geobacillus sp. Y412MC61, respectively. More distantly 
related LanAs (79% identity) are also associated with the genomes of 
Geobacillus thermodenitrificans NG80-2 (GTNG_0265) and Geobacillus sp. 
G11MC16 (G11MC16DRAFT_2956). The homology between the Geobacillus 
LanAs is highest within the leader regions, but, as is the case with nisin-, 
epidermin- and streptin-like lantibiotics, a conserved serine and CTPGC motif in 
the N-terminus of the propeptide is present, which is believed to be involved in 
the binding of these lantibiotics to lipid II in the cell wall in gram positive 
bacteria (Hsu et al., 2004). BLAST analysis of the GK0286-encoded LanA 
highlighted the presence of another potential lantibiotic/lantipeptide cluster in 
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Corynebacterium lipophiloflavum DSM 44291 (57% identity with 
HMPREF0298_1795). Within the HTA426 cluster, the proteins predicted to be 
encoded by GK0300/301 (an apparently frameshifted lanB) and GK0304 are 
homologous to those associated with many other geobacilli. It was also noted 
that this cluster is less condensed than typical lantibiotic gene clusters in that 
there are insertions of 7, 5 and 3 genes (predicted to encode many transposases 
and small, hypothetical proteins) between the lantibiotic associated genes.  
 
Geobacillus thermodenitrificans NG80-2 and Geobacillus sp. G11MC16: G. 
thermodenitrificans are facultative soil bacteria with denitrification qualities. 
Representatives of this species grow between 45°C and 73°C (optimum 65°C). 
NG80-2 was isolated from a deep-subsurface oil reservoir in Dagang oilfield, 
Northern China (Feng et al., 2007) and on the basis of in-silico analysis is 
potentially the producer of both a type 1 (see below) and type 2 lantibiotic 
(Begley et al., 2009). Our analysis reveals that the type I lantibiotic/lantipeptide 
operons in G. thermodenitrificans NG80-2 and Geobacillus sp. G11MC16 are 
very highly conserved. The two LanAs are 100% identical and the homology 
between these, and indeed the associated B and Cs, and the corresponding G. 
kaustophilus HTA426 proteins is discussed above. It was noted that the lanB of 
Geobacillus sp. G11MC16 is apparently frameshifted (G11MC16DRAFT_2955 
(176aa) and G11MC16DRAFT_2954 (848aa)) but that this is not the case in G. 
thermodenitrificans NG80-2 (GTNG_0266).  
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3.4.3.5 Identification of novel Staphylococcus-associated lantibiotic gene 
clusters 
The staphylococci are non-sporeforming, non-motile Firmicutes. The genus 
Staphylococcus contains 33 species, most of which are harmless and reside 
normally on the skin and mucous membranes of humans and other organisms. 
However, staphylococci can also cause a wide variety of diseases either through 
toxin production or penetration and are a common cause of food poisoning and 
nosocomial infections. Several strains of Staphylococcus epidermidis have been 
shown to be producers of type 1 lantibiotics, including epidermin (Allgaier et al., 
1985), Pep5 (Kaletta et al., 1989), epicidin 280 (Heidrich et al., 1998) and 
epilancin K7 (Vandekamp et al., 1995), gallidermin was isolated from S. 
gallinarum (Kellner et al., 1988) while Staphylococcin Au26 (Scott et al., 1992) 
and Bsa (Daly et al., 2010) were isolated from S. aureus. BLAST analysis has 
revealed that several other S. aureus strains possess gene clusters similar to 
those associated with Bsa and BsaRF122 (Daly et al., 2010). These clusters were 
identified in S. aureus A9765, D139 and H19. In A9765, SAPG_01762 and 
SAPG_01760 correspond to the BsaA1 and BsaA2 peptides of S. aureus MW2 
(97% and 100% identity, respectively). The precursor peptides of the D139 
(SATG_00575 and SATG_00574; 76% identical to each other) and H19 
(SAUG_01228 and SAUG_01229; 76% identical to each other) strains are 100% 
identical. The peptides encoded by SATG_00575 and SAUG_01229 are 93% 
identical to BsaA1RF122 of S. aureus RF122 (93% identity) while those 
corresponding to SATG_00574 and SAUG_01228 are 100% identical to 
BsaA2RF122.  
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3.4.3.6 Identification of novel Streptococcus-associated lantibiotic gene 
clusters 
These facultative anaerobes of the phylum Firmicutes are spherical in shape and 
grow in long chains. Many species are part of the normal commensal flora of 
the mouth, skin, intestine and upper respiratory tract of humans but the genus 
also includes numerous human pathogens such as Streptococcus pneumoniae, 
pyogenes and agalactiae. The streptococci are known to be producers of type 1 
lantibiotics (Geis et al., 1983, Nes et al., 2007), such as streptin (Wescombe and 
Tagg, 2003), some mutacins (MotaMeira et al., 1997, Hillman et al., 1998, Qi et 
al., 1999, Qi et al., 2000), nisin U and nisin U2 (Wirawan et al., 2006), as well as 
several non-lantibiotic bacteriocins. Here we discuss two clusters, identified in 
strains of S. pyogenes and S. thermophilus LMG 18311.  
 
Streptococcus pyogenes MGAS10270: S. pyogenes (or Group A Streptococcus, 
GAS) is the cause of many important human diseases ranging from mild 
superficial skin infections to life-threatening systemic diseases. Bacteriocin 
production by these strains may give them a competitive advantage against the 
natural skin microbiota. It has previously been established that many S. 
pyogenes strains, as well as strains of Streptococcus salivarius, produce the type 
2 lantibiotic salivaricin A or closely related variants (Wescombe et al., 2006). The 
type 1 streptins (1 and 2) and type 2 streptococcin A-FF22 are also S. pyogenes 
associated (Wescombe and Tagg, 2003, Hynes et al., 1993). Here our analysis 
focuses on a type 1 cluster within the genome of S.  pyogenes MGAS10270 
(Beres et al., 2006). This includes MGAS10270_Spy0919, which is 100% identical 
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to the propeptide sequence of streptin. While this lantibiotic is thus not novel, 
subsequent BLAST searches were revealing in that they highlighted the 
presence of a LanA with 97% identity in S. pyogenes MGAS10750 
(MGAS10750_Spy0955) which is contained within a cluster which also encodes 
a LanB (MGAS10750_Spy0958) and LanC (MGAS10750_Spy0957).  
 
Streptococcus thermophilus LMG 18311: S. thermophilus is a thermophillic, non-
pathogenic Streptococcus. It is of major importance to the fermented dairy food 
industry. A number of non-lantibiotic bacteriocins (thermophilins) from this 
species have been characterised, including thermophilin 347 (Villani et al., 
1995), thermophilin A (Ward and Somkuti, 1995) and thermophilin ST-1 (Aktypis 
and Kalantzopoulos, 2003). Strain LMG 18311 was sequenced in 2004 and at the 
time it was noted that bacteriocin production was one of the characteristics 
that distinguishes it from strain CNRZ1066 (Bolotin et al., 2004). While the 
existence of a putative lantibiotic/lantipeptide gene cluster in LMG 18311 has 
been reported (Bolotin et al., 2004, Liu et al., 2009), this cluster (Figure 3) has 
not been the focus of a detailed in-silico analysis. The associated LanA, encoded 
by stu0097, is homologous with that predicted to be encoded by SPCG_0144 of 
S. pneumoniae CGSP14 (88% identical) which, on the basis of previous in-silico 
analysis, is also within a lantibiotic gene cluster (Ding et al., 2009). The LanB 
protein (Stu0098) is 73% identical to SPCG_0145 of S. pneumoniae CGSP14 and 
97% identical to a truncated LanB associated with S. thermophilus CNRZ1066 
(Bolotin et al., 2004).  
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3.4.4 Type 1 lantibiotic gene clusters in Bacteroidetes 
The Bacteroidetes are a highly diverse phylum found in soil, seawater and the 
skin and intestines of animals. The Bacteroidales class, which includes the genus 
Bacteroides, are the best-studied of the phylum. Bacteroides comprises the 
most substantial portion of the human gastrointestinal tract (Qin et al., 2010) 
some of which are opportunistic pathogens (Nobles, 1973). 
 
3.4.4.1 Identification of novel Chitinophaga-associated lantibiotic gene 
clusters  
Chitinophaga are rod-shaped mesophiles of the phylum Bacteroidetes which are 
noted for their ability to degrade chitin (Sangkhobol and Skerman, 1981). There 
have been no reports to date of bacteriocin production by any of the 10 
Chitinophaga species. Chitinophaga pinensis DSM 2588 (NC_013132) is unusual 
in that it appears to be a Bacteroidetes possessing genes encoding a type 1 
lantibiotic (Figure 4). There are two predicted LanA peptides, corresponding to 
Cpin_1438 and Cpin_1437, which are 50% identical as a consequence of similar 
N-terminii. Adjacent orfs of note include Cpin_1435 and Cpin_1440, predicted 
to encode a β-lactamase and a 2-component transcriptional regulator of the 
LuxR family, respectively. BLAST analysis of the associated LanB and LanC 
proteins (Cpin_1436 and Cpin_1439 respectively) revealed another putative 
LanB (Cpin_3392; 36% identity) and LanC (Cpin_3397; 23% identity) encoded 
within the same genome. Within this second C. pinensis-associated cluster, 
Cpin_3393 possess a number of features which suggest that it may be a LanA-
encoding gene. Interestingly, BLAST analysis of the Cpin_3397-encoded LanC  
 - 127 - 
 
 
 
 
 
 
 
 
 
 
Figure 4 
Diagrammatic representation of the Chitinophaga pinensis (Bacteroidetes) type 
1 lantibiotic operons, found in the original NisC screen, which contain genes 
predicted to encode a structural peptide LanA, and the modification enzymes 
LanB and LanC. Structural peptides are coloured in black, dehydratases in red, 
synthetases in green and other ORFs in blue. 
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also led to the identification of a number of additional homologs apparently 
encoded within the genomes of strains not previously associated with lantibiotic 
production. The genome of another Bacteroidetes, Spirosoma linguale DSM 74, 
is notable in that it contains 4 putative LanB-encoding genes and 5 putative 
LanC-encoding genes. Of these only one LanB protein (Slin_4704; 31% identity) 
and one LanC protein (Slin_4705; 26% identity), are encoded within what 
appears to be a novel lantibiotic-associated gene cluster. This cluster contains 3 
potentially LanA-encoding genes, Slin_4706-4708. Slin_4706 and Slin_4707, 
which are identical and share 58% identity with Slin_4708. The genome of 
another Bacteroidetes species, Pedobacter heparinus DSM 2366 (NC_013061), 
contains a cluster encoding two LanBs (Phep_0556 and Phep_0557; 37% and 
36% identity, respectively), a LanC (Phep_0555; 33% identity) and a potential 
LanA (Phep_0553; no significant BLAST hits). A cluster within Kordia algicida OT-
1 contains LanB (KAOT1_15523; 36% identity), LanC (KAOT1_15518; 30% 
identity) and LanA determinants (KAOT1_15533; no significant BLAST hits) while 
Microscilla marina ATCC 23134 potentially has five associated LanB homologs, 
but of these, the LanB corresponding to M23134_03921 (28% identity) was the 
only one to be located in close proximity to one of multiple LanC proteins 
(M23134_03925; 22% identity). The putative LanA, M23134_03926, does not 
resemble any other known proteins.  
 
3.4.5 Phylogenetics of LanABC 
The conserved nature of LanB and LanC proteins facilitated a phylogenetic 
analysis of their relatedness. The resultant cladogram of LanB enzymes (all  
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Figure 5 
Cladogram of all the LanB enzymes from clusters encountered during the 
screen. Also included are dehydratases from some well-known lantibiotics 
Green = Actinobacteria; Pink = Firmicutes; Blue = Bacteroidetes; Yellow = 
Chlamydiae 
PHYLOGROUP 1
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those identified in both screens, as well as a number of LanBs from previously 
analysed clusters) highlights the existence of two distinct phylogroups (Figure 
5). The first phylogroup contains Actinobacteria-associated LanBs, all of which 
are from strains not previously known to be producers of 
lantibiotics/lantipeptides. The second contains a variety of lanthionine 
synthetases associated with known lantibiotics (nisin, subtilin, epidermin etc), 
some uncovered by previous in-silico analysis (e.g. S. pneumoniae CGSP14 (Ding 
et al., 2009)), novel clusters from genera with which lantibiotic production has 
previously been attributed, as well as genera not previously associated with 
lantibiotic production. Within this second phylogroup one finds two subgroups; 
one consisting of Bacteroidetes-associated LanBs (2A) and a second consisting 
of Firmicutes-associated LanBs (2B) as well as that from P. ancanthamoeba. 
Among the Firmicutes-associated LanBs further subclustering is evident. One 
common branch contains three offshoots; (i) 
Bacillus/Geobacillus/Enterococcus/Clostridium, (ii) S. pyogenes and (iii) P. 
acanthamoebae str. Hall's coccus LanBs. The Staphylococcus LanBs and that of 
mutacin 1140 (those associated with epidermin-like peptides) also form a 
distinct subgroup as do those encoded with the genomes of S. thermophilus 
LMG 18311 and S. pneumoniae CGSP14. Curiously the epicidin (S. epidermidis) 
LanB does not group with any other LanB. 
 The cladogram of the corresponding lanthionine synthetases (LanCs) is 
quite similar to that of the dehydratases (Figure 6). All can be positioned into 
one of two phylogroups (phylogroups 1 and 2). Phylogroup 1 contains six 
Bacteroidetes-associated LanC’s. In contrast phylogroup 2 is large and can be  
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Figure 6 
Cladogram of all the LanC enzymes from clusters encountered during the 
screen, as well as some from well-known lantibiotics 
Green = Actinobacteria; Pink = Firmicutes; Blue = Bacteroidetes; Yellow = 
Chlamydiae 
PHYLOGROUP 1
PHYLOGROUP 2
2A
2B
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further divided into group 2A, which are Actinobacteria-associated, and the 
Firmicutes-associated group 2B. Further subgrouping follows the patterns 
identified from analysis of the LanB cladogram. 8 exceptional LanCs that avoid 
subgrouping include those associated with C. lipophiloflavum DSM 44291, S.  
thermophilus LMG 18311/S. pneumoniae CGSP14, epicidin, B. cereus F65185, N. 
dassonvillei subsp. dassonvillei DSM 43111, nisin-producing lactococci and 
Actinomyces sp. oral taxon 848.  
 A cladogram of the less highly conserved LanAs revealed 13 major 
branches, several of which contain only one corresponding LanA (Figure 7). 
Notably the various phylogroups do not group in a phylum specific manner to 
the same extent as was evident in LanB and LanC cladograms. The largest 
phylogroups, i.e. phylogroups 11 and 13, are those containing the nisin-like and 
epidermin-like peptides, respectively. While phylogroup 13 is, with the 
exception of the Actinomyces sp. oral taxon 848-associated LanA, composed of 
Firmicutes-associated LanAs, phylogroup 11 contains LanAs from both 
Firmicutes and Actinobacteria. This phylogroup contains three subgroups, with 
subgroup 11A containing LanAs from E. faecalis Fly1 and C. perfringens F4969, 
11B contains Actinobacteria-associated LanAs and 11C contains both 
Actionobacteria- and Firmicutes-associated LanAs. Of the other phylogroups, 
phylogroups 6 and 7 are largest and contain Chlamydiae/Bacteroidetes- and 
Actinobacteria-associated LanAs, respectively. 
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Figure 7 
A cladogram of all the LanA prepeptides identified in this study, as well as a 
number of previously identified LanAs. 
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3.4.6 Alignment of LanABC 
The availability of a significant number of LanA, B and C protein sequences 
enabled further in-silico analysis to identify conserved motifs and residues. 
Alignment of 66 LanB proteins highlighted a number of conserved motifs which 
are summarised in Table 5. A YxxR motif (corresponding to residues 80-83 of 
NisB)  is conserved in 89% of the LanB enzymes, while a GxG motif (363-365) is 
present in 92% of LanBs, with the LanB of C. lipophiloflavum being exceptional 
by virtue of lacking both glycine residues. A GRF motif (463-465) is fully 
conserved in 86% of LanBs with the Streptomyces sp. Mg1 III LanB being the 
only protein to lack this motif. An RxTPFG motif (87-94) is present in 77% of 
LanBs but is completely absent from the LanBs of Geobacillus sp. G11MC16, 
Streptomyces sp. Mg1 III, M. aurantiaca and C. lipophiloflavum. A FxxxYG motif 
(342-347) is present in 82% of LanBs and, although present in only 50% of 
LanBs, a PxxxRxxNV (501-509) motif is at least partially conserved in many such 
proteins i.e. 94% contain the proline, 71% contain the NV residues and the least 
conserved is the arginine with 71% conservation. Elsewhere, there is a RFL motif 
(585-587) conserved in 51% of LanBs, a RYG motif (826-828) conserved in 85% 
of LanBs and a HxxxNR motif (961-966) in 70% of the dehydratases. In addition 
to these, there are multiple highly conserved residues such as aspartates at 
residues 121, 299, 648 and 843, prolines at 612 and 639 and a leucine, 
tryptophan and phenylalanine at 97, 616 and 840.  
 Alignment of the LanC protein also revealed several conserved regions 
(summarised in Table 6). Of these, CHG and WCYG motifs were particularly 
notable. The CHG motif (corresponding to residues 330-333 of NisC) was found  
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Table 5. Highly conserved residues shared by 66 cluster-associated (including 
those from the 49 novel clusters referred to in this paper) lanthionine 
dehydratases (LanB). Residues are numbered according to their position in NisB 
 
From Alignment NisB Position % Conservation 
Motifs   
YxxR 80-83 89% 
RxTPFG 87-94 77% 
FxxxYG 342-347 82% 
GxG 363-365 92% 
GRF 463-465 86% 
PxxxRxxNV 501-509 50% 
RFL 585-587 51% 
RYG 826-828 85% 
HxxxNR 961-966 70% 
   
Single Residues   
R  14 86% 
D  121; 299; 648; 843 86%; 94%; 94%; 85% 
N  145 86% 
L  217 97% 
P 612; 639 100%; 95%  
E  975 89% 
W  616 98% 
F  840 95% 
V  352 83% 
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Table 6. Highly conserved residues shared by 66 cluster-associated (including 
those from 49 novel clusters) lanthionine cyclases. Residues are numbered 
according to their position in NisC 
 
Conserved Residues NisC Position  % Conservation 
Motifs   
LxxG 39-42 83% 
YDxxxGxxG 140-148 67% 
GxAHGxxG 209-216 83% 
WCYG 283-286 95% 
CHG 330-332 98% 
GxxxGxxGxxLxL 377-389 73% 
   
Single Residues   
G 90 94% 
W 258; 401 83%; 92%  
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to be conserved in 98% of the LanCs. The cysteine330 and histidine331 residues, 
which act as ligands to the zinc in the active site of NisC, have been shown to be 
necessary for enzyme activity (Li and van der Donk, 2007). The WCYG motif 
(283-286) was present in 95% of the aligned enzymes. Within the WCYG motif, 
tryptophan283 (W) and cysteine284 (C) have been shown to be vital to subtilin 
and nisin biosynthesis (residue numbers refer to location in NisC) (Helfrich et al., 
2007, Li and van der Donk, 2007). It has previously been shown that although 
alanine subsititution of tyrosine285 (Y) results in enzyme inactivation, a 
phenylalanine change is tolerated indicating that the presence of an aromatic 
ring at this position is of key importance (Li and van der Donk, 2007). In the 
same study, a preceding arginine residue (Arg280), present in 86% of these 
enzymes, was found not to be essential for enzyme activity. 92% of LanCs also 
contained a closely located Gly289 residue. The histidine212 of another highly 
conserved motif, GxAHGxxG (209-216; conserved in 83% of LanCs), together 
with a conserved aspartic acid141 (91% of LanCs) are thought to be involved in 
the electrophilic activation of the carbonyl group of 
dehydroalanine/dehydrobutyrine or in the protonation of the enolate (thiol 
substrate) (Li and van der Donk, 2007). The HG of this latter motif was 
conserved in 98% of the enzymes (the exception being S. aureus subsp. aureus 
D139). In addition to these, other motifs of note included LxxG (39-42; 
conserved in 83% of LanCs), GxxxGxxGxxLxL (377-389; 73%) and YDxxxGxxG 
(140-148; 67%). Highly conserved single residues include Gly90 (94%) and Tryp258 
and Tryp401 (83% and 92% respectively).  
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Figure 8. Alignment of the LanA prepeptides identified in this study, as well as a number of previously identified LanAs. This revealed the 
proposed end of the leader and beginning of the core peptide, between positions 100 and 110. Different groupings based on similar residues 
are highlighted by coloured boxes.   
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Although LanA peptides are less conserved than their modification enzymes, 
some motifs were evident (Figure 8). A DLD motif present in the leader region 
of almost all the phylogroup 13 LanAs is also found in many other LanAs. 
Indeed, the leucine of this motif is conserved across 93% of the 70 aligned 
peptides. The only peptides lacking this residue are those from M. marina, 
B.cereus F65185, N. dassonvillei subsp. dassonvillei and P. heparinus as well as 
mutacin 1140. The leader regions from many actinobacteria, and especially 
those from phylogroup 11, are also distinctive as a consequence of the frequent 
presence of proline residues. 
 Within the propeptide, the most highly conserved residues are 
cysteines corresponding to positions 30 and 34 of the Nisin A prepropeptide 
(Hsu et al., 2004) which significantly are within the lipid II-binding region of the 
peptide. These cysteines are each found in 86% of the type 1 LanAs. The 
Actinobacteria in phylogroups 10 and 11 also share a conserved or partially 
conserved DGCG motif in the propeptide region. A less highly conserved AC 
motif which is closer to the C terminus is also evident. In addition to motifs 
which are conserved across prepeptides, a large number of motifs which are 
conserved within phylogroups are evident. 
 
3.5 Conclusions  
The in-silico strategy adopted here resulted in the initial identification of 56 
proteins which share 20-30% identity with NisC. Further investigation of novel 
LanC proteins in turn led to the identification of even more homologs, revealing 
novel lantibiotic/lantipeptide associated clusters and establishing the existence 
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of subgroups of LanA, B and C proteins. Theoretically, additional homologs 
could be identified through a continuation of this method but the rate at which 
new homologs would be identified would begin to level off. The approach taken 
led to the identification of 49 novel clusters which, prior to this study, had not 
been the subject of a detailed bioinformatic analysis. While the in-silico 
identification of gene clusters in a strain will not always be confirmed by 
detection of an associated lantibiotic/lantipeptide, past experience (Begley et 
al., 2009, Daly et al., 2010, Lawton et al., 2007, McClerren et al., 2006) suggests 
that there is likely to be a strong correlation. It is thus anticipated that the 
peptides produced by these gene clusters will represent a valuable resource, as 
will the associated biosynthetic proteins. 
This study reveals new details regarding type 1 lantibiotics and their 
associated clusters. Type 1 lantibiotics have been predominantly associated 
with the Firmicutes, with the Actinobacteria-produced planosporicin and 
microbisporicin being notable exceptions. It is thus interesting to find type 1 
clusters distributed among the genomes of bacteria representing four different 
phyla, the Actinobacteria, Firmicutes, Bacteroidetes and Chlamydiae, which 
have been isolated from a diverse range of habitats including soil, skin, 
intestines and the deep-sea. Indeed, based on these investigations, it would 
appear that such clusters are as common among Actinobacteria as they are 
among Firmicutes, with Streptomyces and Frankia sp. being particularly rich 
sources. The Actinobacteria clusters are, in general, quite similar, typically 
encoding a LanA, B, C and a methyltransferase. The role of the 
methyltransferase is not clear but may serve to protect specific serine and 
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threonine residues from LanB-mediated dehydration. The presence of five 
clusters within the genomes of five Bacteroidetes, a phylum in which bacteriocin 
production is purportedly quite rare, is particularly noteworthy. However, the 
sequencing of additional representatives of this species may well reveal this to 
be a common feature. The P. acanthamoebae cluster is unusual by virtue of its 
presence in a representative of the Chlamydiae. Phylogenetic analysis indicates 
that the LanB and LanC proteins from this strain are closely related to those of 
several Firmicutes and thus the cluster may originally have been acquired from 
such a source.  
The availability of a much larger collection of LanA, B and C sequences 
for further in-silico analysis is also extremely useful for a number of other 
reasons. In addition to providing greater certainty with respect to the proposed 
conservation of particular motifs, it also reveals the existence of a greater 
number of subgroups of sequences than was previously apparent. This is 
particularly important with respect to LanAs as alignment of these peptides has 
previously been employed as a means of subgrouping type 1 lantibiotics (Piper 
et al., 2009, Rea, 2010). Ultimately, the most significant outcome has been the 
number of new type 1 lantibiotic gene clusters. When one considers that less 
than 25 type 1 lantibiotics had been identified prior to this study, this 
represents a major expansion. While the genome sequenced strains themselves 
can be accessed with a view to purifying the associated peptides and/or utilising 
the biosynthetic machinery, the information gathered will also encourage 
researchers to include Actinobacteria and Bacteroiodetes when carrying out wet 
lab-based screens for novel lantibiotic producers. A combination of this 
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approach and analysis of newly generated bacterial genome sequence data will 
ensure that many more lantibiotics and lantipetides will soon be discovered 
which are associated with unusual microorganisms and a wide variety of 
environments.  
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4.1 ABSTRACT 
Kefir is a fermented milk-based beverage to which a number of health-
promoting properties have been attributed. The microbes responsible for the 
fermentation of milk to produce kefir consist of a complex association of 
bacteria and yeasts, bound within a polysaccharide matrix, known as the kefir 
grain. The consistency of this microbial population, and that present in the 
resultant beverage, has been the subject of a number of previous, almost 
exclusively culture-based, studies which have indicated differences depending 
on geographical location and culture conditions. However, culture-based 
identification studies are limited by virtue of only detecting species with the 
ability to grow on the specific medium used and thus culture-independent, 
molecular-based techniques offer the potential for a more comprehensive 
analysis of such communities. Here we describe a detailed investigation of the 
microbial population, both bacterial and fungal, of kefir, using high-throughput 
sequencing to analyse 25 kefir milks and associated grains sourced from 8 
geographically distinct regions. This is the first occasion that this technology has 
been employed to investigate the fungal component of these populations or to 
reveal the microbial composition of such an extensive number of kefir grains or 
milks. As a result several genera and species not previously identified in kefir 
were revealed. Our analysis shows that the bacterial populations in kefir are 
dominated by 2 phyla, the Firmicutes and the Proteobacteria. It was also 
established that the fungal populations of kefir were dominated by the genera 
Kazachstania, Kluyveromyces and Naumovozyma, but that a variable sub-
dominant population also exists.  
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4.2 INTRODUCTION 
Kefir is a fermented milk-based beverage. It is a viscous, self-carbonated, acidic 
drink, which contains a low alcohol percentage and is believed to have 
originated in the Caucasian mountains some 2000 years ago. The milk is 
fermented by a solid, cauliflower-like, polysaccharide matrix known as a kefir 
grain, which is reused to start subsequent fermentations. The grain is primarily 
composed of bacterially-produced kefiran (La Riviere and Kooiman, 1967), 
which contains within it a complex consortium of bacteria and yeast that work 
in symbiosis to ferment the milk (Farnworth, 2005).  
The microbial composition of kefir and kefir grains is believed to vary 
depending on geographic, climatic and cultural conditions as well as the 
diversity of local species of wild yeasts and bacteria. Culture-based analyses 
suggest that bacteria constitute the majority, up to 90%, of the population in 
the grain (Simova et al., 2002). Such culture-based studies have also revealed 
that the bacterial composition of kefir predominantly consists of the lactic acid 
bacteria (LAB) Lactobacillus, Lactococcus, Leuconostoc and Streptococcus as well 
as acetic acid bacteria from the genus Acetobacter (Witthuhn et al., 2005, Chen 
et al., 2008, Kesmen and Kacmaz, 2011). Bacteria contribute to the production 
of lactic acid, which preserves the milk, and produces various antimicrobial and 
flavour compounds (e.g. acetaldehyde) in addition to other metabolites (e.g. 
extracellular polysaccharides), free amino acids and vitamins (Guzel-Seydim et 
al., 2011). Other studies have revealed that the yeast component of kefir 
consists of Kluyveromyces, Saccharomyces, Candida and Torulaspora (Wyder et 
al., 1997, Simova et al., 2002, Lin et al., 1999, Loretan et al., 2003, Angulo et al., 
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1993). Other yeast which have less frequently been associated with kefir include 
Pichia/Issatachenkia (Lin et al., 1999, Latorre-Garcia et al., 2007), 
Brettanomyces/Dekkera (Wyder et al., 1997, Pintado et al., 1996), 
Zygosaccharomyces (Witthuhn et al., 2005) and Yarrowia (Loretan et al., 2003), 
while recent molecular-based studies have detected the presence of 
Kazachstania (Zhou et al., 2009, Magalhaes et al., 2011, Gao et al., 2012). Yeasts 
perform the vital role of alcohol and carbon dioxide production in the milk, and 
produce metabolites thought to be important with respect to mouthfeel and 
taste (Kwak et al., 1996). Ultimately, following a 24 hour fermentation, culture-
based approaches indicate that lactococci/streptococci are present at 108-109 
ml-1, Leuconostoc at 107-108 ml-1, acetic acid bacteria at 105-106 ml-1, lactobacilli 
at 105-106 ml-1 and yeasts at 106-107 ml-1 (Rea et al., 1996, Garrote et al., 2001). 
Despite the undoubted value of the aforementioned studies, culture-
based analyses are limited by virtue of only detecting species with the ability to 
grow on the specific medium used. Thus, culture-independent techniques have 
the potential to provide a more accurate and in-depth analysis. Although 
culture-independent techniques such as Sanger sequencing (Gao et al., 2012, 
Tas et al., 2012, Latorre-Garcia et al., 2007, Wang et al., 2008) and DGGE 
(Garbers et al., 2004, Magalhaes et al., 2011, Zhou et al., 2009) have been 
employed to explore the kefir population, the application of high-throughput 
DNA sequencing to investigate such microbial ecosystems has been a 
particularly significant development. This strategy has been employed to study 
the microbial composition of a number of fermented food environments such as 
cheese (Quigley et al., 2012b, Masoud et al., 2011), fermented fish (Koyanagi et 
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al., 2011, Roh et al., 2010), fermented vegetables (Park et al., 2012), rice bran 
(Sakamoto et al., 2011) and pearl millet slurry (Humblot and Guyot, 2009). 
Indeed, high-throughput DNA sequencing was also recently utilised to gain a 
more comprehensive understanding of the bacterial population of one Irish 
kefir grain and milk, and three Brazilian kefir grains (Dobson et al., 2011, Leite et 
al., 2012). 
The benefits of gaining a better appreciation of the microbial 
composition of kefir and kefir grains relate to the fact that the history of kefir 
has long been linked to its purported health benefits. Preliminary studies have 
shown kefir to reduce lactose intolerance symptoms, stimulate the immune 
system, lower cholesterol, and to have antimutagenic and anticarcinogenic 
properties (Guzel-Seydim et al., 2011). It is thus unsurprising that, as a 
functional dairy food, kefir has become the focus of increased study in recent 
years. While some of the health benefits thought to be derived from the 
consumption of kefir may be associated with the biochemical changes that 
occur within the milk, such as the production of organic acids, bioactive 
peptides etc., the microbial species present may also have health-promoting 
attributes. Notably, genera to which many strains with health-beneficial or 
probiotic properties are assigned, such as Lactobacillus, Bifidobacterium, 
Enterococcus, Bacillus and Streptococcus, have been isolated from kefir in the 
past (Parvez et al., 2006, Tas et al., 2012). From a fungal perspective, strains of 
the yeast Saccharomyces boulardii have been established to possess health-
promoting properties in clinical trials (Czerucka et al., 2007, Desreumaux et al., 
2011, Foligne et al., 2010). Strains of Saccharomyces cerevisiae, as well as 
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Kluyveromyces lactis/Candida kefyr, commonly associated with kefir, also show 
potential in this regard (Etienne-Mesmin et al., 2011, You et al., 2006, Kumura 
et al., 2004). Conversely, however, Candida kefyr has been shown to cause 
oesphagitis in a patient with squamous cell carcinoma (Listemann et al., 1998).  
Aside from identifying potentially health-promoting populations, the 
commercialisation of kefir production could benefit from gaining a detailed 
understanding of the associated microbial populations. There is also a need to 
assess the heterogeneity of these populations across a large number of grains 
and, in particular, to employ molecular approaches to better characterise the 
associated yeast populations. In light of these requirements, the aim of this 
study was to use high-throughput sequencing techniques to provide in-depth 
analysis of the microbial consortium of 25 distinct kefir grains and milks 
obtained from a variety of different sources in order to minimise any geographic 
bias that might influence the floras. This study represents the first occasion 
upon which this technology has been applied to such an extensive number of 
kefir samples and is the first study of its kind to reveal the fungal component of 
kefir.  
 
4.3 MATERIALS AND METHODS 
4.3.1 Culture maintenance 
9 Irish kefir grains were recultured from -80°C storage within the Teagasc 
Culture Collection by fermenting in 10% reconstituted skimmed milk (RSM), 
which had been sterilized at 115°C for 15mins. These were originally acquired 
from housewives across the country (Rea et al., 1996), and for the purposes of 
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this study were designated IR1, 2, 3, 4, 5, 6, 8, 9 and 10. An additional 16 grains 
were obtained from individual and commercial suppliers from a number of 
different locations (Table S1), and cultivated under uniform conditions. Samples 
from the United Kingdom were designated UK1 to UK5 and samples from the 
United States were designated US1, 2, 3 and 5. Other kefir grains were sourced 
from Spain (Sp1), Belgium (Bel1), France (Fr1), Italy (It1), Canada (Ca1) and 
Germany (Ger1 and Ger2). Cultures were maintained at room temperature and 
inoculated into fresh milk 3 times per week, for a minimum of 4 months prior to 
extraction.  
  
4.3.2 Metagenomic DNA extraction 
100mls of 10% RSM was inoculated with 1g of kefir grain and fermented at 25°C 
for 24 hours, the time at which kefir is most frequently prepared. To extract 
DNA from the kefir, 1.8mls of fermented milk was centrifuged to generate a 
pellet which was suspended in 450ul of lysis buffer P1 from the Powerfood 
Microbial DNA Isolation kit (MoBio Laboratories Inc, USA). The resuspended 
pellet was subjected to enzymatic digestion with enzymes mutanolysin 
(100U/ml) and lysozyme (50μg/ml) at 37°C for 1 hour, followed by proteinase K 
(250μg/ml) digestion at 55°C for 1 hour. Extraction was optimised with a 10 
minute 70°C incubation (Quigley et al., 2012a) prior to mechanical lysis using 
the Qiagen TissueLyser II (Retsch®). The Powerfood Microbial DNA Isolation kit 
was then used as per the manufacturer’s instructions. Pure DNA was eluted in 
HPLC grade sterile water. DNA from kefir grain was isolated using a modified 
phenol-chloroform-based extraction procedure (Garbers et al., 2004).  
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4.3.3 DNA amplification and pyrosequencing 
Metagenomic DNA extracts were used as a template for PCR amplification, with 
BioMix red (Bioline) which has a reported error rate of 2x105 errors/bp 
(Lundberg et al., 1991). PCR amplification of the V4-V5 variable region (408 bp) 
of the 16S rRNA gene was performed using the universal primers F1 (5’-
AYTGGGYDTAAAGNG) and R5 reverse (5'-CCGTCAATTYYTTTRAGTTT) to facilitate 
an investigation of the bacterial component of the microbial populations 
(Claesson et al., 2010). Unique multiplex identifier adaptors, 8 bp in length, 
were attached between the 454 adaptor sequences and the forward primers to 
facilitate the pooling and subsequent differentiation of samples (Cole et al., 
2009). Tagged universal primers were also used to amplify fungal DNA from the 
variable ITS-1 rRNA region (Buee et al., 2009). In this instance the forward 
primer ITS1F (5’-CTTGGTCATTTAGAGGAAGTAA) and ITS2 reverse (5’-
GCTGCGTTCTTCATCGATGC) generated PCR products of circa 410 bp. The PCR 
conditions used for 16S amplification were 94°C denaturation for 2 min, 35 
cycles of 94°C for 1 min (denaturation), 52°C for 1 min (annealing) and 72°C for 
1 min (extension) followed by a final 72°C for 2 mins. The PCR conditions used 
for ITS amplification were 94°C denaturation for 4 min, 35 cycles of 94°C for 30 
seconds (denaturation), 50°C for 1 min (annealing), and 72°C for 1 min and 30 
seconds (extension). A final annealing step of 72°C for 10 mins was performed. 
All DNA was subject to a 10 min hotstart at 94°C prior to PCR amplification. 
Amplicons generated from three PCR reactions/template DNA were pooled and 
cleaned using the Agencourt AMPure® purification system (Beckman Coulter 
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Genomics, Takeley, UK).  Purified products were quantified using the Nanodrop 
3300 Fluorospectrometer (Thermo Scientific) and the Quant-iT™ Picogreen® 
dsDNA Assay kit (Invitrogen). Equal concentrations of 16S or ITS amplicons were 
pooled, AMPure cleaned and assessed by an Agilent 2100 Bioanalyser (Agilent 
Technologies) to determine purity and to ensure the absence of primer dimers. 
Sequencing of the 16S rRNA V4-V5 and ITS1 rDNA amplicons was performed 
using a 454 Genome Sequencer FLX Titanium System (Roche Diagnostics Ltd) at 
Teagasc Food Research Centre, Moorepark, according to 454 protocols. 
 
4.3.4 Pyrosequencing data analysis 
Raw sequences were quality trimmed and filtered using the Qiime Suite of tools 
(Caporaso et al., 2010); any reads not meeting the quality criteria of a minimum 
quality score of 25 and sequence length shorter than 150bps for 16S amplicon 
reads and 200bps for ITS amplicon reads were discarded. The maximum 
homopolymer limit was increased to 10 for ITS amplicons as ITS sequences are 
known to harbour long homopolymer runs. Trimmed fasta sequences were 
assessed by BLAST analysis against the SILVA database (version 100) for 16S 
reads (Pruesse et al., 2007). The ITS-1 specific database, ITSoneDB, was used to 
BLAST all ITS sequences (Santamaria et al., 2012). BLAST outputs were parsed 
using MEGAN (Huson et al., 2007) with a bit-score of 86 was employed for 16S 
ribosomal sequence data, and a bit-score of 35 was used for ITS sequence data. 
The QIIME suite of programs was used to calculate alpha diversity including 
Chao1 richness, Shannon diversity, Simpson index, Phylogenetic Diversity and 
Observed species (Caporaso et al., 2010). Sequencing depth was estimated 
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using rarefaction analysis. QIIME was also used to generate weighted UniFrac, 
unweighted UniFrac and Bray-Curtis distances matrices. Principal Co-ordinate 
Analysis plots based on these distance matrices were generated with Qiime and 
visualised using King (Chen et al., 2009b). Statistically significant differences 
between the combined kefir grains and combined fermented milks were 
determined by the non-parametric Mann-Whitney test using the Minitab® 
statistical package. Reads were deposited in the SRA database under the 
accession number ERP002650.  
 
4.4 RESULTS 
4.4.1 The bacterial population of kefir milk is more consistent and less diverse 
than that of the corresponding grains  
Post-quality filtering, 106,235 and 136,815 reads for 23 grain and the 
corresponding 23 milk samples, respectively remained, equating to an average 
of 4,619 reads for each grain sample and 5,949 reads per milk sample.  
Chao1 values (reflective of OTU/species richness), Shannon and Simpson 
indices (to determine species diversity) as well as the Phylogenetic Diversity and 
Observed Species numbers were all calculated (Table S2). Rarefaction curves, 
calculated at 97% similarity, are approaching parallel to the x-axis for all 
samples, indicating sufficient reads were obtained to adequately assess the 
population (Figure S1). Box-plot analysis suggests that the bacterial population 
in kefir milk is generally less diverse than that present in the kefir grains (Figure 
S2), where the median value (black bar) for milk was lower in all metrics, with 
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the exception of the Shannon index. The only significant difference between the 
grain and milks was in Phylogenetic Diversity (p<0.001).  
 Principal Co-ordinate Analysis plots were generated based on the 
unweighted UniFrac distance matrix (Figure 1AB), the only tree-based metric. 
From this analysis, it was evident that there was no clustering amongst kefir 
populations from different countries (Figure 1AB), and correlated with the other 
distance matrices (data not shown). Procrustes analysis indicated that the 
ordinations of kefir and kefir grains were not related to each other (M2 = 0.924, 
p = 0.644, Figure 2A). The similarities between kefir grain communities were not 
the same as the similarities between kefir communities.  
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Figure 1: Principle Coordinate Analysis (PCoA) plots, based on unweighted 
UniFrac distance matrices, show the diversity within bacterial populations from 
kefir grains (A) and kefir fermented milk (B) and fungal grain (C) and milk (D) 
populations. Green = Irish kefir, Orange = Belgian kefir, Light Brown = Spanish 
kefir, Red = German kefir, Grey = US kefir, Pink = Italian kefir and Purple = UK 
kefir.  
 
 
 
 
A) 16S Grain B) 16S Milk 
C) ITS Grain D) ITS Milk 
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Figure 2: Procrustes imaging of unweighted UniFrac distance matrices highlight 
the diversity amongst the 16S bacterial component (A) and fungal component 
(B) of the different kefir samples. The two different sample types are linked with 
a bar (white represents grain flora; red represents milk flora). The direction of 
each axis is arbitrary.  
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4.4.2 The alpha diversity of fungal populations in kefir milks and grains vary 
but the beta diversity of kefir grains is greater than that of milks 
Post quality filtering a combined total of 118,879 and 118,976 reads 
corresponding to 23 grain and the corresponding 23 milk populations, 
respectively, were generated. This equated to an average read number of 5,167 
and 5,173 per grain and milk sample, respectively.  
Alpha diversity values established that there is a naturally low diversity 
in the kefir grains and milks (Table S3). Box-plot analysis of Chao1, Observed 
Species and Phylogenetic Diversity indices suggest diversity is greater in the 
kefir milk than in the grains (Figure S3). However, statistical difference between 
the two was limited to Phylogenetic Diversity (p<0.001). Rarefaction curves are 
approaching parallel to the x-axis for all samples, suggesting a sufficient depth 
of sequencing (Figure S4). 
To measure beta diversity, Principal Co-Ordinate Analysis Plots were 
generated based on unweighted UniFrac distance matrices (Figure 1CD), but no 
clustering was evident. Procrustes analysis of the two PCoAs again shows that 
the similarities between the kefir grains and kefir milks were not the same, with 
respect to the fungal populations (M2 = 0.855, p = 0.139, Figure 2B).  
 
4.4.3 The kefir grains and associated kefir-fermented milks are dominated by a 
relatively small number of bacterial genera 
Four bacterial phyla were detected in the kefir grain. These were the 
Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. Of these, the 
Bacteroidetes were not identified among the milk bacteria, and were found in 
 - 167 - 
only 9 grains. Across both the grains and milks, the two dominant phyla were 
the Firmicutes and the Proteobacteria. Indeed most grain samples contained a 
majority (>50%) of Firmicutes, with the exception of Ir6, which possessed 
69.14% Proteobacteria. Proteobacteria were not detected in grains Ca1, Ir9 or 
UK3. Among the milk samples, Ir1, Ir5, Ir10, US1 and Ir8 were also unusual by 
virtue of containing a bacterial population dominated by Proteobacteria, which 
in the case of Ir8, was as high as 90.4%. Milks corresponding to Fr1 and UK3 
lacked Proteobacteria. No consistent shift (increase or decrease) in 
Proteobacteria populations from kefir grain to kefir milk was evident (Table S4; 
Table S5). Bacteria corresponding to the phylum Actinobacteria were detected 
in only two grains, Ir9 (5.87%) and UK2 (0.24%). The relatively high percentage 
of Actinobacteria in Ir9 may explain why the corresponding kefir milk was the 
only sample in which Actinobacteria were detected (0.26%). There was a 
significantly greater abundance of unassigned phyla among the total grains than 
the total milks (p<0.001).  
At the family level, the greater bacterial diversity (in terms of number of 
different families) within the grain is evident. Only five families of bacteria were 
detected in the milk whereas twelve were identified in the grain samples 
(Tables S4-S5). The grains were predominantly composed of Lactobacillaceae, 
which accounted for >50% of the populations in all but grain Ir6. The other 
major family were the Proteobacteria-associated Acetobacteraceae. Other 
families detected were Streptococcaceae (19 grains), Leuconostocaceae (4 
grains), Lachnospiraceae (16 grains), Ruminococcaceae (8 grains), 
Bifidobacteriaceae (2 grains), Clostridiaceae (2 grains), Propionibacteriaceae (2 
 - 168 - 
grains), Bacteroidaceae (2 grains), Enterococcaceae (1 grain) and Rikenellaceae 
(1 grain) (Table S4). Among the other families, Streptococcaceae were detected 
in 19 of the 23 grains with the highest proportions found in UK2 (5.12%). 
Leuconostocaceae were found in only four of the grain samples (Bel1, 0.31%; 
Fr1, 0.13%; UK1, 0.29%; UK2, 0.51%). Lachnospiraceae were found in 16 grains 
from highest abundance in Ir9 at 0.51%, to lowest in US2 at 0.09%. 
Ruminococcaceae were found in 8 samples, from a high of 8.21% in Bel1 to a 
low of 0.08% in UK2. Bifidobacteriaceae were present in only 2 grains (0.81% in 
Ir9, and 0.10% in UK2), as were Clostridiaceae (Ger1, 0.39% and US2, 0.12%), 
Propionibacteriaceae (Ir9, 4.94% and UK2, 0.13%) and Bacteroidaceae (UK2 and 
UK3, 0.08%). Enterococcaceae (Ir9, 0.22%) and Rikenellaceae (US2, 0.07%) were 
present in only one grain each.  The bacterial populations within the milks were 
dominated by Streptococcaceae, which were found at greater proportions in the 
kefir milks than in the grains (p<0.001), and form the dominant population 
(>50%) in 13 samples. Ir3, Ir8 and US1 were notable exceptions by virtue of 
containing 10.16%, 2.87% and 10.91% Streptococcaceae, respectively. In its 
place, Ir3 has the highest proportions of Lactobacillaceae at 60.51%, whereas 
Ir8 and US1 had the two highest proportions of Acetobacteraceae with 90.41% 
and 77.06%, respectively. However, in general, proportions of Lactobacillaceae 
were significantly lower in the milks than in the corresponding grains (p<0.001). 
The overall average proportion of Acetobacteraceae did not change significantly 
from the grains to the corresponding milks despite the fact that large increases 
were evident in some cases (i.e. the aforementioned Ir8 and US1 as well as Ir1 
and Ir5). Proportions of Leuconostocaceae were detected in all kefir milk 
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samples (in contrast to just 4 grain samples), reflecting a significant overall 
increase (p<0.001). Propionibacterineae was found in a single milk sample, Ir9, 
at 0.22%, which is a reduction from the 4.94% in corresponding grain. The 
proportions of unassigned reads were <1% in almost all grain and milks, with 
the exception of 1.02% in the grain of Ca1 (Table S4; Table S5). 
 The distribution pattern at the genus levels closely resembles that 
observed at family level, with one genus frequently corresponding to all reads 
assigned to that family (Figure 3). Lactobacillus (p<0.001) is the dominant genus 
in the grain with proportions of Lactococcus and Leuconostoc being significantly 
higher in the kefir milks (p<0.001). Once again, the differences in proportions 
and distribution of Acetobacter (of family Acetobacteraceae) in the grain and 
milk were numerically, but not statistically, different.  
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Figure 3: 16S phylogenetic composition of the bacterial component of the kefir 
grain (A) and kefir fermented milk (B) at genus level. 
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4.4.4 ITS sequencing provides a detailed insight into the fungal composition of 
kefir grains and associated kefir-fermented milks  
The only fungal phylum assigned in the grain was Ascomycota, the largest 
phylum of the fungal kingdom. Ascomycota were also shown to dominate 
within the kefir milk, ranging from a high of 100% in Ger1 to a low of 89.38% in 
Ir10 (Table S6; Table S7). Basidiomycota, the other phylum belonging to the 
subkingdom Dikarya, was found in 9 milk samples at relatively low read 
numbers. 9 of the milk samples also harboured trace amounts of uncultured 
fungi. The lower diversity in the grain is again evident at the family level where 
all but one sample (Sp1) contain >99% Saccharomycetaceae. The overall 
average proportion of Saccharomycetaceae is significantly lower in the milks 
(p<0.001), but still correspond to >99% of reads in 16 of the 23 samples. The 
fungal composition of kefir milk Sp1 was unusual by virtue of containing 34.27% 
Pichiaceae. In contrast, the next highest proportion of Pichiaceae was 0.48% (in 
milk UK3). Other fungal families detected in both the kefir milks and grains were 
Davidiellaceae and Trichocomaceae. Herpotrichiellaceae, Teratosphaeriaceae, 
Valsaceae, Debaryomycetaceae, Phaffomycetaceae, Malasseziaceae, 
Bondarzewiaceae, Dermataceae, Pezizaceae, Ganodermataceae, 
Tricholomataceae, Tremellomycetes. In addition, Wallemiomycetes were only 
detected in the milks whereas Dothioraceae were only detected in the grains.  
The most common fungal genus across both the kefir milk and grains 
was Kazachstania (Figure 4). This genus was detected in all samples except kefir 
grain Ger1. Given that the corresponding milk contained Kazachstania at a 
proportion of 5.68%, it would seem likely that this grain did contain  
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Figure 4: ITS phylogenetic composition of the fungal component of the kefir 
grain (A) and kefir fermented milk (B) at genus level. 
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Kazachstania at levels below the limit of detection for this study. The 
proportions of Kazachstania were >50% in 11 of the grains and in 13 of the 
milks and was highest in grains Ir2 and US1 (99.40% and 99.25%, respectively) 
and the milks Ir2 and US3 (99.20% and 98.07%, respectively). In contrast, 
proportions were low in grains Bel1 and UK3 (0.24% and 0.39%, respectively) 
and milks UK2 and US5 (0.44% and 0.89%, respectively). Naumovozyma was the 
second most prevalent fungal genus, being present in 16 grains and 10 milk 
samples, accounting for 13.09% total grain reads, and 9.98% total milks reads. 
Proportions of Naumovozyma varied from being dominant in Ir9 (96.02%, grain; 
81.87%, milk) and Ir4 (57.56%, grain; 59.41%, milk) to sub-dominant in Ger2 
(2.46%, grain; 0%, milk) and US1 (0.18%, grain; 1.81%, milk), amongst others. 
Notably, although no Naumovozyma were detected in grain Fr1, this genus 
became dominant in the resultant kefir milk (59.3%), again suggesting the 
presence of Naumovozyma in the grain below the detection threshold. The third 
most commonly assigned genus was Kluyveromyces, which was detected in 17 
of the grains and 18 of the milks, accounting for 7.6% and 7.32% of total grain 
and milk reads respectively. Although Kluyveromyces was present at a high of 
50.16% in the milk of Bel1, this genus was more frequently present at sub-
dominant proportions, with a detected low of 0.05% in the milk of Ir1. At genus 
level, many of the reads corresponding to the Saccharomycetaceae could not be 
reliably assigned. These corresponded to >50% of reads corresponding to grains 
Bel1, Fr1, Ger1, Ger2, It1, UK1, UK3, UK4 and UK5 and milks Ger1, It1, UK2 and 
US5. This is likely a result of such high similarity amongst ITS sequences that 
they cannot be reliably separated and assigned. Despite numerical differences 
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in the proportions of the different fungal genera present in the kefir grains and 
milks, the only significant difference related to a higher proportion of Dekkera in 
the milks than in the grains (p=0.004). The kefir milks also contained a larger 
number of different genera, often at trace levels, which were not detected in 
the corresponding grains. These included Zygosaccharomyces, Wallemia, 
Eurotium, Microdochium, Cryptococcus, Teratosphaeria, Debaromyces, 
Cyberlindnera, Malassezia, Heterobasidion, Neofabraea, Peziza, Ganoderma, 
Mycena and Dioszegia. Penicillium and Aureobasidium were each detected in 
only a single instance, i.e. in kefir grain Sp1 (0.13%) and grain UK3 (0.09%), 
respectively.  
Unlike the 16S reads which are subject to a high level of sequence 
homology, the ITS reads were sufficiently dissimilar to enable assignment to 
species level. Table 1 shows the total number of different species identified and 
whether there has been a previous association with kefir. The population profile 
at species level strongly mirrors that at genus level.  The most common species, 
Kazachstania unispora, was present in 20 grains and all milks. All reads from the 
Kluyveromyces and Naumovozyma genera were assigned to the species 
Kluyveromyces marxianus and Naumovozyma castelli, respectively (Table S6; 
Table S7). Although the Saccharomyces genus was identified in small amounts 
in a number of grains and milks, only those in Ir5 were assigned at the species 
level (to Saccharomyces cerevisiae).  
 
 
 Table 1: List of fungal species identified in the study, listed in teleomorph form with anamorph or synonym names and previous kefir 
association  
Species (Teleomorph)  Anamorph Synonym  Previous Kefir Association 
Kazachstania barnettii  N/A Saccharomyces barnettii No  
Kluyveromyces marxianus Candida kefyr Kluyveromyces fragilis,  Candida pseudotropicalis Yes (Zhou et al., 2009) 
Kazachstania unispora  N/A Saccharomyces unisporus Yes (Zhou et al., 2009, Leite et 
al., 2012) 
Naumovozyma castelli  N/A Saccharomyces castellii, Naumovia castellii No 
Saccharomyces cerevisiae Candida robusta Saccharomyces oviformis, Saccharomyces italicus Yes (Zhou et al., 2009, Angulo 
et al., 1993) 
Davidiella tassiana  Cladosporium herbarum Mycosphaerella tulasnei, Mycosphaerella tassiana No 
Penicillium sp. Vega 347 N/A N/A No 
Pichia kudriavzevii Candida acidothermophilum Issatchenkia orientalis, Candida krusei,  Yes (Gao et al., 2012) 
Pichia fermentans  Candida lambica Candida fimetaria, Mycoderma lambica, Pichia sp. AWRI 1271 Yes (Lin et al., 1999) (Chen et 
al., 2005) 
Dekkera anomala  Brettanomyces anomalus N/A Yes (Wyder et al., 1997) 
Dekkera bruxellensis Brettanomyces bruxellensis Brettanomyces custersii No 
Zygosaccharomyces lentus  N/A N/A No 
Eurotium amstelodami Aspergillus amstelodami Aspergillus vitis No 
Wallemia sebi  N/A N/A No 
Microdochium nivale N/A Fusarium nivale No 
Cryptococcus sp. Vega 039 N/A N/A No 
Teratosphaeria knoxdaviesii N/A N/A No 
Cyberlindnera jadinii Candida utilis Pichia jadinii,  Hansenula jadinii, Torula utilis, Torulopsis utilis  No 
Malassezia pachydermatis  N/A N/A No 
Heterobasidion annosum  N/A N/A No 
Peziza campestris N/A Kimbropezia campestris No 
Ganoderma lucidum N/A N/A No 
Dioszegia hungarica  N/A Bullera armeniaca, Cryptococcus hungaricus No 
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4.5 DISCUSSION 
The study represents the most comprehensive investigation of the microbial 
population of kefir (both grains and milk) to date. This analysis was facilitated by 
high-throughput sequencing of 16S rRNA (bacteria) and, for the first time, ITS 
(fungi) amplicons, generated from a considerably larger collection of samples 
than has been employed heretofore. The number of reads compare well with 
previous studies i.e. Dobson et al. generated a combined total of 17,416 V4 16S 
rRNA (4,883 reads for the interior grain, 3,455 reads for the exterior grain and 
9,078 reads for the milk fermentate; (Dobson et al., 2011)) while Leite et al. 
generated a total of 14,314 16S rDNA reads (2,641, 2,690 and 8,983 reads for 
the three grains sequenced, respectively (Leite et al., 2012)). In each index, 
alpha diversity values were reflective of a naturally low diversity and a 
homogeneity between kefir samples, relative to other environmental analyses, 
and rarefaction patterns were consistent with that of previous kefir studies 
(Dobson et al., 2011, Leite et al., 2012). 
16S rRNA profiling revealed that the bacterial population of kefir milks 
tested is composed of Actinobacteria, Firmicutes and Proteobacteria, with 
Bacteroidetes also being detected in the grain. The kefir grains were dominated 
by Lactobacillaceae/Lactobacillus, establishing that this pattern, which was 
previously noted in high-throughput sequencing-based studies of a much 
smaller number of kefirs (Simova et al., 2002, Dobson et al., 2011), is consistent. 
In contrast, Streptococcaceae dominate in the kefir milk. More specifically, 
lactococci dominate as other genera from this family were not detected. This 
contrasts with a subset of previous studies in which Streptococcus species have 
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been identified (Simova et al., 2002, Yuksekdag et al., 2004, Leite et al., 2012). 
The next most common LAB were Leuconostoc spp.; Leuconostoc have been 
associated with kefir on a number of previous occasions (Lin et al., 1999, 
Garrote et al., 2001, Mainville et al., 2006, Motaghi et al., 1997), but the data 
presented here reveals for the first time that the proportions of this genus 
increase considerably in the milk relative to the grain where they may 
significantly impact the sensory profile of kefirs. Acetobacteraceae (genus 
Acetobacter) were also identified as major components of the bacterial 
population of many grains despite having been identified in some (Garrote et 
al., 2001, Miguel et al., 2010), but not all, previous kefir studies. However, given 
that kefir milks in which acetic acid bacteria were present at only very low levels 
(e.g. Bel1, Ir2, UK1), or were not detected (e.g. Fr1, UK3), underwent a 
successful fermentation, as determined by a reduction in pH and milk 
coagulation after 24-48 hours (data not shown), it may be that acetic acid 
bacteria are not strictly required for the fermentation process but rather 
contribute in some other way. Our further studies will focus on elucidating the 
precise contribution of specific populations on the consistency of kefir milk. The 
fact that Lachnospiraceae and Ruminococcaceae are present in several grains 
but not detected in the milk samples implies a poor ability to proliferate in the 
milk medium. Bifidobacteria were detected in two grains only (Ir9, 0.81% and 
UK2, 0.10%). These findings, coupled with previous studies, establish that 
bifidobacteria represent only a minor proportion of the kefir grain consortium. 
Furthermore, its poor endurance in the kefir milk suggests that it would need to 
be added in an encapsulated, or other such form, if kefir were to be employed 
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as a vehicle for Bifidobacterium supplementation (Gonzalez-Sanchez et al., 
2010). High-throughput sequencing also effectively unveiled the presence of a 
number of other rare populations in the kefir grains, which accounted for <1% 
of the overall population in most kefirs. Of these, Faecalibacterium, Allistipes, 
Rickenellaceae, Allobaculum and Enterococcus have not been identified in kefir 
previously and are typically associated with gut microbial populations. In 
contrast, Pseudomonas spp., identified in the grains of other high-throughput 
sequencing efforts in trace amounts, were not identified in these kefirs (Dobson 
et al., 2011, Leite et al., 2012).  
After investigating the application of several ITS-specific databases, such 
as UNITE (http://unite.ut.ee/index.php), it was found that ITSoneDB, which 
consists of a comprehensive set of well-annotated and phylogenetically-
classified ITS1 sequences derived form from Genbank and arranged on the NCBI 
taxonomy tree, gave the best assignment levels (Santamaria et al., 2012). The 
composition of the kefir-associated yeast population has been the subject of 
some attention (Farnworth, 2005, Lopitz-Otsoa et al., 2006) which has not been 
helped by nomenclature-related difficulties and a reliance, to date, on culture-
based investigations. The Saccharomycetaceae have a poorly defined group-
specific morphology and such a basis for classification can lead to unreliable 
distinction of species from close relatives. Furthermore, many yeasts of the 
Ascomycota and Basidiomycota have sexual (teleomorphic) and asexual 
(anamorphic) states of reproduction, sometimes leading to classification of 
species under two names. It has been proposed that in 2013, fungi shall be 
known by only their teleomorph name, unless in extenuating circumstances 
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(Hawksworth, 2011), and thus this approach has been taken here. Examination 
of the literature highlights that Candida kefyr has previously been shown to 
constitute up to 90% of the yeast population in kefir milk (Kwon et al., 2003) 
and has routinely been isolated from kefir (Witthuhn et al., 2005, Engel et al., 
1986, Kwon et al., 2003). Despite a significant presence in the ITS database, no 
Candida were detected in this study. Notably, however, a number of reads 
which displayed similarity with C. kefyr were instead assigned to the 
corresponding teleomorph, Kluyveromyces marxianus, by virtue of higher 
percent similarity. Kluyveromyces marxianus has previously been associated 
with kefir (Latorre-Garcia et al., 2007, Gao et al., 2012, Loretan et al., 2003). 
The dominant yeast detected in this study was Kazachstania, consisting 
of Kazachstania barnetti and Kazachstania unispora. K. unispora was previously 
known as Saccharomyces unipsorus (Kurtzman, 2003), which has been identified 
in kefir (Latorre-Garcia et al., 2007, Loretan et al., 2003, Zhou et al., 2009, 
Magalhaes et al., 2011, Gao et al., 2012)  and has been associated with other 
fermented beverages (Montanari et al., 1996, Las Heras-Vazquez et al., 2003). It 
would appear that K. unispora is particularly well adapted to the dairy 
environment as it is the most prevalent species, out-competing rival species 
including K. barnetti. This marks the first time K. barnetti, found in the grain but 
not in the milk, has been identified in a kefir environment. Naumovozyma is a 
genus that closely resembles Saccharomyces and Kazachstania, and the species 
identified here, Naumovozyma castellii, was reclassified from Saccharomyces 
castellii in the past (Kurtzman and Robnett, 2003). Although it has not 
previously been linked with kefir, the only other species in the genus, 
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Naumovozyma dairenensis (formerly Saccharomyces dairenensis) has been 
(Martini and Kurtzman, 1988). In contrast to the significant presence of the 
aforementioned fungal species, the relative absence of Saccharomyces is at first 
striking given its historical association with kefir. This is most likely reflective of 
the reclassification of Naumovozyma and Kazachstania. Despite this, it is 
notable that previous studies have suggested that Saccharomyces cerevisiae is 
quite common in kefir (Gao et al., 2012, Motaghi et al., 1997, Simova et al., 
2002) whereas here the genus was detected in just three grains and three milks, 
and in trace amounts. It is possible that this genus is not as widespread as 
previous evidence suggested or may have been misassigned in previous studies. 
Alternatively, Saccharomyces may be more common in kefirs from geographic 
locations not included in this study. The origin of the grain may also have been 
significant with respect to the identification of Pichia kudriavzevii (previously 
known as Issatchenkia orientalis) at levels that were atypically high, relative to 
other samples, in the Spanish kefir (grain, 0.57%; milk, 34.27%). Notably, 
Latorre-Garcia et al identified Issatchenkia orientalis as one of the most 
representative species of Spanish kefir (Latorre-Garcia et al., 2007) and, until 
recently (Gao et al., 2012), it had not been found among non-Spanish kefir 
grains or milks. With respect to other species, it was also notable that 
Torulaspora delbreuckii was not detected in this study despite the fact that both 
it (Angulo et al., 1993, Loretan et al., 2003) and its anamorph form, Candida 
colliculosa, have previously been detected in kefir (Wyder et al., 1997). There 
were also many instances whereby we identified species not previously 
detected in kefir milks, for instance while Dekkera anomala (anamorph: 
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Brettanomyces anomalus) has been isolated from kefir (Wyder et al., 1997), 
Dekkera bruxellensis (anamorph: Brettanomyces bruxellensis) has not been 
isolated from kefir before now (but has been found in traditional fermented 
Mongolean and Zimbabwean milks (Gadaga et al., 2001, Miyamoto et al., 
2010)). Other species which had not previously been detected, but were 
present in lower abundance and few (often just one) milk sample(s) included 
Cryptococcus sp. Vega 039, Zygosaccharomyces lentus, Penicillium sp. Vega 347, 
Wallemia sebi, Ganoderma lucidum, Cyberlindnera jadinii, Eurotium 
amstelodami, Heterobasidion annosum, Peziza campestris, Teratosphaeria 
knoxdaviesii, Dioszegia hungarica and Malassezia pachydermatis. Cryptococcus 
and Zygosaccharomyces have been found in kefir before (Witthuhn et al., 2005), 
but this marks the first identification of the respective species, Cryptococcus sp. 
Vega 039 and Z. lentus. Cryptococcus is a ubiquitous basidiomycotic yeast that 
was previously identified in a kefir that had been frozen and recultivated. This 
point is noted as the Cryptococcus-associated milks described in the current 
study resulted from two kefir grains, Ir8 and Ir9, which had been recultivated 
from -80°C storage. Z. lentus is considered a food spoilage organism associated 
with low-pH beverages and can grow at low temperatures (Steels et al., 1999). 
C. jadinii is used in animal and human dietary supplements, and is a good source 
of vitamins, minerals, proteins and essential amino acids (Lee and Kim, 2001). 
Despite not being isolated from kefir, it has been used to scale-up single-cell 
protein production using kefir (Koutinas et al., 2005). Additionally, E. 
amstelodami is frequently isolated from bakers products (Abellana et al., 1999). 
H. annosum, P. campestris, T. knoxdaviesii and D. hungarica are all regarded as 
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environmental fungi. H. annosum is the causative agent in the root and butt rot 
of pine trees (Asiegbu et al., 2005), Peziza is associated with saprophytic cup 
fungal growth on rotten wood (Hansen et al., 2005), Teratosphaeria have been 
described as eucalyptus pathogens (Hunter et al., 2009) and D. hungarica has 
been shown to inhabit arbuscular mycorrhizal fungi (Renker et al., 2004). M. 
pachydermatis, detected in Ir9, is a known pathogen which threatens neonatal 
infants and has been associated with domesticated canines (Chang et al., 1998). 
Finally, in multiple samples (Bel1, Fr1, Ger1, Ger2, It1 and UK1-5), many 
Saccharomycetaceae-associated reads could not be assigned at the genus level 
and were designated as “other” (Figure 4). It is anticipated that as more fungal 
sequences are deposited, the species corresponding to these reads can be 
uncovered. The PCoA plots visualising the kefir microfloras do not show any 
obvious clustering amongst the different kefirs, showing the diversity between 
kefir populations regardless of their source.  
The fact that natural kefir is capable of hosting several health-associated 
organisms suggests it could theoretically be altered to incorporate pre-
established and certified probiotic strains, with minimal sensory impact. Indeed, 
the ultimate application of kefir may be as a potential delivery system for viable 
health-promoting organisms to the gut (Ivanova et al., 2012). However, the fact 
that grains have yet to be produced from pure culture (Chen et al., 2009a) 
suggests that there remains a lot to be understood regarding the population 
dynamics of kefir grains. 
In conclusion, the study represents the most comprehensive 
investigation of the microbial composition of kefir grains and milks to date. It 
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provides important information that may facilitate the reconstitution of kefir 
grains to create tailored kefir grains and milks while further investigation of the 
specific components identified can reveal their contribution to the kefir grain 
structure and the health-promoting aspect of the associated beverages.  
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CHAPTER V 
Sequence-based analysis of the microbial composition of water kefir from 
multiple sources 
 
 
 
 
 
 
 
 
 
 
 
FEMS Microbiology Letters (2013) Accepted 
 
 - 194 - 
5.1 ABSTRACT 
Water kefir is a water-sucrose based beverage, fermented by a symbiosis of 
bacteria and yeast to produce a final product that is lightly carbonated, acidic 
and that has a low alcohol percentage. The microbes present in water kefir are 
introduced via water kefir grains, which consist of a polysaccharide matrix in 
which the microorganisms are embedded. We aimed to provide a 
comprehensive sequencing-based analysis of the bacterial population of water 
kefir beverages and grains, while providing an initial insight into the 
corresponding fungal population. To facilitate this objective, four water kefirs 
were sourced from the UK, Canada and the United States. Culture-independent, 
high-throughput, sequencing-based analyses revealed that the bacterial fraction 
of each water kefir and grain was dominated by Zymomonas, an ethanol-
producing bacterium, which has not previously been detected at such a scale. 
The other genera detected were representatives of the lactic acid bacteria and 
acetic acid bacteria. Our analysis of the fungal component established that it 
was comprised of the genera Dekkera, Hanseniaspora, Saccharomyces, 
Zygosaccharomyces, Torulaspora and Lachancea. This information will assist in 
the ultimate identification of the microorganisms responsible for the health-
promoting attributes of these beverages. 
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5.2 INTRODUCTION 
Water kefir is a water-sucrose beverage that is fermented to produce carbon 
dioxide and low concentrations of ethanol. Traditionally, figs or other dried fruit 
and lemon are added to provide additional minerals and flavour, with acidity 
being proportional to the length of the fermentation process. Water kefir is 
fermented via a combination of bacteria and yeast which live in symbiosis in 
water kefir grains. Also known as Tibicos or sugary kefir, water kefir differs from 
the more popular milk-based kefir in that the grains are principally composed of 
dextran, and are translucent and crystal-like in appearance (Neve and Heller, 
2002).  
There are two prevalent theories as to the origin of water kefir, but the 
exact source remains unknown. The first theory is that soldiers returning from 
the Crimean war brought grains to western Europe (Ward, 1892), while the 
second proposes the spontaneous formation of grains on the pads of the 
Opuntia cactus in Mexico (Lutz, 1899). Regardless, water kefir grains were 
passed from household to household and this is still the most common means 
by which grains and beverages are acquired as water kefir production has yet to 
be commercialised on a significant scale.  
Water kefir is less studied than other fermented beverages such as milk 
kefir or kombucha and, as such, any claimed health benefits have yet to be 
confirmed. Culture-based studies have shown that the bacterial component is 
comprised of a varied mixture of Lactobacillus, Lactococcus, Leuconostoc and 
Acetobacter (Pidoux, 1989, Pidoux et al., 1990, Franzetti et al., 1998, Neve and 
Heller, 2002, Gulitz et al., 2011). Culture-independent methods have also been 
 - 196 - 
used to assess the microbial populations of water kefir, including one recent 
study that used high-throughput sequencing to assess the bacterial component 
of four water kefir grains (Gulitz et al., 2013). The yeast component has most 
commonly been identified, via culture-based studies, as Saccharomyces, 
Hanseniaspora/Kloeckera, Zygotorulaspora and Candida (Pidoux, 1989, Neve 
and Heller, 2002, Waldherr et al., 2010, Gulitz et al., 2011). It is estimated that 
bacteria are present in the grains at approx 106-108 per gram, with yeast 
numbers at 106-107 per gram (Gulitz et al., 2011).  
As a potential functional/health-promoting food, it is noteworthy that 
water kefir contains strains from species with which health benefits have been 
frequently attributed, such as lactobacilli, bifidobacteria (Gulitz et al., 2013) and 
to a lesser extent, Saccharomyces-related yeasts (Czerucka et al., 2007, 
Desreumaux et al., 2011, Foligne et al., 2010). Water kefir therefore represents 
a potentially effective means of probiotic delivery. With this in mind, the aim of 
this study was to characterise the bacterial and, to a lesser extent, yeast 
components within water kefir using high-throughput, culture-independent 
techniques. This study represents the first occasion upon which high-
throughput sequencing has been utilised to investigate the fungal component of 
water kefir, and together with the corresponding bacterial analysis, provides a 
comprehensive insight into the microbiological profile of water kefir. It is worth 
noting that this study reports the microbial composition of water kefir grains 
composed of dextrose, which have not been associated with milk fermentation, 
unlike a small number of studies reporting water kefir that would appear to 
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have been prepared from milk kefir grains introduced into sucrose-water 
solution (Puerari et al., 2012, Miguel et al., 2011). 
 
5.3 MATERIALS AND METHODS 
5.3.1 Culture maintenance 
Four water kefir grains were acquired from commercial and individual suppliers 
from Canada [Ca], the UK [UK] and the United States [US1 and US2]. The 
cultures were fermented under uniform conditions by adding 60g grains/litre of 
sterilised Ballygowan® mineral water supplemented with 10% sucrose, followed 
by the addition of one dried, organic fig (Rainbow Organic Wholefoods, Ireland). 
The culture was fermented at 25°C and after 24 hours DNA was extracted from 
the fermentate and the grains. Each culture was routinely changed two times 
per week for a minimum of 10 fermentation cycles prior to extraction and 
cultures were kept separate from one another to prevent cross-contamination.  
 
5.3.2 Metagenomic DNA extraction 
 To extract DNA from the fermentate, 1.8mls was centrifuged to generate a 
pellet which was suspended in 450 μl of lysis buffer P1 from the Powerfood 
Microbial DNA Isolation kit (MoBio Laboratories Inc, USA). The resuspended 
pellet was subjected to enzymatic digestion with enzymes mutanolysin (100 
U/ml; Sigma) and lysozyme (50 μg/ml; Sigma) at 37°C for 1 hour, followed by 
proteinase K (250 μg/ml; Sigma) digestion at 55°C for 1 hour. Extraction was 
optimised with a 10 minute 70°C incubation (Quigley et al., 2012) prior to 
mechanical lysis. The Powerfood Microbial DNA Isolation kit was then used as 
 - 198 - 
per the manufacturer’s instructions. For extraction of DNA from the grain, 1g of 
grains were washed twice in sterile H2O and homogenised using a mortar and 
pestle, after which DNA was isolated using a modified phenol-chloroform-based 
extraction procedure (Garbers et al., 2004). 
 
5.3.3 DNA amplification and pyrosequencing 
 PCR amplification of the V4-V5 variable region (408 bp) of the 16S rRNA gene 
was performed using the universal primers F1 (5’-AYTGGGYDTAAAGNG) and R5 
reverse (5'-CCGTCAATTYYTTTRAGTTT) to allow an investigation of the bacterial 
component of the microbial populations (Claesson et al., 2010). Unique 
multiplex identifier adaptors were attached between the 454 adaptor 
sequences and the forward primers. Tagged universal primers were also used to 
amplify fungal DNA from the variable ITS-1 rRNA region (Buee et al., 2009). In 
this instance the forward primer ITS1F (5’-CTTGGTCATTTAGAGGAAGTAA) and 
ITS2 reverse (5’-GCTGCGTTCTTCATCGATGC) generated two different sets of PCR 
products of circa 410 bp and 250 bp. To prevent preferential sequencing of the 
smaller-sized reads, these were pooled and sequenced separately. Amplicons 
generated from three PCR reactions of template DNA were pooled and cleaned 
using the Agencourt AMPure® purification system (Beckman Coulter; Takeley, 
UK). Sequencing of the 16S rRNA V4-V5 and ITS1 rDNA ribosomal amplicons was 
performed using a 454 Genome Sequencer FLX (Roche Diagnostics Ltd, Burgess 
Hill, West Sussex, UK) at Teagasc Food Research Centre, Moorepark.  
 
 
 - 199 - 
5.3.4 Pyrosequencing data analysis 
 Raw sequences were quality trimmed and filtered using the Qiime Suite of 
programs (Caporaso et al., 2010). Any reads not meeting a minimum quality 
score of 25 and sequence length shorter than 150 bps for 16S amplicon reads 
and 200 bps for ITS amplicon reads were discarded. Trimmed fasta sequences 
were assessed by BLAST analysis against the SILVA database (version 100) for 
16S reads and a previously published ITS-specific database for ITS samples 
(Pruesse et al., 2007, Santamaria et al., 2012). BLAST outputs were parsed using 
MEGAN (Huson et al., 2007); a bit-score of 86 was employed for 16S ribosomal 
sequence data, and a bit-score of 35 was used for ITS sequence data. Reads 
were deposited in the SRA database under the accession number ERP002661. 
 
5.4 RESULTS AND DISCUSSION  
5.4.1 High-throughput sequencing reveals the alpha and beta diversity of the 
bacterial population in water kefir  
In this study, both grains and fermentates were analysed, as it has been shown 
that the grains and fermentates of associated beverages can differ (e.g. milk 
kefir), with the solid material typically having a more complex microbial 
population than the final fermented beverage (Marsh et al., 2013). To prevent 
an origin-based bias, water kefir was sourced from different geographical 
locations, and was fermented to simulate natural artisanal fermenting 
conditions. DNA was extracted from both the grain and 24-hour fermentate to 
afford the most accurate assessment of total microbial population.  
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Amplicons corresponding to the V4-V5 variable region of the bacterial 
16S rRNA gene were generated using universal tagged primers. To determine 
species richness and diversity, Chao1 values and Shannon and Simpson indices 
were calculated, in addition to Phylogenetic Diversity and Observed Species 
numbers (Table S1). Values for these were low by comparison to other 
environmental analyses, highlighting low alpha diversity. Rarefaction curves 
were calculated at 97% similarity, and are approaching parallel to the x-axis for 
all samples, indicating sufficient reads were obtained to adequately assess the 
bacterial population (Figure S1). Beta diversity was measured using the 
unweighted UniFrac distance matrix. A Principal Coordinate Analysis (PCoA) plot 
was generated based on unweighted UniFrac distance matrices in order to 
visualise any clustering amongst the different groups (Figure S2). No clustering 
was evident based on sample type or origin, but it was apparent that the data 
points corresponding to grains of US2 and Ca were each distantly removed from 
all other data points establishing a quite different beta diversity among these 
samples. ITS rDNA amplicons were in general sequenced at a lower depth and 
thus corresponding alpha and beta diversity analyses were not completed. 
 
5.4.2 The bacterial component of water kefir was dominated by the genus 
Zymomonas, with a LAB and AAB presence  
16S reads from both the grain and the fermentate were assigned to three 
bacterial phyla; Actinobacteria, Firmicutes and Proteobacteria. Across both the 
grains and fermentates, the dominant phyla were Proteobacteria and 
Firmicutes. Proportions of Proteobacteria were in general greater in the grain 
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(>70%) than the fermentates (50-60% abundance for Ca, UK and US1 but 75% 
abundance for US2; Table S2). Proportions of Firmicutes were consistently 
higher in the fermentates than in the grains. The abundance of Actinobacteria 
was low in general but was higher in each of the grains than in the fermentates.  
The most striking difference between a recent high-throughput 
sequencing-based study (Gulitz et al., 2013) and data presented here relates to 
the fact that in this study the most abundant genus was Zymomonas. Indeed, 
Zymomonas was dominant in all grains and fermentates, with proportions being 
consistently higher in the grains. Proportions of Zymomonas ranged from 87% in 
the grain of US1 to 49.5% in the fermentate (Figure 1). Zymomonas is 
traditionally regarded as a fermentation-associated microorganism and forms 
part of the microbial population of several fermented beverages from plants in 
tropical regions of America, Africa and Asia. It has been isolated from Mexican 
pulque, a fermented beverage made from agave sap which resembles water 
kefir if theories with respect to the Opuntia cactus are correct (Ward, 1892). 
Additionally, it has already been established that Zymomonas can constitute 
part of the microbial population of water kefir (Hsieh et al., 2012), albeit not at 
similarly high levels.  
Zymomonas is capable of producing ethanol in such high quantities that 
it rivals the fermentation capabilities of Saccharomyces (Panesar et al., 2006). 
Zymomonas species have also been shown to produce levan, a polysaccharide 
used as a thickening agent, which has been demonstrated to have antitumor 
effects (Calazans et al., 1997, Yoon et al., 2004), immunostimulating activity (Xu 
et al., 2006), effects on lipid metabolism (Yamamoto et al., 1999) and prebiotic  
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Figure 1 
16S phylogenetic composition of the bacterial component of the water kefir 
grain (A) and kefir fermentate (B) at genus level. 
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activity (Dal Bello et al., 2001, Jang et al., 2003). Zymomonas itself has been 
shown to be safe for consumption (de Azeredo et al., 2010) and to have 
beneficial immunomodulatory effects by protecting against sepsis in mice 
(Campos et al., 2013). Further analysis is required to characterise the strains of 
Zymomonas present in these beverages and their contribution, through the 
production of leaven, sorbitol and ethanol, on the consistency, flavour and 
safety of the final beverage. Nonetheless, at the significant proportions 
detected, members of this genus are undoubtedly of considerable importance 
with respect to the composition of these beverages. It should be noted that 
while Zymomonas represents a dominant component of these water kefirs, 
additional studies with a larger number of samples will be required to assess the 
distribution of this genus in beverages from other regions and prepared in 
different ways.  
The majority of non-Zymomonas reads from the water kefir grains and 
fermentates were assigned to the lactic acid bacteria (LAB), and Lactobacillus in 
particular. This genus has long been associated with water kefir and in a number 
of instances has been reported to be the dominant bacterial genus present 
(Gulitz et al., 2013, Gulitz et al., 2011). Here Lactobacillus accounted for 25.4%, 
16.4%, 12% and 22.3% of the grains of Ca, UK, US1 and US2, respectively, and 
38.8%, 38.5%, 23.4% and 25.1% of the corresponding fermentates, respectively, 
and thus proportions increased from the grain to the fermentate in all 
instances. Lactobacillus hilgardii was believed to be the primary 
exopolysaccharide producer in water kefir (Pidoux, 1989, Waldherr et al., 2010), 
whereas Gulitz et al reported L. nagelii and L. hordei to be the major EPS 
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producers (Gulitz et al., 2011). Leuconostoc was recognized as the major LAB in 
the fermentate of US1 (25.6%), but was less abundant in the grain environment 
(Ca, 1.1%; US1, 0.4%). Thus, while water kefir-associated Leuconostoc has been 
shown to be competitive and to be capable of EPS-production (Gulitz et al., 
2011), its detection in such low grain abundance suggests that this genus does 
not contribute significantly to grain formation in these samples. No lactococci 
were detected in our study, despite representatives of this genus having been 
isolated as part of culture-based studies of other water kefirs previously 
(Pidoux, 1989, Waldherr et al., 2010).  
The genera Acetobacter and Gluconacetobacter were represented as a 
minor proportion of the overall bacterial component of water kefir (Figure 1). 
Gluconacetobacter were present in the grains of Ca, US1 and US2 at <1%, and 
were undetected in the fermentates and UK grain, whereas, interestingly, 
Acetobacter appeared to be better adapted to the fermentate (Ca, 0.4%; UK, 
2.8%; US1, 1.1% and US2, 0.6%). Acetic acid bacteria have been consistently 
detected at trace levels in water kefir studies (Franzetti et al., 1998, Gulitz et al., 
2011, Gulitz et al., 2013) but, as yet, no role has been attributed to them.  
Members of the Bifidobacteriaceae family were detected at low 
proportions, but could not be confidently assigned to genus level. The presence 
of Bifidobacterium in water kefir was only recently revealed via high-throughput 
sequencing (Gulitz et al., 2013), but had not been detected by previous culture- 
or molecular-based analyses. Our analysis showed levels of Bifidobacteriaceae 
were lower than in the fermentate (<2%) than the grain (Ca, 3.6%; UK, 7.8%; 
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US1, 0.2% and US2, 2.5%), perhaps indicative of poor survival of representatives 
from this family in a non-EPS protected environment.  
 
5.4.3 Insight into the fungal composition of water kefir and associated water 
kefir grain 
As the primary focus of this study was the investigation of the bacterial 
composition of kefir grains and beverages, fungal (ITS) amplicons were 
sequenced at a much lower depth with a view to providing an initial insight into 
this population. Amplification with ITS primers yielded two amplicons of 
approximately 250 bp and 410 bp, respectively, which were purified and 
sequenced separately. The existence of two pools limited, to a certain extent, 
inter-pool comparisons but the dominant components of the fungal population 
were nonetheless evident. All reads were assigned to the phylum Ascomycota. 
At the family level Saccharomycetaceae and Saccharomycodaceae were 
detected in both the grain and water kefir fermentate, while Debaromycetaceae 
were detected in the fermentate only (Table S3). Almost all reads from the 250 
bp pool were assigned to the genus Dekkera while the 410 bp pool contained 
amplicons corresponding to a variety of species.  
Dekkera was represented by two species, Dekkera anomala and Dekkera 
bruxellensis. Both are common fermentation-associated species, with D. 
bruxellensis frequently associated with the spoilage of fermented beverages 
(Heresztyn, 1986). To our knowledge, Dekkera has not been previously 
identified in water kefir but has been found in other fermented beverages 
(Pintado et al., 1996, Wyder et al., 1997, Miyamoto et al., 2010). The fact that 
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Dekkera has previously been overlooked by culture-based approaches may in 
part be due to the fact that it has a slow doubling time when cultured on 
standard yeast media and, thus, can be outcompeted by other genera such as 
Saccharomyces (Ibeas et al., 1996).  
From the 410 bp pool, proportions of Saccharomyces were highest in the 
fermentate of US1. Saccharomyces were also detected in the fermentates of Ca 
and US2, despite having not been detected in the corresponding grains (Table 
S3). Saccharomyces could only be assigned to the species level among ITS reads 
corresponding to the UK grain, with 1.3% of reads being assigned as 
Saccharomyces cerevisiae. This has previously been identified as a key yeast in 
several water kefirs (Franzetti et al., 1998, Gulitz et al., 2011). Despite this, the 
proportions of Saccharomyces detected in our study were lower than expected. 
Waldherr et al also noted this phenomenon, which suggests that levels of 
Saccharomyces may have been overestimated in previous studies (Waldherr et 
al., 2010). The genus Hanseniaspora, whose anamorphic form is Kloeckera, has 
frequently been detected in water kefir, most often as Hanseniaspora 
valbyensis and Hanseniaspora vineae (Galli et al., 1995, Franzetti et al., 1998, 
Waldherr et al., 2010, Gulitz et al., 2011). Both species were also detected in our 
study. While H. vineae was detected in more samples, it was generally (with the 
exception of US1) present at a lower abundance than H. valbyensis. H. 
valbyensis was most prominent in the Ca fermentate, and was also present in 
the US1 fermentate and UK grain. The genus Lachancea was not detected in the 
fermentate, but was found in the grain of UK, with all reads being assigned to 
Lachancea fermentati. This species was formerly known as Zygosaccharomyces 
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fermentati (Kurtzman, 2003) and has been detected in water kefir previously 
(Gulitz et al., 2011). Torulaspora was detected in the grain of UK and the 
fermentates of US1 and US2, but could not be assigned at the species level. 
Torulaspora has been identified in water kefir on only one previous occasion as 
Torulaspora pretoriensis (Pidoux, 1989). Zygotorulaspora florentina (formerly 
Zygosaccharomyces florentinus/Saccharomyces florentinus (Kurtzman, 2003)) 
was unexpectedly not identified in any of the cultures, despite frequently 
appearing as a dominant species in previous analyses (Gulitz et al., 2011, Neve 
and Heller, 2002, Pidoux, 1989). While it is possible that it was present in lower 
abundance and thus was below our detection limits, this species probably does 
not exert the positive impact on the growth of lactobacilli that that has been 
attributed to it in previous studies (Leroi and Pidoux, 1993a, Stadie et al., 2013, 
Leroi and Pidoux, 1993b). It may be that another species of yeast performs this 
role within the samples assessed on this occasion.  
Finally, two other yeast have been detected which have not previously 
been associated with water kefir. One species of Zygosaccharomyces, 
Zygosaccharomyces lentus, was detected at low levels in the fermentate of UK 
and grains of Ca, US1 and US2. Z. lentus is often considered a spoilage yeast 
(Steels et al., 1999) and this is the first report of the detection of this species in 
water kefir. Meyerozyma was detected in the fermentates of US1 and US2, but 
of these reads only 0.3% from US2 could be assigned at the species level (from 
the 250 bp pool; Table S4) to Meyerozyma caribbica.  
In conclusion, we have established that the bacterial population of a 
number of water kefirs analysed through high-throughput sequencing consists 
 - 208 - 
of a dominant population of Zymomonas with lactic acid bacteria (Lactobacillus, 
Leuconostoc), acetic acid bacteria (Acetobacter and Gluconacetobacter) and 
Bifidobacteriaceae being detected in descending proportions. While dextran-
producing lactic acid bacteria are not the dominant bacteria, it would seem that 
the possibility exists for the modulation of the microbiology of water kefir 
through the introduction of non-indigenous lactobacilli and bifidobacteria to 
facilitate its use as a non dairy-based system for the delivery of probiotics. Our 
results revealed that the yeast component of the water kefir samples was 
comprised of several species previously associated with water-kefir, but notably 
a number of species not traditionally associated with water kefir, including 
Dekkera, Zygosaccharomyces and Meyerozyma were also identified. 
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Sequence-based analysis of the bacterial and fungal compositions of multiple 
kombucha (tea fungus) samples 
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6.1 ABSTRACT 
Kombucha is a sweetened tea beverage that, as a consequence of fermentation, 
contains ethanol, carbon dioxide, a high concentration of acid (gluconic, acetic 
and lactic) as well as a number of other metabolites and is thought to contain a 
number of health-promoting components. The sucrose-tea solution is 
fermented by a symbiosis of bacteria and yeast embedded within a cellulosic 
pellicle, which forms a floating mat in the tea, and generates a new layer with 
each successful fermentation. The specific identity of the microbial populations 
present has been the focus of attention but, to date, the majority of studies 
have relied on culture-based analyses. To gain a more comprehensive insight 
into the kombucha microbiota we have carried out the first culture-
independent, high-throughput sequencing analysis of the bacterial and fungal 
populations of 5 distinct pellicles as well as the resultant fermented kombucha 
at two time points. Following the analysis it was established that the major 
bacterial genus present was Gluconacetobacter, present at >85% in most 
samples, with only trace populations of Acetobacter detected (<2%). A 
prominent Lactobacillus population was also identified (up to 30%), with a 
number of sub-dominant genera, not previously associated with kombucha, also 
being revealed. The yeast populations were found to be dominated by 
Zygosaccharomyces at >95% in the fermented beverage, with a greater fungal 
diversity present in the cellulosic pellicle, including numerous species not 
identified in kombucha previously. Ultimately, this study represents the most 
accurate description of the microbiology of kombucha to date.   
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6.2 INTRODUCTION 
Kombucha is a sweetened, black tea beverage, which is fermented to contain 
ethanol and carbon dioxide. Traditionally fermented for 8-10 days, kombucha 
has a sour taste, resembling that of sparkling apple cider, which develops over 
prolonged fermentation into a mild vinegar flavour (Blanc, 1996, Reiss, 1994). 
The tea is fermented by the presence of a cellulosic pellicle or mat that rests 
above the broth forming a fresh layer with each successful fermentation. The 
fermentation itself is performed by a symbiosis of bacteria and yeast embedded 
within the cellulosic matrix. Kombucha, known by several names, including tea 
fungus and Haipao (Liu et al., 1996), has been brewed in China for over 2000 
years, where it was fermented by many households. Although probiotic effects 
have yet to be directly associated with kombucha-derived microorganisms 
(Kozyrovska et al., 2012), initial studies have shown promising health benefits in 
relation to the tea itself. Such health benefits include anti-carcinogenic 
(Jayabalan et al., 2011) and anti-diabetic (Hiremath et al., 2002, Aloulou et al., 
2012) effects, treatment for gastric ulcers (Banerjee et al., 2010) and high 
cholesterol (Yang et al., 2009), and it also has been shown to impact immune 
response (Ram et al., 2000) and liver detoxification (Loncar et al., 2000).  
The majority of microbiology-orientated studies of kombucha to date 
have been culture-based. These are limited in that certain species can be 
difficult to isolate and the exclusive reliance on phenotypic traits can lead to 
misidentification (Raspor and Goranovic, 2008). Additionally, culture-based 
studies tend to be low-throughput and thus only a certain proportion of isolates 
will ever be investigated. Traditionally, only a few genera of bacteria have been 
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isolated from kombucha, most frequently Acetobacter (Hesseltine, 1965, Sievers 
et al., 1996, Liu et al., 1996, El-Salam, 2012, Dutta and Gachhui, 2006, Zhang et 
al., 2011, Chen and Liu, 2000), but species of Gluconacetobacter and 
Lactobacillus have also been identified (Zhang et al., 2011, Wu et al., 2004, 
Trovatti et al., 2011, Yamada et al., 1997, Yang et al., 2010). The most important 
of these species are those which produce bacterial cellulose, such as 
Komagataeibacter xylinus, which was recently reclassified from 
Gluconacetobacter xylinus (Yamada et al., 2012) (also previously known as 
Acetobacter xylinum (Yamada et al., 1997)) and is considered the best studied 
and most efficient bacterial cellulose producer in kombucha (Mikkelsen et al., 
2009, Strap et al., 2011). The yeast population is generally believed to be more 
varied in composition (Mayser et al., 1995, Teoh et al., 2004). Yeasts identified 
include species of the genera Zygosaccharomyces, Candida, 
Kloeckera/Hanseniaspora, Torulaspora, Pichia, Brettanomyces/Dekkera, 
Saccharomyces and Saccharomycoides (Teoh et al., 2004, Liu et al., 1996, 
Mayser et al., 1995, Hesseltine, 1965, Jankovic and Stojanovic, 1994, Chen and 
Liu, 2000, Markov et al., 2001). The role of yeasts in the fermentation of 
kombucha is to convert sucrose to organic acids, carbon dioxide and ethanol, 
with the latter then used by acetic acid bacteria to form acetaldehyde and 
acetic acid. Acetic acid bacteria also use yeast-derived glucose to synthesise 
bacterial cellulose and gluconic acid (Dufresne and Farnworth, 2000, Greenwalt 
et al., 1998). Bacterial and yeast numbers are generally thought to reach 104 – 
106 cfu ml-1 ml in the kombucha after approximately 10 days of fermentation, 
with yeast slightly outnumbering bacteria (Teoh et al., 2004, Chen and Liu, 2000, 
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Goh et al., 2012). Microbial counts have been reported to be greater in the tea 
broth than the cellulosic pellicle (Goh et al., 2012). It has also been found that 
the viability of the microbes present decreases gradually over the course of the 
fermentation due to oxygen starvation and extremely acidic (pH 2.5) conditions 
(Chen and Liu, 2000). While first generation (Sanger) sequencing of 16S rRNA 
genes has been used to identify kombucha bacterial isolates (El-Salam, 2012, 
Trovatti et al., 2011, Dutta and Gachhui, 2006), the significant developments in 
the field of microbial ecology that have been possible through the use of high-
throughput, culture-independent techniques (Ercolini, 2013) have, to date, yet 
to be applied to kombucha populations.  
In this study, high-throughput amplicon sequencing was performed on 
DNA extracts from cellulosic pellicles sourced from 5 distinct geographic 
locations and from the corresponding kombuchas at two time points during 
fermentation. This analysis provides the most in-depth analysis of the 
kombucha microflora to date. 
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6.3 MATERIALS AND METHODS 
6.3.1 Culture maintenance 
Five kombucha cellulose pellicles with approximately 200 ml starter culture 
were acquired from suppliers from different geographic locations. Two 
kombucha samples were sourced from Canada and designated Ca1 and Ca2; 
other kombucha samples were sourced from the United Kingdom (UK), United 
States (US) and Ireland (Ire). All kombuchas were cultivated under uniform 
conditions. 2L of tap water was sterilised at 121°C for 15mins in a 3L glass 
container. The water was brought to the boil and 0.49% w/v black tea (Barry’s 
Original Blend) was added, and allowed to steep for 15 mins. After removal of 
the tea leaves, 10% sucrose was added and stirred to dissolve. Once the 
sucrose-tea solution had cooled to room temperature, 10% fermented tea (of 
the previous fermentation brew from kombucha with the same origin, 
corresponding to the aforementioned starter culture) was added to acidify the 
solution. The cellulose pellicle was placed in the culture, light side up. The 
container was covered with a 100% cotton towel and fixed with an elastic band. 
Cultures were fermented at room temperature (23°C) and re-inoculated into 
fresh tea every 10 days. Samples were taken at days 3 and 10 of fermentation 
for DNA extraction.  
 
6.3.2 Metagenomic DNA extraction 
To extract DNA from the fermented kombucha at day 3 and 10 of fermentation, 
1.8ml of fermented tea was centrifuged to generate a pellet which was 
suspended in 450μl of lysis buffer P1 from the Powerfood Microbial DNA 
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Isolation kit (MoBio Laboratories Inc, USA). The resuspended pellet was 
subjected to enzymatic digestion with enzymes mutanolysin (100U/ml) and 
lysozyme (50μg/ml) at 37°C for 1 hour, followed by proteinase K (250μg/ml) 
digestion at 55°C for 1 hour. Extraction was optimised with a 10 minute 70°C 
incubation (Quigley et al., 2012) prior to mechanical lysis using the Qiagen 
TissueLyser II (Retsch®). The Powerfood Microbial DNA Isolation kit was then 
used as per the manufacturer’s instructions. Pure DNA was eluted in HPLC-
grade sterile water. For extraction of DNA from the pellicle, 0.25g of cellulosic 
pellicle was removed from the surface mat of a fresh fermentation, washed 
twice in sterile H2O, and chopped into small fragments using a sterile blade. 0.3g 
of sterile glass beads and 750μl of cellulase (Sigma-Aldrich) were added to a 
microcentrifuge tube containing the pellicle, which was mechanically lysed for 
10mins in a Qiagen TissueLyser II (Retsch®). The solution was incubated for 1 
hour at 40°C, after which it was centrifuged to generate a pellet. The 
supernatant was discarded and the pellet was resuspended in 450μl of pre-
warmed buffer P1. The extraction was then subjected to enzyme digestion and 
the modified Powerfood extraction was performed as described above. 
 
6.3.3 DNA amplification and high-throughput sequencing 
Metagenomic DNA extracts were used as a template for PCR amplification. PCR 
amplification of the V4-V5 variable region (408 bp) of the 16S rRNA gene was 
performed using the universal primers F1 (5’-AYTGGGYDTAAAGNG) and R5 
reverse (5'-CCGTCAATTYYTTTRAGTTT) to facilitate an investigation of the 
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bacterial component of the microbial populations (Claesson et al., 2010). 
Unique multiplex identifier adaptors were attached between the 454 adaptor 
sequences and the forward primers to facilitate the pooling and subsequent 
differentiation of samples. Tagged universal primers were also used to amplify 
fungal DNA from the variable internal transcribed spacer (ITS)-1 rDNA region 
(Buee et al., 2009). In this instance the forward primer ITS1F (5’-
CTTGGTCATTTAGAGGAAGTAA) and ITS2 reverse (5’-GCTGCGTTCTTCATCGATGC) 
generated two different sets of PCR products of circa 410 bp and 250 bp. To 
prevent preferential sequencing of the smaller amplicons, the bands were 
extracted separately using the Roche High Pure PCR Cleanup Micro Kit, and two 
pools were created and sequenced separately. The PCR conditions used for 16S 
amplification were 94°C denaturation for 2 min, 35 cycles of 94°C for 1 min 
(denaturation), 52°C for 1 min (annealing) and 72°C for 1 min (extension) 
followed by a final 72°C for 2 mins. The PCR conditions used for ITS 
amplification were 94°C denaturation for 4 min, 35 cycles of 94°C for 30 seconds 
(denaturation), 50°C for 1 min (annealing), and 72°C for 1 min and 30 seconds 
(extension). A final annealing step of 72°C for 10 mins was performed. All DNA 
was subject to a 10 min hotstart at 94°C prior to PCR amplification. Amplicons 
generated from three PCR reactions/template DNA were pooled and cleaned 
using the Agencourt AMPure® purification system (Beckman Coulter Genomics, 
Takeley, UK). Purified products were quantified using the Nanodrop 3300 
Fluorospectrometer (Thermo Scientific) and the Quant-iT™ Picogreen® dsDNA 
Assay kit (Invitrogen). Equal concentrations of 16S or ITS amplicons were 
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pooled, AMPure cleaned and assessed by an Agilent 2100 Bioanalyser (Agilent 
Technologies) to determine purity and to ensure the absence of primer dimers. 
Sequencing of the 16S rRNA V4-V5 and ITS-1 rDNA ribosomal amplicons was 
performed using a 454 Genome Sequencer FLX Titanium System (Roche 
Diagnostics Ltd) at Teagasc Food Research Centre, Moorepark, according to 454 
protocols. 
 
6.3.4 Amplicon sequencing data analysis 
Raw sequences were quality trimmed and filtered using the Qiime Suite of 
programs (Caporaso et al., 2010); any reads not meeting the quality criteria of a 
minimum quality score of 25 and sequence length shorter than 150 bps for 16S 
amplicon reads and 200 bps for ITS amplicon reads were discarded. The 
maximum homopolymer limit was increased to 10 for ITS amplicons as ITS 
sequences are known to harbour long homopolymer runs. All chimeras were 
removed using ChimeraSlayer (http://microbiomeutil.sourceforge.net/#A_CS). 
Trimmed fasta sequences were assessed by BLAST analysis against the SILVA 
database (version 100) for 16S reads and a previously published ITS-specific 
database for ITS samples (Pruesse et al., 2007, Santamaria et al., 2012). MEGAN 
was used to parse BLAST outputs (Huson et al., 2007) and a bit-score of 86 was 
employed for 16S ribosomal sequence data, with a bit-score of 35 for ITS 
sequence data. The QIIME suite of programs was used to calculate alpha 
diversity including Choa1 richness, Shannon diversity, Simpson index, 
Phylogenetic Diversity and Observed species (Caporaso et al., 2010). Sequences 
were clustered into operational taxonomical units, chimera checked (0.11% of 
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16S and 0.02% of ITS sequences removed) and aligned using the default pipeline 
within Qiime for 16S sequences and a modification to implement MUSCLE 
(Edgar, 2004) for the alignment of ITS sequences. The FastTree package (Price et 
al., 2009) was used to generate phylogenetic trees for both sequence types. For 
16S sequences, default clustering and alignment methods were implemented 
within Qiime, whilst the default pipeline was modified for the ITS sequences. 
Sequencing depth was estimated using rarefaction analysis. QIIME was also 
used to generate weighted UniFrac, unweighted UniFrac and Bray-Curtis 
distances matrices. Principal Co-ordinate Analysis plots based on these distance 
matrices were generated with Qiime and visualised using King software (Chen et 
al., 2009). Reads were deposited in the SRA database under the accession 
number ERP002661.  
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6.4 RESULTS AND DISCUSSION 
6.4.1 High-throughput sequencing reveals the α and β diversity of the 
microbial population in kombucha 
In advance of carrying out this study, a number of steps were taken to ensure 
that the results generated would be as representative as possible. Five 
kombuchas were acquired from individual and commercial suppliers from 
Canada ([Ca1] and [Ca2]), Ireland [Ire], the United Kingdom [UK] and the United 
States [US], in order to mitigate against geographical bias. Although a sample 
number of five kombuchas will not provide a definitive microbial analysis, this is 
the first time high-throughput, culture-independent analysis has been applied 
to the microbial population of kombucha and, as such, represents the most in-
depth study to date. As it has been proposed that the microbiological 
composition of the fermented product can vary with time (Teoh et al., 2004, 
Sreeramulu et al., 2000), DNA was extracted from the fermented kombucha tea 
(fermentate) at days 3 and 10 of the fermentation and from the pellicle. Given 
that the pH of the fermented product dropped as the process continued, 
reaching pH 3-3.5 by day 10, the microorganisms detected at this time point 
reflect a more acid tolerant population. It was also decided that the sucrose-tea 
solution should not be sterilised by autoclaving in advance of inoculation as this 
has in the past been shown to generate toxic chemicals inhibitive of kombucha 
growth (Teoh et al., 2004). Instead, culturing conditions adhered to were those 
closest to that which occur in the home, with black tea and sucrose considered 
the best substrates for metabolic and microbial activity (Kallel et al., 2012).  
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Using universal tagged primers, amplicons corresponding to the V4-V5 
region of the bacterial 16S rRNA gene were generated. This region was chosen 
as it provides longer reads which enable more confident assignments than 
shorter products generated by amplification of other variable regions. Following 
high-throughput sequencing of the amplicons, a total of 15,209, 13,409 and 
13,400 reads were successfully assigned to the pellicle, day 3 and day 10 
extracts, respectively, equating to a respective average of 3,042, 2,682 and 
2,680 reads per individual sample (Table S1). To identify fungal populations 
present, ITS rDNA amplicons were generated from the variable ITS-1 region 
using primers adapted from Buee et al (Buee et al., 2009). These primers 
produced amplicons of circa 410 bps in all samples. Additional amplicons of 
circa 250 bps from UK (the pellicle, day 3 and day 10) were also sequenced. In 
order to prevent preferential sequencing of the smaller-sized reads, the 
respective amplicons were extracted individually via gel extraction and 
separated into two pools according to approximate size, and sequenced 
independently, with the quality-approved reads subsequently combined to form 
an overall total. Due to the approach taken, comparisons between ITS 
amplicons of specific sizes, rather than of all amplicons, was carried out. It was 
found that reads from the 250 bp pool were assigned specifically to the genus 
Dekkera whereas amplicons from other fungi were approx. 400 bp in length. In 
total, 11,795 reads were obtained for the pellicle, corresponding to an average 
of 2,949 reads per individual sample. Total reads for day 3 and day 10 were 
18,592 and 37,868, respectively (Table S1). 
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To determine species richness and diversity, Chao1 values, Shannon and 
Simpson indices, Phylogenetic Diversity and Observed Species were calculated 
(Tables S2-S3). The values for each were reflective of the naturally low bacterial 
and fungal diversity in fermented beverages (Marsh et al., 2013) relative to 
other environmental samples such as gastrointestinal or soil populations. 
Rarefaction curves, calculated at 97% similarity, are approaching parallel to the 
x-axis for all samples, indicating sufficient reads were obtained to adequately 
assess the populations (Figure S1). Averages for Observed Species and 
Phylogenetic Diversity suggest that bacterial diversity was greatest at day 3 of 
the fermentation. Across all measures of alpha diversity, except Chao1, diversity 
was shown to be greater within the fungal component of the kombucha 
population than the bacteria.  
Beta diversity was measured using three different distance matrices i.e. 
weighted UniFrac, unweighted UniFrac and Bray-Curtis (weighted UniFrac and 
Bray-Curtis data not shown). Visualisation of the populations, reflecting the 
different samples and time points, was performed by generating Principal Co-
ordinate Analysis (PCoA) plots (Figure 1). From this analysis it was shown that 
the bacterial populations of the pellicles were distinct from one another, as 
evidenced by a lack of clustering. However, there was some clustering amongst 
day 3 samples, and by day 10, the bacteria had converged on a more 
comparable population, denoted by clustering in blue. Thus the pellicle  
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Figure 1 Principle Coordinate Analysis (PCoA) plots, based on unweighted 
UniFrac distance matrices, show clustering of the bacterial populations from 
several kombuchas, where Red = day 3 extracts, Blue = day 10 extracts and 
Orange = pellicle extracts  
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populations were shown to possess the greatest diversity, with only the most 
competitively fit populations dominating within the fermented medium.  
 
6.4.2 16S analysis reveals a dominant Gluconacetobacter, with a prominent 
LAB, presence in kombucha   
Five bacterial phyla were identified across the various samples, including 
Actinobacteria, Bacteroidetes, Deinococcus-Thermus, Firmicutes and 
Proteobacteria. Of these, Proteobacteria were the most abundant, accounting 
for >90% of reads in each sample, with the exception of Irish-sourced 
kombucha, where this phylum constituted 87.9% of the kombucha population 
at day 3 of the fermentation and 60% of the pellicle (Table S4). Members of this 
phylum consisted of 2 genera, Acetobacter and Gluconacetobacter. In every 
kombucha, and in every sample type, reads assigned to Gluconacetobacter 
greatly exceeded those of Acetobacter (Figure 2; Table 1). Indeed, 
Gluconacetobacter accounted for >85% of assigned reads from all samples, with 
the exception of Ire, where it is present at a low of 58% in the pellicle, making it 
the dominant bacterial genus in every sample. The genus Acetobacter was 
consistently found in Irish-sourced kombucha only, where proportions were 
highest in the pellicle (1.9%) but represented <1% of the bacterial population in 
the fermentates. Although 16S reads of this length cannot be accurately 
assigned beyond genus level due to the high level of sequence homology, the 
reclassification of Acetobacter xylinum to Gluconacetobacter xylinus (Yamada et 
al., 1997), a species considered to be the dominating bacterium and principal  
 
  
 
 
 
 
 
 
 
 
 
Figure 2 16S phylogenetic composition of the bacterial component of the kombucha pellicle (A) and the tea at day 3 (B) and day 10 (C) of 
fermentation, at genus level. 
A) Pellicle B) Day 3 C) Day 10
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40%
60%
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Ca1 Ca2 Ire UK US
Other Enterococcus Propionibacterium
Ruminococcaceae Incertae Sedis Allobaculum Thermus 
Bifidobacterium Leuconostoc Lactococcus 
Lactobacillus Gluconacetobacter Acetobacter 
Day 3 Ca1 Ca2 Ire UK US 
Acetobacter  0.86 0 0.43 0 0 
Gluconacetobacter 86.91 97.79 93.09 98.14 95.73 
Lactobacillus 3.93 1.13 3.57 1.19 1.77 
Lactococcus  1.56 0.51 1.77 0.37 0 
Leuconostoc 0.52 0 0 0 0 
Bifidobacterium  0.3 0 0 0 0 
Thermus  0.22 0 0.2 0 0 
Allobaculum  0 0 0 0 0.88 
Ruminococcaceae Incertae Sedis  0 0 0 0 0.19 
Propionibacterium 0 0 0.2 0 0 
Other 5.75 0.58 0.75 0.3 1.42 
      
Day 10  Ca1 Ca2 Ire UK US 
Acetobacter  0 0 0.19 0 0 
Gluconacetobacter 92.17 93.16 87.62 94.26 95.73 
Lactobacillus 5.96 6.17 9.59 1.44 3.47 
Lactococcus  0 0.23 0.19 0 0.18 
Leuconostoc 0 0 0 0 0 
Bifidobacterium  0 0 0 0 0 
Thermus  0.66 0 1.62 3.73 0 
Allobaculum  0 0 0 0 0 
Ruminococcaceae Incertae Sedis  0 0 0 0 0 
Other 1.22 0.45 0.79 0.58 0.61 
      
Pellicle Ca1 Ca2 Ire UK US 
Acetobacter  0 0 1.93 0.28 0 
Gluconacetobacter 99.77 95.73 58.02 92.97 99.82 
Lactobacillus 0 1.72 30.57 4.64 0 
Lactococcus  0 1.29 7.76 1.62 0 
Leuconostoc 0 0 0 0 0 
Bifidobacterium  0 0 0 0 0 
Thermus  0 0 0 0 0 
Allobaculum  0 0 0 0 0 
Ruminococcaceae Incertae Sedis  0 0 0 0 0 
Enterococcus  0 0 0.69 0.21 0 
Propionibacterium 0 0 0.38 0 0 
Other 0.23 1.26 0.66 0.28 0.18 
 
 
Table 1  
Relative abundances of the 16S bacterial genera at day 3, day 10 and in the 
pellicle.  
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contributor of bacterial cellulose in kombucha (Hesseltine, 1965, Sievers et al., 
1996, Mikkelsen et al., 2009, Strap et al., 2011), might partially account for the 
high frequency of the genus Gluconacetobacter, and the relative lack of 
Acetobacter. Moreover, the genus Gluconacetobacter has recently been 
subdivided into three genera: Nguyenibacter, Komagataeibacter and 
Gluconacetobacter (Vu et al., 2013, Yamada et al., 2012). Most noteworthy is 
the fact that G. xylinus is now the type strain of the genus Komagataeibacter, 
and is known as Komagataeibacter xylinus. It is possible that reads assigned to 
Gluconacetobacter may actually belong to the genus Komagataeibacter as, at 
the time of writing, microbial databases have yet to be updated to 
accommodate the reclassification. In addition, while there are risks associated 
with assigning short 16S amplicons at the species level, it was noted here that 
the most prominent Gluconacetobacter hits were to an uncultured species and 
Gluconacetobacter sp. Rh1-MS-CO. 
More recently, there have also been several other species of 
Komagataeibacter and Gluconacetobacter identified in kombucha including 
Komagataeibacter kombuchae (Dutta and Gachhui, 2007), Gluconacetobacter 
sp A4 (Yang et al., 2010) and Gluconacetobacter sacchari (Trovatti et al., 2011). 
The high proportions of Gluconacetobacter also indicate that other species of 
Acetobacter, such as A. aceti (Liu et al., 1996, El-Salam, 2012), its close relative 
A. nitrogenificans (Dutta and Gachhui, 2006), A. pasteurianus (Chen and Liu, 
2000, Liu et al., 1996) and A. liquefaciens (Zhang et al., 2011) that have been 
found in the past to be a dominant component in kombucha are not as common 
in the kombuchas prepared in this study or were inaccurately classified in the 
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past (Sreeramulu et al., 2000). Similar acetic acid species have been found in 
related wine and vinegar cultures (Gonzalez et al., 2004, De Vero et al., 2006).  
The detection of considerable proportions of lactic acid bacteria (LAB), 
such as Lactobacillus and Lactococcus, in kombucha pellicles is another key 
observation. Reads representative of the corresponding phylum, the Firmicutes, 
were consistently detected in the fermentates, increasing in each instance from 
day 3 to 10, and were also detected in the pellicles of Ca2, Ire and UK at 
abundances of 3.3%, 39.4% and 6.6%, respectively. Of the fermented teas, the 
Irish kombucha contained the greatest proportions of Firmicutes at 5.6% and 
10.5% in the day 3 and day 10 extracts, respectively. The Firmicutes-associated 
reads were predominantly assigned to the genus Lactobacillus, which was 
detected in all fermentates, but only in the pellicles of Ca2, Ire and UK. 
Proportions of lactobacilli were lowest in the day 3 extracts, with proportions 
being higher at day 10 in all instances. Lactobacilli have been isolated in only 
two previous kombucha studies, both of which focused on Chinese kombuchas 
(Zhang et al., 2011, Wu et al., 2004), and thus the frequency and abundance at 
which lactic acid bacteria were detected in this study is particularly novel. The 
Irish-sourced pellicle stood out in this regard with >35% of reads assigned at 
genus level corresponding to lactic acid bacteria. The data presented here 
suggests that lactobacilli are more prevalent in kombucha than was previously 
understood, particularly at the latter stages of fermentation. Studies have 
indicated that one role for these microorganisms might be to assist in the 
growth of acetic acid species in that Lactobacillus has been shown to greatly 
increase cellulose production by Gluconacetoabcter in co-culture (Seto et al., 
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2006) and, even more relevantly, LAB have been shown to support the growth 
of Gluconacetobacter in kombucha (Yang et al., 2010). The abundance of 
Lactococcus varied but was generally lower, consistently representing <2% of 
reads across all fermentates and pellicles with the exception of the Irish pellicle 
(7.8%). Proportions were greatest in the three pellicles in which it was detected, 
and numbers reduced from <2% in four of the five day 3 fermentates to <1% in 
three day 10 fermentates, suggesting poor lactococcal survival as the 
fermentation proceeded. It appeared that the most frequent species of 
Lactobacillus identified was Lactobacillus kefiranofaciens subsp. kefirgranum. A 
number of other genera from the Firmicutes were detected at low proportions, 
which have not been identified in kombucha previously, including Leuconostoc 
(Ca1, day 3 - 0.5%), Allobaculum (US, day 3 - 0.9%), Ruminococcaceae Incertae 
Sedis (US, day 3 - 0.3%) and Enterococcus (Ire and UK, pellicle – 0.7% and 0.2% 
respectively) (Table 1). The number of different genera detected was greatest 
among the day 3 samples.  
Actinobacteria were less common amongst the kombuchas, with reads 
corresponding to the genera Propionibacterium (Ire, day 3 - 0.2%; pellicle - 
0.4%) and Bifidobacterium (day 3 - 0.3%). To our knowledge this marks the first 
time that Bifidobacterium has been identified in natural kombucha, though it 
should be noted that there are instances of it having been added to 
commercially brewed kefir. The low abundance of both bifidobacteria and 
propionibacteria, and their absence from day 10 samples, suggests that these 
bacteria do not thrive in the fermented environment. It should be noted that 
the presence of these traditionally gut-associated organisms may reflect their 
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introduction through poor sanitation or some other means at some point during 
the formation of specific pellicles and thus there is no guarantee that these 
populations are active in this environment. However, in the case of the 
Actinobacteria, it’s worth mentioning that these microorganisms have been 
detected at similar abundances in fermented milk (Dobson et al., 2011), and 
bifidobacteria can constitute a significant proportion of the microbiota of 
fermented water beverages (Gulitz et al., 2013). Further investigations will be 
required to ultimately determine the source of individual populations and their 
contribution to the formation and health-promoting characteristics of 
kombucha. This point also relates to other populations detected at low 
frequencies. Reads corresponding to the phylum Deinococcus-Thermus were 
only consistently detected across Ca1 samples (0.2%, 0.9% and 0.2% at day 3, 
day 10 and pellicle, respectively), but were also present in the fermented Irish 
(day 3 - 0.2%; day 10 1.6%) and UK (day 10 - 3.8%) teas. Reads from this phylum 
were assigned to the genus Thermus. The presence of bacteria corresponding to 
this genus is interesting, since these species are traditionally regarded as being 
associated with thermophillic niches (Vajna et al., 2012, Beffa et al., 1996). The 
specific requirements for culturing such bacteria, in this case, high temperature, 
might explain why these and other such species have not been detected 
through culture-based approaches previously. Reads corresponding to the 
phylum Bacteroidetes were found in the US sample only at day 3 of the 
fermentation at 0.4% abundance. Reads that could not be assigned at the 
phylum level consistently represented <1% across all samples, and were not 
assigned to the level of genus. Finally, it was notable that a number of 16S reads 
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corresponding to the order Sphingomonadales and the family Lachnospiraceae, 
respectively, could not be further assigned. Again, this marks the first occasion 
upon which these microorganisms have been identified in kombucha, though 
Sphingobium and Zymomonas, genera of Sphingomonadales, have been 
identified in beverages fermented by milk and water kefir grains respectively 
(Ninane et al., 2007, Hsieh et al., 2012).  
 
6.4.3 The fungal population in kombucha is dominated by Zygosaccharomyces 
with a variable sub-dominant population  
From a fungal perspective, the use of culture-independent approaches was 
particularly beneficial as the difficulties associated with slow growth on yeast-
specific media makes culture-based assessments difficult. The only fungal 
phylum detected in the fermented tea was Ascomycota, while Basidiomycota, 
the other phylum of the sub-kingdom Dikarya, was also detected in the cellulose 
pellicle extracts of Ca1, Ca2, and UK at sub-dominant levels.  
Zygosaccharomyces was the dominant genus in all pellicle and broth 
extracts from Irish and Canadian-sourced kefirs (Figure 3; Table 2), accounting 
for >95% of each population with the exception of the pellicle of Ca1, which 
contained a lower abundance (79%) as a consequence of containing a higher 
proportion of Pichia (8.3%) and unassigned (10.9%) reads. Genera proportions 
of the fermented teas matched that of the corresponding pellicle, thereby 
suggesting that the fungal composition of the cellulosic pellicle used to 
inoculate the tea is the key determinant. 
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Figure 3 ITS phylogenetic composition of the fungal component of the kombucha mat (A) and fermented tea at day 3 (B) and day 10 (C) of 
fermentation, at genus level, and the kombucha mat (D) and fermented tea at day 3 (E) and day 10 (F) of fermentation, at species level.
Day 3 Ca1  Ca2 Ire1 
Dekkera  0.57 0 0 
Zygosaccharomyces  99.43 99.8 99.57 
Kazachstania   0 0 0 
Other 0 0.2 0.43 
    
Day 10 Ca1  Ca2 Ire1 
Dekkera  0.43 0.74 0.83 
Zygosaccharomyces  99.19 99.13 98.69 
Kazachstania 0 0 0 
Other 0.38 0.14 0.49 
    
Pellicle Ca1  Ca2 Ire1 
Dekkera  1.07 0.41 0 
Zygosaccharomyces  78.96 93.26 95.39 
Davidiella 0.16 0 0 
Pichia  11.54 0 0.62 
Wallemia  0.58 0 0 
Lachancea 0 0.3 0 
Leucosporidiella 0 5.56 0 
Kazachstania  0 0 0.33 
Kluyveromyces 0 0 0.25 
Naumovozyma  0 0 0.54 
Meyerozyma 0 0 0 
Saccharomyces 0 0 0 
Hanseniaspora 0 0 0 
Other 7.68 0.48 2.87 
 
 
Table 2 
Relative abundances of the ITS fungal genera at day 3, day 10 and in the pellicle.  
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The occurrence of amplicons of circa 250 bp in the pellicle, day 3 and 
day 10 extracts of UK-sourced kombucha necessitated sequencing of these 
smaller-sized reads separately from the regular 400 bp pool. Most reads from 
this pool were assigned to the genus Dekkera (Table S5). Mayser et al. have 
previously found that Brettanomyces (the anamorph of Dekkera) and 
Zygosaccahromyces were the most common yeast genera in a culture-based 
study of German kombucha samples (Mayser et al., 1995). There have also been 
some other instances upon which both Zygosaccharomyces and Dekkera have 
been identified (Teoh et al., 2004, Liu et al., 1996).  
Analysis of ITS sequence data also facilitated assignment at the species 
level. The Zygosaccharomyces population consisted of two species, 
Zygosaccharomyces lentus and Zygosaccharomyes bisporus, with Z. lentus 
present in consistently higher abundance, and in the case of Irish-sourced 
kombucha, was the only species detected. It has been proposed that Z. lentus 
isolates have probably been phenotypically misidentified as Z. bailii in the past 
(Steels et al., 1999a), which may account for the reported presence of Z. bailii in 
some culture-based studies (Teoh et al., 2004, Liu et al., 1996, Chen and Liu, 
2000). The dominant Dekkera species in UK samples was Dekkera bruxellensis, 
which out-numbered the Dekkera anomala, present in the pellicle. The 
identification of this particular species is consistent with some previous studies 
(Liu et al., 1996, Teoh et al., 2004). Dekkera bruxellensis, often considered a 
spoilage yeast, is commonly found in fermented beverages such as fruit juices, 
red wine, beer and cider where it is responsible for the development of 
unpleasant odour and taste (Heresztyn, 1986b, Heresztyn, 1986a). Conversely, it 
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is thought to have a beneficial contribution to the flavour of lambic beer 
(DeKeersmaecker, 1996). Similarly, Zygosaccharomyces sp. are problematic in 
the brewing and juice industries with Z. lentus in particular being considered a 
food spoilage yeast due to its osmotolerance, ability to grow at low pH, and 
resistance to preservatives (Steels et al., 1999b). Kazachstania was the only 
other genus detected among the tea broths, being present in UK day 10, and is 
solely represented by the genus Kazachstania unispora which has not been 
linked with kombucha previously. Considering the variation in kombucha-
associated yeast, it is likely that the role of yeast in kombucha fermentation can 
be performed by several non-specific fermentative yeast, with 
Zygosacharomyces-dominated populations being particularly common. 
Investigation of fermentations produced by defined starters is required to 
elucidate the exact contribution of each yeast to the final flavour and 
biochemical composition of kombucha.  
While Zygosaccharomyces, Dekkera and Kazachstania were the only 
genera detected across the various fermented tea samples, several other 
genera were detected in the pellicle samples and were represented by one 
species. Of these, Davidiella tassiana, Lachancea fermentati, Kluyveromyces 
marxianus, Naumovozyma castelli and the Basidiomycota representatives, 
Wallemia sebi and Leucosporidiella fragaria, have not been found in kombucha 
previously. Of the others, Hanseniaspora has previously been identified in one 
kombucha study (Mayser et al., 1995) while Pichia kudriavzevii and other Pichia 
and Pichia-like species such as P. fermentans and P. membranaefaciens and 
Hyphopichia burtonii, have been detected on a number of previous occasions 
 - 240 - 
(Mayser et al., 1995, Jankovic and Stojanovic, 1994, Chen and Liu, 2000). 
Although there were a number of hits that could not be assigned to a species 
within the fungal database, it is believed that, as more sequences are deposited, 
it will be possible to assign greater proportions of fungal ITS sequences from 
studies such as this one.  
Ultimately, it would appear that the naturally low pH and ethanol 
content of the beverage generated under regular, household brewing 
conditions, combined with other forms of competition involving the indigenous 
microbial population, is sufficient to limit contamination from undesirable 
populations. This indigenous population appears robust, with those microbes 
contained within the matrix of the cellulosic pellicle dictating the microbiota of 
the eventual beverage. Further investigations will reveal the link between the 
different populations, their bioactive peptides and the purported health 
benefits of kombucha. It is believed that the information presented here will 
assist in future microbiology-focused kombucha studies and may ultimately 
assist in the development of defined kombucha starter cultures.  
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CHAPTER VII 
Screening of milk kefir, water kefir and kombucha for antimicrobial 
producers 
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7.1 ABSTRACT 
A high-throughput screening strategy was employed to identify antimicrobial 
producers among microbes cultured from the fermented beverages kefir, water 
kefir and kombucha. In addition to identifying producers of the lactococcin ABM 
bacteriocin complex from the milks of three Irish kefirs, a proteinaceous 
antimicrobial was found to be produced by the yeast Dekkera bruxellensis, 
isolated from kombucha sourced from both Ireland and the United States. This 
antimicrobial was consistently active against strains of Lactobacillus bulgaricus 
but not other targets. Characterisation of the protein showed it to be active in a 
pH range of 3-8, moderately heat stable, negatively charged and have a mass 
>30 kDa. On the basis of these characteristics the novel antimicrobial is thought 
to be a glycosylated mycocin.   
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7.2 INTRODUCTION 
Interest in functional foods has increased greatly in recent years, with functional 
beverages becoming particularly popular amongst consumers (Granato et al., 
2010). Several attributes of such beverages can account for their description as 
‘functional’, including their nutritional, organic and probiotic properties. There 
are a number of traits that contribute to the probiotic potential of a 
microorganism, one being the production of antimicrobial peptides known as 
bacteriocins (Dobson et al., 2012, Gillor et al., 2008). These peptides are 
produced by bacteria and are active against other, typically closely-related, 
bacteria. Producers are immune to their own bacteriocin via self-immunity 
mechanisms, and are mainly produced by gram positive bacteria (Arnison et al., 
2013, Nes et al., 1996). Bacteriocins from food-grade bacteria have the 
potential to be used as effective, natural additives in lieu of chemical food-
preservatives, while bacteriocin-producers can also inhibit undesirable 
microorganisms when introduced as starter cultures (Galvez et al., 2007, 
Cleveland et al., 2001). Additionally, given the shortage of novel antibiotic 
discoveries to combat emerging pathogen resistance, the potential use of 
bacteriocins for therapeutic applications has been the focus of ever greater 
attention (Cotter et al., 2013). Yeast are also capable of producing 
proteinaceous antimicrobials, known as mycocins or yeast killer toxins, which 
are analogous to bacteriocins (Magliani et al., 1997). Producers are referred to 
as killer yeast, and the genes responsible for killer toxins can be encoded by 
several different genomes including dsRNA viral particles that reside 
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symbiotically within yeast cells, chromosomal DNA, and linear DNA plasmids. 
These killer proteins are larger than bacteriocins, ranging in size from 10-300 
kDa, often contain glycosyl residues and are typically active at acidic pHs (Table 
1). As with bacteriocins, killer toxins are typically most active against closely 
related species and producers are immune to their own toxins. Killer toxins have 
several potential applications as antifungals in human therapy and agriculture 
as well as in the prevention of wine spoilage and biotyping (Meinhardt and 
Klassen, 2009). A study by Comitini et al showed that protease- and heat-
sensitive antimicrobials, distinct from mycocins, were produced by 
Saccharomyces cerevisiae and displayed activity against Oenococcus oeni, a 
wine bacterium (Comitini et al., 2005). While detailed characterisation of these 
peptides was not completed, analysis indicated a complex mix of proteinaceous 
yeast metabolites contributed to the inhibitory activity. 
The aim of this study was to screen the microbial populations of the 
fermented beverages kefir, kombucha and water kefir for the presence of 
antimicrobial producers. In the past, fermented foods have proven to be a good 
source of bacteriocin-producers. This is consistent with the observation that 
environments with a high cell-density of competing/complex microbial 
populations have been shown to harbour bacteriocin producers in the past 
(Kreth et al., 2006, Riley and Gordon, 1999). Fermented foods from which 
bacteriocin producers have been sourced include, for example, kimchi (Han et 
al., 2013, Choi et al., 1999), kefir (Powell et al., 2007, Atanassova et al., 1999, 
Ryan et al., 1996, Powell, 2006), fermented sausage (Alvarez-Cisneros et al., 
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2010, Rekhif et al., 1995), sauerkraut (Harris et al., 1992, Ge et al., 2009) and 
cheese (Izquierdo et al., 2009, Ghrairi et al., 2005). The beverages selected for  
Table 1: A list of known mycocins, their producers and toxin sizes (Adapted from 
Meinhardt & Klassen 2009) 
 
Organism  Killer Toxin  Toxin Size (kDa) 
   
Chromosomal DNA     
Pichia anomala NCYC 434 K5/Panomycin 49 
Pichia anomala ATCC 96603 PaKT/PKT 85 
Pichia anomala DBVPG 3003 Pikt >3 
Pichia farinosa KK1 SMKT α 6.6 / β 7.9 
Pichia membranfaciens CYC1106 PMKT 18 
Williopsis californica DSM 12865 Wicaltin 34 
Williopsis saturnus IFO 0117 HYI 9.5 
Kluyveromyces wickerhamii DBVPG 6077 Kwkt >10 
Kluyveromyces phaffii DBVPG 6076 KpKt 33 
Kluyveromyces amrxianus NCYC 587 K6 42 
Saccharomyces cerevisiae 111 KHR 20 
Saccharomyces cerevisiae 115 KHS 75 
   
Extrachromosomal dsRNA     
Saccharomyces cerevisiae KL88 K1 α 9.5 / β 9.0 
Saccharomyces cerevisiae CBS8112 K28 α 10 / β 11 
Hanseniaspora uvarum 470 N/A 18 
Zygosaccharomyces bailii 412 Zygocin 10 
   
Extrachromosomal dsDNA     
Kluyveromyces lactis IFO1267 Zymocin  α 99.0 / β 30.0 / y 28.0 
Pichia inositovora NRRL Y-18709 N/A >100 
Pichia acaciae NRRL Y-18665 PaT α 110.0 / β 39.0 / y 38.0 
Debaromyces robertsiae CBS6693 N/A >100 
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this study are fermented by a mixed population of bacteria and yeast at room 
temperature, and are protected from spoilage by undesirable microorganisms, 
suggesting the presence of additional inhibitory mechanisms. Kefir is a milk-
based beverage and originates from the Caucasian mountains, whereas water 
kefir is fermented sucrose-water and is believed to derive from the pads of the 
Opuntia cactus in Mexico. Both beverages are fermented by polysaccharide 
grains harbouring a symbiosis of bacteria and yeast. The bacterial component is 
typically composed of Lactobacillus, Lactococcus, Streptococcus, Leuconostoc 
and some species of acetic acid bacteria (Marsh et al., 2013c, Marsh et al., 
2013b). Kombucha is a sweetened tea of Chinese origins, fermented by acetic 
acid bacteria, some lactobacilli and a variety of yeast (Marsh et al., 2013a). The 
populations of these beverages are known to be influenced by external factors 
such as the environment and country of origin, and can vary considerably from 
one culture to another. 
With recent technological advances, high-throughput screening is 
increasingly being employed for bacteriocin discovery. High-throughput robotics 
can be used to screen banks of bioengineered bacteriocin producers for isolates 
with enhanced activity (Field et al., 2008), while screening of environmental 
samples for specific phenotypes lead to the discovery of planosporicin and 
microbisporicin (Castiglione et al., 2007, Castiglione et al., 2008). Screening has 
also been used in the isolation of bacteriocin-producing lactic acid bacteria from 
malt samples (Rouse et al., 2007, Marsh et al., 2012). Using similar high-
throughput robotics, the focus of this study was to create a bank of bacterial 
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isolates from the aforementioned fermented beverages, to screen these 
isolates for antimicrobial production and to characterise associated 
antimicrobial peptides/proteins. 
 
7.3 MATERIALS AND METHODS 
7.3.1 Maintenance of fermented cultures  
Kefir grains were sourced from different countries including 9 grains from 
Ireland (designated IR1, 2, 3, 4, 5, 6, 8, 9 and 10), 5 from the UK (UK1-5), 4 from 
the United States (designated US1, 2, 3 and 5) as well as others from Spain 
(Sp1), France (Fr1), Italy (It1), Canada (Ca1) and Germany (Ger1 and Ger2) 
(Marsh et al., 2013c). Kefirs were fermented in 10% reconstituted skimmed milk 
(RSM), which had been sterilized at 115°C for 15mins. Water kefir grains were 
sourced from Canada [Ca], the UK [UK] and the United States [US1 and US2] and 
fermented by adding 60g grains/litre of sterilised Ballygowan® mineral water 
supplemented with 10% sucrose, followed by the addition of one dried, organic 
fig (Rainbow Organic Wholefoods, Ireland) (Marsh et al., 2013b). Kombucha 
samples sourced from UK (UK), Ireland (Ire), Canada (Ca1 and Ca2) and the 
United States (US) and were prepared in black tea with 10% sucrose and 10% 
previous fermentate to acidify the culture (Marsh et al., 2013a). All cultures 
were fermented at room temp (23-25°C).  
 
7.3.2 Strains and growth conditions  
Listeria innocua DPC 3572, Salmonella Typhimurium LT2 and Staphylococcus 
aureus ATCC 25923 were cultured in Brain-Heart Infusion (BHI) at 37°C (Oxoid). 
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Lactobacillus bulgaricus DPC 5838 was grown in MRS (Difco) anaerobically at 
37°C. Leuconostoc mesenteroides subsp. cremoris DPC 223 was cultured in MRS 
at 30°C while Lactococcus lactis MG 1363 and a pMRC01+ derivative were both 
cultivated on M17 (Difco) supplemented with 0.5% glucose (Sigma) at 30°C. 
Other bacteria used as indicators are listed in Table 2. All yeast indicators (Table 
3) were grown on potato  
dextrose agar (PDA) (Neogen, USA) at 25°C for 5 days, and maintained on PDA 
slants at 4°C. Overnights were prepared by inoculating the culture into potato 
dextrose broth and growing at 25°C for 48-72 hours. 
 
7.3.3 Sample preparation 
1g of kefir grain and 1g of kombucha cellulose pellicle were rinsed twice in 
sterile water and blended separately using a T-25 Digital Ultra-Turrax in 9mls 
Ringers solution (Sigma) until homogenised. 1g of rinsed water kefir grains were 
homogenised using a sterile mortar and pestle and added to 9mls of Ringers. 
Microbes from kefir and water kefir were isolated after an initial 24 hour 
fermentation, and microbes from kombucha were isolated after 10 days of 
fermentation. All samples were serially diluted in Ringers to give approx 1000 
CFUs per Qtray (Molecular Devices). Qtrays were prepared by pouring 250mls of 
the relevant molten agar, supplemented with 1% nystatin (Sigma), into a sterile 
Qtray and allowed to set on a flat surface. 1ml of the diluted sample was spread 
across the surface using sterilised 5mm borosilicate beads (Sigma). The media 
employed were: Wallerstein Laboratory (WL) fermentation media (Oxoid) (to 
select for specific kombucha isolates), while GM17 and MRS were used to select 
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for presumptive lactococci and lactobacilli from all sources. These agars were 
incubated aerobically at 30°C and anaerobically at 37°C, respectively. Tryptic soy 
agar, supplemented with yeast extract (TSA-YE), was also used as a non-
selective nutritious medium to culture microbes from a variety of sources and 
was incubated at 37°C. Cultures were grown for 24-48 hours.  
 
7.3.4 Robotic screening  
The QPix2-XT (Genetix, New Milton, Hampshire, UK) was used to pick single 
colonies from the plates, which were then added to 384-well plates (Molecular 
Devices) containing freezing buffers. These buffers were prepared by adding 
K2HPO4 (36 mM), KH2PO4 (13.2 mM), sodium citrate (1.7 mM), MgSO4 (0.4 mM), 
(NH4)2SO4 (6.8 mM) and 4.4% glycerol to the relevant growth media. Isolates 
were incubated appropriately overnight and stored at -80°C. 6 x 384-well plates 
were stamped over the surface of each Qtray containing the appropriate media 
and allowed to grow for up to 48 hours (Figure 1). Plates were then exposed to 
UV light for 30 minutes to inactivate the colonies, which were then overlaid 
with molten sloppy agar (0.75%) containing 0.25% of indicator bacterium. After 
further overnight incubation the plates were inspected for zones of inhibition. 
In instances where a strain merited further inspection, it was sourced from the 
corresponding frozen 384-well stocks. In specific instances where pH buffering 
of agar was required, 3-(N-morpholino)propanesulfonic acid (MOPS) was added 
at 0.2M or 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  (HEPES) at 0.2M.  
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7.3.5 Antimicrobial activity assays  
Antimicrobial activity against bacteria was assayed using the well diffusion 
method. Briefly, 20mls of agar seeded with 50ul of indicator strain was allowed 
to set, holes were bored in the agar, and 50ul of cell free supernatant (CFS) 
from an overnight culture of the putative antimicrobial producer was added to 
the wells. Plates were incubated overnight and visually inspected to identify 
zones of inhibition.  
Antimicrobial activity against yeast was assessed using three methods. In the 
first two cases, overnight cultures of the yeast indicators were counted using a 
hemocytometer and cells were diluted to seed PDA with 105cells/ml. For the 
first assay, the putative antimicrobial producer was streaked across the surface 
of the seeded agar. In the second, wells were made and 50ul CFS from an 
overnight culture of the putative antimicrobial producer was added. Finally, 
yeast versus yeast antagonism was also tested using a swab approach, where 
106 cells were swabbed across the surface of both a regular and NaCl-enriched 
(4%) agar plates, and Whatman discs soaked in crude antimicrobial protein 
preparation were placed on the surface (Golubev and Tomashevskaya, 2012, 
Llorente et al., 1997). All plates were incubated at 25°C and monitored over 5 
days. 
 
7.3.6 Species identification  
DNA was extracted from overnight cultures of strains of interest according to 
the protocol of the Roche High Pure PCR Template Preparation Kit (Roche). PCR 
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amplification of the bacterial 16S gene was carried out using the universal 16S 
primers CO1 AGTTTGATCCTGGCTCAG and CO2 TACCTTGTTACGACTT. For fungi, 
PCR amplification of the internal transcribed spacer (ITS-1) was carried out using 
primers ITSF CTTGGTCATTTAGAGGAAGTAA and ITSR 
GCTGCGTTCTTCATCGATGC. DNA was quantified and amplicons were sent to 
Source Bioscience (Dublin, Ireland) for Sanger sequencing and speciation. 
Species were identified through BLAST analysis of the resultant DNA sequences.  
 
7.3.7 pH, temperature, solvent and protease stability 
The stability of antimicrobial-containing CFS following exposure to a variety of 
treatments was assessed. The pH of the CFS was measured using a pH meter 
(Hannah Instruments) and adjusted to a range of pH 2-9 using dilute HCl and 
NaOH to assess the pH range over which the antimicrobials were active. The 
sensitivity of the antimicrobial-containing CFS to protease was tested through 
treatment with equal volumes of the following enzymes: proteinase K 
(25mg/ml), alpha-chymotrypsin (10mgs/ml), trypsin (10mg/ml) and pepsin 
(25mg/ml). To assess temperature stability, samples were heat treated at 60°C, 
70°C, 80°C and 90°C for 15mins each. To determine the sensitivity of the 
supernatants to solvents, 300ul of supernatant was combined with 700ul 
ethanol, acetonitrile, methanol, and isopropanol, respectively, and additionally 
with the same solvents containing 0.1% trifluoroacetic acid (TFA), and allowed 
to equilibrate for 6 hours prior to assaying. Following treatments the level of 
antimicrobial activity retained was assessed via well diffusion using L. lactis HP 
and L. bulgaricus DPC 5838, as  indicators.  
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7.3.8 Protein characterisation 
To determine the charge of the peptides and proteins and, in turn, decide how 
best to proceed with their purification, individual samples were passed through 
several columns including C18 Solid Phase Extraction (SPE), SCX-SPE and the 
anionic resins SAX (Phenomenex), and DEAE and Q Sepharose (GE Healthcare). 
Passage through an Amicon Ultra centrifugal unit with 3kDa, 10kDa and 30kDa 
molecular weight cut-off membranes (Millipore) were used to gauge the 
molecular mass of the antimicrobial.  
 
7.3.9 Bacteriocin purification 
Bacteriocins were purified by growing bacteriocin-producing cultures in TY 
broth at 30°C for 24 hours, after which cells were separated from the 
supernatant by centrifugation at 8000 rpm for 20 minutes. The cells were mixed 
with 250 ml of 70% isopropan-2-ol (IPA) 0.1% TFA and stirred for 3-4 hours at 
room temperature before centrifugation at 8000 rpm for 20 minutes after 
which point the cell pellet was discarded. The isopropan-2-ol was removed from 
the supernatant and was passed through a 5g 20 ml STRATA C18 SPE column 
pre-equilibrated with methanol and water. The column was washed with 20 ml 
30% ethanol and bacteriocin activity was eluted with 20 ml 70% IPA 0.1% TFA. 
MALDI TOF Mass Spectrophotemetry was then performed. The sample was 
concentrated to 4 ml and applied to a semi prep Vydac C8 RP-HPLC column 
running a 25-60% acetonitrile 0.1% TFA gradient over 45 minutes at 2.5 
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ml/minute. Fractions were collected at 1 minute intervals and assayed for 
antimicrobial activity against the relevant indicator.  
7.3.10 Antimicrobial protein preparation 
The antimicrobial producer was grown in PDB at 25°C for 2 nights. Cell-free 
supernatant was generated by centrifugation at 8000 rpm for 20 minutes. 
Supernatant was passed through a Vivaflow 200 (Sartorius stedim biotech, 
Goettingen, Germany) with a 30 kDa cut-off membrane. Retentate was freeze-
dried, and 140mg was resuspended in 20 ml 100 mM sodium acetate buffer at 
pH 5, and anion exchange chromatography was performed by passage through 
a DEAE Sepharose Hitrap column (GE Healthcare). The antimicrobial was eluted 
in 1M NaCl, and 5 samples were pooled together and desalted by passing 
through a millipore sirred cell unit fitted with a 5 kDa cutoff membrane 
(Millipore). 15ul of this sample was run on SDS-PAGE.  
 
7.3.11 Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
SDS-PAGE of proteins was carried out using the Laemmlli protocol (Laemmli, 
1970) and were stained with Coomassie brilliant blue R-250. A 2-212 marker 
(Roche) was used to determine the size of the protein.  
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7.4 RESULTS AND DISCUSSION 
7.4.1 A high-throughput screen of strains isolated from fermented beverages 
reveals that antimicrobial producers are present at a low frequency 
Since fermented foods have in the past been shown to be a good source of 
bacteriocin producers, it was anticipated that fermented beverages sourced 
from a number of different countries would serve as a good source of new 
antimicrobials. As the microbial composition of the fermentate and inoculation 
material of such beverages often differ (Marsh et al., 2013c), it was decided that 
there was merit in screening both the fermentate and inoculating material for 
bacteriocin producers.  
Different agars were used to select for different components of the 
microbial populations, including GM17 for lactococci, MRS for lactobacilli, WL 
for fermentation kombucha isolates and TSA supplemented with yeast extract 
as a nutritious media that would facilitate the growth of many other strains. 
Approximately 63,000 colonies were picked and stocked in 384-well plates. The 
contents of six 384-well plates were stamped onto agar within Qtrays, which 
were then overlaid with different indicators to identify antimicrobial producers 
(Figure 1). The indicators selected were bacteriocin sensitive strains, i.e. 
Lactococcus lactis MG 1363 and Lactobacillus bulgaricus DPC 5838, 
representatives of pathogenic genera, i.e. Listeria innocua DPC 3572, Salmonella 
typhimurium LT2 and Staphylococcus aureus ATCC 25923, as well as a strain of 
Leuconostoc mesenteroides subsp. cremoris DPC 223 as a representative of a 
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species frequently found in kefir. Given that a number of producers of the 
lantibiotic lacticin 3147 have previously  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1  
Flowchart showing the process for screening of the fermented beverages. Kefir, 
kombucha and water kefir were used as sources for the isolation of colonies, 
which were picked and stocked by the QPix2-XT. These were then stamped onto 
Qtrays, and overlaid with different indicators to assess for antimicrobial 
production.  
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been isolated from kefir (Ryan et al., 1996), L. lactis MGpMRC01, which is 
immune to lacticin 3147, was also used as an indicator to address the possibility 
that a considerable number of lacticin 3147 producers may be present in the 
samples.  
Although these beverages and kefir, in particular, had in the past been 
good sources of novel bacteriocins such as lacticin 3147, ST8KF and others (Ryan 
et al., 1996, Aslim et al., 2005, Kojic et al., 2007), on this occasion relatively few 
antimicrobial producers were detected and only known lactococcins were 
identified from Irish kefir (see below). As water kefir has often been shown to 
have a similar microbial population to milk kefir, but had yet to be used as a 
source of antimicrobial producers, the fact that antimicrobial producers were 
not identified was disappointing. In the case of kombucha cultures, very few 
isolates grew on media other than WL media. Many of those that did grow were 
subsequently suspected to be yeast. This was despite the inclusion of the 
antifungal nystatin. While the lactic acid bacteria component of kombucha are 
known to be difficult to isolate, acetic acid bacteria are not commonly noted for 
their ability to produce bacteriocins (Qingping and Huaguang, 1999, Zhang et 
al., 2008), which may explain the lack of success in that regard.  
It was found that acid production became an issue in that isolates 
cultured on MRS produced acid in such quantities that the growth of the 
indicator strains was severly retarded, making the identification of antimicrobial 
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producers extremely difficult. The addition of MOPS to buffer the agar did not 
solve the problem, and ultimately a representative number of MRS isolates 
from the frozen bank of 384-well plates were selected for direct well diffusion 
assays, but bacteriocin producers were not identified.  
While the number of antimicrobial producers was lower than 
anticipated, a recent study involving bacteria revealed that only 0.08% of 
isolates produced bacteriocins with activity against L. bulgaricus and Listeria 
innocua, and that many of these had been previously characterised 
(Lakshminarayanan et al., 2013). It is thus clear that even highly diverse 
microbial communities can on occasion be of limited value with respect to the 
discovery of novel bacteriocins.  
 
7.4.2 The lactococcin ABM complex was identified in several Irish kefir  
A large number of colonies cultured from Irish kefir samples stamped on TSA-YE 
(from IR4 and IR6) or GM17 (from IR8) exhibited antimicrobial activity against L. 
lactis MGpMRC01. Representative colonies from each kefir sample were 
selected and the antimicrobial produced was further assayed via well-diffusion 
of the associated CFS. It was revealed that the antimicrobial was only active 
against other strains of Lactococcus lactis (i.e. the strains MG 1363, NZ 900, HP 
and DPC 3147). Sanger sequencing of 16S amplicons revealed that the three 
producers were of the species Lactococcus lactis and the peptide was therefore 
considered to be a lactococcin. Colony mass spectrometry revealed that the 
peptide mass profiles for three isolates were similar to one another, but none of 
the peaks identified corresponded to known lactococcins. The antimicrobial 
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from IR6, which was selected as a representative for further characterisation, 
was shown to be predominantly cell-associated. Initial investigations to 
determine how best to purify the antimicrobial established that the peptide was 
not soluble in ethanol or acetonitrile, was slightly soluble in methanol and 
isopropanol, was positively charged and active at low pH. Ultiamtely, the culture 
was grown in TY broth, and the cells were separated from the supernatant and 
washed in 70% IPA/0.1% TFA to release the peptide and purified by passing 
through a reverse phase SPE column. MALDI TOF mass spectrophotometry was 
performed on this sample and the presence of a 5774 Da peptide suggested the 
culture may be producing lactococcin A, which has a molecular mass of 5778 Da 
(Figure 2) (Holo et al., 1991). The sample was concentrated and run on HPLC, 
and the resulting fractions analysed. Peaks from the HPLC chromatogram 
corresponded to zones of inhibition in well diffusion assays, and mass 
spectrometry was performed on the resulting fractions. Peaks were identified 
which were found to closely relate to the masses of lactococcin A, lactococcin B 
and LcnN of lactococcin M respectively (van Belkum et al., 1991, van Belkum et 
al., 1992) (Figure 2).  
These three bacteriocins are frequently co-produced by strains. The 
corresponding gene clusters have been identified on a single plasmid in L. lactis 
from an Irish cheese factory and starter culture previously (Morgan et al., 1995, 
Geis et al., 1983), and would appear to be adapted to fermented milk 
environments. From a kefir perspective, five L. lactis strains have previously 
been isolated from Serbian kefir that produce peptides that resemble 
lactococcins A and B (Kojic et al., 2007). These lactococcins, and producers 
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thereof, have shown potential as cheese ripening agents, whereby they 
accelerate flavour development by cell lysis  
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
Chromatogram showing the different activities obtained from HPLC, and the 
masses of the different fractions were shown to correspond to Lactococcins A, B 
and LcnN of Lactococcin M. Fractions were also assayed against L. lactis HP to 
assess for antimicrobial activity (top right). 
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(Morgan et al., 1997, Morgan et al., 2002). Since these peptides have previously 
been associated with kefir isolates and are well-characterised, it was decided to 
instead focus on another, apparently novel, antimicrobial.   
 
7.4.3 Identification of proteinaceous killer toxin produced by a kombucha-
associated Dekkera bruxellensis strain 
Colonies from UK and US-sourced kombucha, grown on WL agar supplemented 
with nystatin to inhibit fungal growth, were shown to inhibit L. bulgaricus DPC 
5838. The antimicrobial was found to be sensitive to proteinase K indicating 
that the agent responsible for antimicrobial activity is proteinaceous in nature. 
16S rRNA specific primers failed to generate amplicons when colony PCR was 
performed but internal transcribed specific (ITS) primers did generate a PCR 
product. Sanger sequencing of the ITS amplicon revealed that the producer was, 
in fact, the yeast Dekkera bruxellensis, that had grown despite the presence of 
nystatin, in the media, an antifungal which has been shown to inhbit this 
species (Rodrigues et al., 2001). This raised the question as to the nature of this 
antimicrobial. Yeast are capable of producing antimicrobials, known as mycocins 
or yeast killer toxins. These are analogous to bacteriocins in that they are 
generally active against closely related species and are proteinaceous by nature. 
However, they are larger than bacteriocins (usually 10-100 kDa), sometimes 
contain glycosyl residues and are generally, though not exclusively, active from 
pH 3-6 (Golubev, 2013). Despite reports of the antibacterial activity of some 
yeast killer toxins (Izgu and Altinbay, 1997, Meneghin et al., 2010, Fuentefria et 
al., 2008, Silva et al., 2011), there has yet to be a study that unambiguously 
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establishes that killer toxins inhibit prokaryotes. It is notable that a recent study 
has suggested that a killer toxin from Pichia kudriavzevii RY55 exhibits activity 
against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and 
Enterococcus faecalis, in addition to several species of Aspergillus (Bajaj et al., 
2013), but further analysis of this antimicrobial is required.  
To further investigate the nature of the antimicrobial that was the focus 
of our studies, the culture D. bruxellensis culture was centrifuged to generate 
cell free supernatant. When the CFS was filltered through molecular weight 
cutoff membranes, activity was found in the >30 kDa retentate, indicating the 
antimicrobial is a protein rather than a peptide. The protein was not active at 
pH2, and bound to anionic columns, revealing that it is negatively charged, both 
traits characteristic of mycocinogenic proteins. These characteristics meant that 
typical bacteriocin purification strategies could not be employed to purify the 
protein. The antimicrobial was shown to be heat stable after treatment at 60°C 
for 15mins, but activity was reduced following treatment for 15mins at 70°C and 
80°C, with a loss of activity occurring when incubated at 90°C. This relative lack 
of heat stability is notable given the generally heat-labile nature of mycocins. 
Activity was retained through alkaline and acidic pHs (pH 3-8), which is also 
unusual for killer toxins. DEAE Sepharose anionic columns have been used to 
purify killer toxins in the past (Buzdar et al., 2011, Wang et al., 2007, Guo et al., 
2013), and was therefore used to partially purify the antimicrobial. Faint bands 
of approximately 66 kDa, 55 kDa, 48 kDa, 34kDa and 31kDa could be seen when 
the partially purifed prep was run on SDS polyacrylamide gel, indicating the 
presence of several proteins in the preperation. The specific protein or proteins 
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responsible for antimicrobial activity remain unknown, and further purification 
is necessary. Additionally, the faint nature of the bands suggests there was a 
small yield from the purification process. 
In addition to investigating the nature of the antimicrobial, its spectrum 
of activity was assessed in light of previous suggestions that such antimicrobials 
could be used to protect industrial fermentations from spoilage yeast (Ciani and 
Comitini, 2011, Santos et al., 2011). Dekkera bruxellensis is itself a species which 
has long been associated with the spoilage of wine (Woolfit et al., 2007). Since 
killer proteins are, like bacteriocins, typically active against closely related 
species, assays were carried out to screen species of Dekkera for sensitivity to 
the antimicrobial (Table 3). However, despite the use of several approaches 
including well diffusion, cell-cell antagonism and NaCl+/smear assays, no 
inhibition of Dekkera was observed. Other genera of yeast, including those 
often identified in kombucha fermentations such as Candida, Saccharomyces, 
Zygosaccharomyces and Pichia, including the highly mycocin sensitive Pichia 
heedi NCYC 1490 strain (Vital et al., 2002), were also resistant. This resistance 
was apparent even when NaCl, which has been shown to enhance antimicrobial 
activity or enable activity (Golubev and Tomashevskaya, 2012, Llorente et al., 
1997), was added. A recent study revealed a mycocin produced by 
Kluyvermoyces lactis, most active at alkaline pH, which was not active against 
closely related species, but rather “rare representatives” of yeast genera 
(Golubev, 2013), suggesting that further assays with a larger range of indicator 
taxa should be considered in the future. A number of bacteria were also used as 
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indicators, but activity was only reliably and consistently shown against 
different strains of Lactobacillus bulgaricus (Table 2).  
The Lactobacillus genus is found, albeit at low abundance in kombucha 
fermentations, so activity against this bacterium might provide a competitive 
advantage to D. bruxellensis in this environment. The fact that this antimicrobial 
is being produced by two different kombuchas (sourced from the UK and US) 
establishes that its occurrence is not unique.  
While most known mycocins are active at acidic pHs and are heat labile, 
recent studies are providing information about proteins that do not conform 
with these general rules and which are active against non-related species 
(Golubev, 2013, Buzzini et al., 2004, Ochigava et al., 2011, Antunes and Aguiar, 
2012), and thus the D. bruxellensis-associated protein may also be an atypical 
mycocin. While the killer phenotype has been associated with D. bruxellensis on 
one previous occasion, with activity against Candida and Zygosaccharomyces 
(Antunes and Aguiar, 2012), a mycocin has yet to be purified from this genus. 
However, the antimicrobial that was the emerged from our study does 
not show activity against any of the yeasts screened, and further 
characterisation is required to confirm that it is mycocinogenic in nature. 
Regardless, further screening of the yeast component of these and other 
fermented foods for producers of antimicrobials merits consideration.  
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Table 2 
A list of the Lactobacillus bulgaricus strains (A), Lactobacillus strains (B) and 
other strains (C) used as bacterial indicators in screening for antibacterial 
activity  
 
A) Sensitive Lactobacillus bulgaricus strains Zone 
Lactobacillus bulgaricus DPC 5396 1mm 
Lactobacillus bulgaricus DPC 1184 2mm 
Lactobacillus bulgaricus DPC 6104 3mm 
Lactobacillus bulgaricus DPC 5384 3mm 
Lactobacillus bulgaricus DPC 3966 2mm 
Lactobacillus bulgaricus DPC 1185 1mm 
Lactobacillus bulgaricus DPC 1187 1mm 
Lactobacillus bulgaricus DPC 1181 1mm 
Lactobacillus bulgaricus DPC 1183 1.5mm 
Lactobacillus bulgaricus DPC 3322 3mm 
Lactobacillus bulgaricus DPC 5838 3mm 
 
 
B) Other Lactobacillus spp.  Zone 
Lactobacillus amylovorus DPC 6499 X 
Lactobacillus bulgaricus DPC 5406 X 
Lactobacillus bulgaricus DPC 1186 X 
Lactobacillus bulgaricus DPC 1182 X 
Lactobacillus casei DPC 6063 X 
Lactobacillus crispatus LMG 9479 X 
Lactobacillus fermentum LMG 6902 X 
Lactobacillus gallinarum LMG 9435 X 
Lactobacillus mucosae DPC 6426 X 
Lactobacillus murinus DPC 6139 X 
Lactobacillus paracheseii NFBC 338 X 
Lactobacillus pentosus DPC 6140 X 
Lactobacillus plantarum DPC 4850 X 
Lactobacillus rhamnosus LMG 6400 X 
Lactobacillus ruminis DPC 6419 X 
Lactobacillus salivarius DPC 6196 X 
Lactobacillus salivarius DPC 6488 X 
Lactobacillus salivarius UCC 118 X 
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C) Other Indicators  Zone 
Bacillus cereus ATCC 9139 X 
Bacillus subtilis LMG 8198  X 
Enterococcus faecalis E265 X 
Lactococcus lactis HP  X 
Lactococcus lactis MG 1363  X 
Lactococcus lactis NZ 900 X 
Lactococcus lactis DPC 3147 X 
Leuconostoc cremoris DPC 223 X 
Listeria innocua DPC 3572  X 
Pediococcus pentosaceus LMG11488 X 
Salmonella typhimurium LT2  X 
Staphylococcus aureus ATCC 25923 X 
Streptococcus faecalis DPC 3556 X 
Streptococcus faecalis DPC 3557 X 
Streptococcus agalactiae LMG 14694/ATCC 13813 X 
Streptococcus uberis DPC 5344 X 
Streptococcus mutans NCTC 10449 X 
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Table 3 
A list of the yeast indicators used in the screening for antifungal activity from 
the Dekkera bruxellensis antimicrobial protein 
 
Strain  Zone  
Candida intermedia DPC 6270 X 
Candida intermedia DPC 6271 X 
Zygosaccyaromyces visicolier DPC 5734 X 
Debaryomyces hansenii DPC 5729 X 
Debaryomyces Kloackeri var. major WSH 50 DPC 5731 X 
Candida Catenulata WSYC 319 DPC 5730 X 
Yarrowia lipolytica DPC 6266 X 
Debaryomyces hansenii DPC 6264 X 
Debaryomyces hansenii DPC 6265 X 
Dekkera anomala DSM 70727 X 
Dekkera bruxellensis DSM 70001 X 
Dekkera custersiana DSM 70736 X 
Dekkera naardenensis DSM 70743 X 
Zygosaccharomyces bisporus DSM 70415 X 
Pichia anomala DSM 6766 X 
Pichia heedii NCYC 1490 X 
Rhodotorula mucilaginosa (unspecified strain) X 
Candida parapsilosis(unspecified strain) X 
Saccharomyces cerevisiae (unspecified strain) X 
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Appendix A: Supplemental information for Chapter 4 
 
 
Sequencing-based analysis of the bacterial and fungal composition of kefir 
grains and milks from multiple sources 
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Supplemental Figure 1: Rarefactions for the 16S kefir milk and grain Chao1 and 
Shannon indices where A = Grains and B = Milks  
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Supplemental Figure 2: Box plots of the 16S alpha diversity  
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Supplemental Figure 3: Box plots of the ITS alpha diversity  
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Supplemental Figure 4: Rarefactions of the ITS kefir milk and grain Chao1 and 
Shannon indices where A = Grains and B = Milks 
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Kefir Name Origin Source Additional Info
US1 United States Company Cultures For Health Dehydrated
US3 United States Company Your Kefir Source
Ger1 Germany Company Vital Drinks 
UK1 United Kingdom Company Kefir Shop 
US2 United States Company Kefir Lady
US5 United States Company Rejoice in Life Dehydrated
US4 United States Company Savvy Teas and Herbs Unpasteurised Milk
IT1 Italy Individual Contact
FR1 France Individual Contact
Ger2 Germany Individual Contact
SP1 Spain Individual Contact
Bel1 Belgium Individual Contact
UK2 United Kingdom Individual Contact
UK3 United Kingdom Individual Contact
UK4 United Kingdom Individual Contact
CA1 Canada Individual Contact
UK5 United Kingdom Individual Contact  
 
 
 
 
Supplemental Table 1: Sources of kefir samples  
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Grain Chao1 Simpson Shannon Phylogenetic Diversity Observed Species
BEL1 89.857143 0.322229747 1.151474964 4.90177 47
CA1 60.428571 0.356148569 1.000360006 3.61941 36
FR1 62.428571 0.24393226 0.831990501 3.45632 38
GER1 41.428571 0.208659552 0.733845708 3.73523 32
GER2 59.428571 0.576212719 1.778737293 3.02014 35
IR1 29.6 0.161181917 0.679678613 1.81705 24
IR10 58.363636 0.687076709 2.055196176 3.74655 46
IR2 62.272727 0.195994136 0.821974127 3.9069 45
IR3 66 0.682011448 2.033049794 2.52558 31
IR4 63.2 0.515064403 1.631761195 3.67431 36
IR5 41 0.357235569 1.246135312 2.70234 26
IR6 91.5 0.583847951 1.719909851 3.88363 39
IR8 77.333333 0.575493025 1.82049819 3.57961 32
IR9 72.25 0.718006417 2.223508843 3.62395 34
IT1 55.5 0.66535649 1.832230731 3.21449 38
SP1 39.428571 0.581939422 1.494818705 2.64333 30
UK1 63.375 0.429743322 1.358610597 4.35213 42
UK2 84.111111 0.51106434 1.710162536 4.64035 56
UK3 39.166667 0.174024314 0.599510645 3.79165 30
US1 60 0.551344418 1.71823702 4.35363 41
US2 90.428571 0.579748985 1.728058155 3.70098 51
US3 45 0.705011851 2.203295841 2.84788 32
US5 148.5 0.575570837 1.689024412 3.6874 47
Milk Chao1 Simpson Shannon Phylogenetic Diversity Observed Species
BEL1 47.5 0.374153184 1.152567837 1.2791 25
CA1 46.75 0.702884236 2.06730088 2.17078 33
FR1 30 0.121015053 0.451194038 1.56664 23
GER1 29.5 0.552708593 1.461280595 1.38427 25
GER2 57 0.623888494 1.862857158 1.83503 33
IR1 87.428571 0.539376805 1.832544164 2.13412 48
IR10 60 0.643189906 1.960675459 2.21297 43
IR2 38 0.133633116 0.500955457 1.64722 23
IR3 116 0.591569875 1.922007927 2.67777 51
IR4 51.666667 0.535551288 1.633770127 2.00318 40
IR5 108 0.663702199 2.247030145 2.31915 48
IR6 102.75 0.670655411 2.074999006 2.11627 45
IR8 65.2 0.21038868 0.80972062 2.25856 38
IR9 48.142857 0.678040313 2.003182555 2.24123 37
IT1 60 0.589212289 1.606192441 1.9759 36
SP1 31 0.153816039 0.543628859 1.4283 22
UK1 40.25 0.271931852 0.92880951 1.85377 29
UK2 41 0.264076933 0.921660013 1.46781 26
UK3 43.5 0.326426064 0.963303442 1.1724 27
US1 31.666667 0.524193804 1.723050492 1.47926 27
US2 86.666667 0.52825382 1.717945614 2.63327 61
US3 32.8 0.598057595 1.748797963 1.52136 30
US5 70.5 0.524047565 1.72577908 2.48339 45  
 
Supplemental Table 2: 16S alpha diversities  
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Grain Chao1 Simpson Shannon Phylogenetic Diveristy Observed Species 
BEL1 14.66666667 0.102980374 0.334582493 0.8708 13
CA1 4 0.551584484 1.302291763 1.03134 4
FR1 25.14285714 0.484204239 1.073251729 3.74179 20
GER1 15 0.259954001 0.657617505 1.58687 12
GER2 26.5 0.198410653 0.622425 1.74371 16
IR1 7 0.031239654 0.147844986 1.53319 7
IR10 7.333333333 0.277525423 0.706306939 1.20657 7
IR2 11 0.013961747 0.071403438 1.38798 9
IR4 94 0.494759438 1.07495927 5.74017 26
IR5 18.5 0.506409666 1.075015608 2.28067 11
IR6 68.5 0.095145764 0.37856945 4.25407 23
IR8 14 0.456511803 0.955377948 1.19739 9
IR9 11 0.077047309 0.257707014 1.34051 8
IT1 23.5 0.446011764 1.132317594 2.5282 16
SP1 56 0.464657173 1.151908449 5.00048 23
UK1 41.375 0.54433288 1.372674234 3.11514 30
UK2 75.33333333 0.696429187 2.081158637 4.66894 30
UK3 53 0.055138315 0.254210336 3.08227 20
UK4 62 0.545478875 1.332518118 5.232 23
UK5 17.2 0.090414508 0.359503994 1.67322 16
US1 14 0.035466069 0.166738874 1.94581 11
US2 50 0.462742166 1.191925426 1.42621 14
US3 72 0.521756462 1.473312785 5.15106 34
US5 82.33333333 0.744162084 2.467399236 4.28862 37
Milk Chao1 Simpson Shannon Phylogenetic Diveristy Observed Species 
BEL1 47.33333333 0.619656262 1.809163769 4.91291 29
CA1 50.5 0.07776884 0.327360687 6.63581 23
FR1 24.33333333 0.527069894 1.316372942 2.84088 15
GER1 44.5 0.525933215 1.300491676 3.985 25
GER2 61 0.504229437 1.098739283 4.97076 26
IR1 10.75 0.008172839 0.049624645 2.59532 10
IR10 68 0.181660438 0.572385267 8.19713 28
IR2 23 0.015763689 0.092257005 5.24963 16
IR4 34.2 0.488282384 1.057285126 6.66776 21
IR5 41 0.011386143 0.069382641 3.91416 13
IR6 24.2 0.024167974 0.129321558 4.41839 17
IR8 34 0.03857195 0.225372863 11.10525 30
IR9 46 0.268675267 1.076586742 15.87415 37
IT1 54 0.449213635 1.249934207 3.7605 30
SP1 41.11111111 0.495165149 1.299695516 10.41399 35
UK1 47.5 0.635171659 1.732553533 6.89271 30
UK2 52.33333333 0.491523022 1.132283402 3.45618 22
UK3 83.5 0.567377268 1.555601362 7.29881 31
UK4 34.75 0.430419871 1.093167883 3.38308 21
UK5 35 0.544022869 1.280250436 6.24733 22
US1 64.66666667 0.571574795 2.000269036 12.44054 42
US2 23.625 0.240205749 0.79374936 3.38219 21
US3 55 0.039897894 0.195217424 5.91388 22
US5 33 0.102658629 0.453759347 6.36783 24  
 
Supplemental Table 3: ITS alpha diversities  
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BEL1 CA1 FR1 GER1 GER2 IR1 IR2 IR3 IR4 IR5 IR6 IR8
Phylum 
Proteobacteria 0.004454 0 0.011704 0.003378 0.199126 0.01558 0.020174 0.033619 0.270081 0.032357 0.691367 0.266499
Firmicutes 0.994432 0.997711 0.987913 0.992629 0.798932 0.98416 0.978735 0.965392 0.72796 0.96569 0.30771 0.732383
Bacteroidetes 0 0 0 0.003071 0 0 0.000909 0 0.001679 0 0 0
Actinobacteria 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.001114 0.002289 0.000384 0.000921 0.001943 0.00026 0.000182 0.000989 0.00028 0.001953 0.000923 0.001119
Family  
Acetobacteraceae 0.003341 0 0.011512 0.002764 0.199126 0.01558 0.019993 0.033619 0.269801 0.032357 0.690905 0.266499
Lachnospiraceae 0.003619 0 0.002302 0.002457 0 0.002597 0.001272 0 0.002519 0 0.00277 0.001957
Ruminococcaceae 0.082127 0 0 0 0.002428 0.018437 0.006361 0 0.013434 0 0 0
Lactobacillaceae 0.895601 0.989827 0.978319 0.981572 0.775134 0.955077 0.948201 0.960448 0.706409 0.947559 0.2994 0.723154
Streptococcaceae 0.005568 0 0.004797 0 0.01797 0.006232 0.021628 0.002966 0.002519 0.014784 0.004155 0.005034
Leuconostocaceae 0.003062 0 0.001343 0 0 0 0 0 0 0 0 0
Clostridiaceae 0 0 0 0.003686 0 0 0 0 0 0 0 0
Enterococcaceae 0 0 0 0 0 0 0 0 0 0 0 0
Propionibacterineae 0 0 0 0 0 0 0 0 0 0 0 0
Bifidobacteriaceae 0 0 0 0 0 0 0 0 0 0 0 0
Bacteroidaceae 0 0 0 0 0 0 0 0 0 0 0 0
Rikenellaceae 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.006682 0.010173 0.001727 0.009521 0.005342 0.002077 0.002545 0.002966 0.005318 0.0053 0.00277 0.003356
Genus  
Acetobacter 0.003341 0 0.011512 0.002764 0.199126 0.01558 0.019993 0.033619 0.269801 0.032357 0.690905 0.266499
Faecalibacterium 0.0799 0 0 0 0 0.018177 0.005634 0 0.012594 0 0 0
Ruminococcaceae Incertae Sedis 0.001392 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus 0.895601 0.989827 0.978319 0.981572 0.775134 0.955077 0.948201 0.960448 0.706409 0.947559 0.2994 0.723154
Lactococcus 0.005568 0 0.004797 0 0.01797 0.006232 0.021628 0.002966 0.002519 0.014784 0.004155 0.005034
Leuconostoc 0.003062 0 0.001343 0 0 0 0 0 0 0 0 0
Allobaculum 0 0.005595 0 0 0 0 0 0 0.003079 0.001395 0 0
Rickenella 0 0 0 0.001536 0 0 0 0 0 0 0 0
Clostridium 0 0 0 0.003378 0 0 0 0 0 0 0 0
Enterococcus 0 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium 0 0 0 0 0 0 0 0 0 0 0 0
Bacteroides 0 0 0 0 0 0 0 0 0 0 0 0
Alistipes 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.011136 0.004578 0.004029 0.010749 0.007771 0.004934 0.004544 0.002966 0.005598 0.003905 0.00554 0.005313  
Supplemental Table 4: Relative abundances for the 16S grain 
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BEL1 CA1 FR1 GER1 GER2 IR1 IR2 IR3 IR4 IR5 IR6 IR8
Phylum
Proteobacteria 0.011737 0.430899 0 0.00261 0.102909 0.7524 0.008217 0.256513 0.016942 0.605441 0.293759 0.904079
Fimicutes 0.988263 0.56881 1 0.99739 0.897091 0.247419 0.991592 0.74314 0.98291 0.393271 0.705631 0.09577
Actinobacteria 0 0 0 0 0 0 0 0 0 0 0 0
Other 0 0.000291 0 0 0 0.000181 0.000191 0.000347 0.000149 0.001288 0.00061 0.000151
Family 
Acetobacteraceae 0.011737 0.430899 0 0.00261 0.102909 0.7524 0.008217 0.256513 0.016942 0.605441 0.293759 0.904079
Lactobacillaceae 0.121909 0.20934 0.004622 0.425802 0.25657 0.071545 0.004204 0.605071 0.223362 0.23519 0.199024 0.064653
Streptococcaceae 0.784194 0.330957 0.942142 0.540268 0.559077 0.163195 0.930633 0.101598 0.6524 0.148583 0.489124 0.028701
Leuconostocaceae 0.080751 0.028077 0.052757 0.024609 0.079238 0.012317 0.056373 0.03265 0.104325 0.007405 0.015044 0.001511
Propionibacterinaceae 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.001408 0.000727 0.000478 0.006711 0.002207 0.000543 0.000573 0.004168 0.002972 0.003381 0.003049 0.001057
Genus  
Acetobacter 0.011737 0.430899 0 0.00261 0.102909 0.752038 0.008217 0.256339 0.016942 0.604958 0.293759 0.903776
Lactobacillus 0.121909 0.20934 0.004622 0.425802 0.25657 0.071545 0.004204 0.605071 0.223362 0.235029 0.199024 0.064653
Lactococcus 0.784038 0.330957 0.942142 0.540268 0.559077 0.163195 0.930633 0.101598 0.652251 0.148261 0.489124 0.028701
Leuconostoc 0.080751 0.028077 0.052757 0.024609 0.079238 0.012317 0.056373 0.03265 0.104325 0.007405 0.015044 0.001511
Propionibacterium 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.001565 0.000727 0.000478 0.006711 0.002207 0.000906 0.000573 0.004342 0.003121 0.004346 0.003049 0.00136  
 
Supplemental Table 5: Relative abundances for the 16S milk 
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BEL1 FR1 GER1 GER2 IR1 IR2 IR4 IR5 IR6 IR8 IR9 IR10
Phylum 
Ascomycota 1 0.99945 1 0.999846 1 1 0.99712 0.999623 0.999181 0.999465 0.999797 0.999636
Other 0 0.00055 0 0.000154 0 0 0.00288 0.000377 0.000819 0.000535 0.000203 0.000364
Family  
Saccharomycetaceae 1 0.99945 0.999011 0.999846 1 1 0.99712 0.999623 0.998567 0.999465 0.999797 0.999636
Davidiellaceae 0 0 0 0 0 0 0 0 0 0 0 0
Trichocomaceae 0 0 0 0 0 0 0 0 0 0 0 0
Pichiaceae 0 0 0 0 0 0 0 0 0 0 0 0
Dothioraceae 0 0 0 0 0 0 0 0 0 0 0 0
Other 0 0.00055 0.000989 0.000154 0 0 0.00288 0.000377 0.001433 0.000535 0.000203 0.000364
Genus  
Kazachstania 0.0024 0.006047 0 0.080488 0.987949 0.994039 0.420266 0.532264 0.952498 0.650864 0.038774 0.835333
Kluyveromyces 0.051514 0.37768 0.148179 0 0.004544 0 0 0.00717 0.005938 0 0 0.009269
Naumovozyma 0 0 0 0.024564 0.002371 0 0.575594 0.459245 0.003481 0.348245 0.960211 0.155035
Saccharomyces 0 0 0 0 0 0 0 0.000943 0.002867 0 0 0
Davidiella 0 0 0 0 0 0 0 0 0 0 0 0
Penicillium 0 0 0 0 0 0 0 0 0 0 0 0
Pichia 0 0 0 0 0 0 0 0 0 0 0 0
Dekkera 0 0 0 0 0 0 0 0 0 0 0 0
Aureobasidium 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.946086 0.616273 0.851821 0.894948 0.005136 0.005961 0.00414 0.000377 0.035217 0.000891 0.001015 0.000364
Species  
Kazachstania barnetti 0.0024 0.006047 0 0 0 0 0 0 0 0 0 0
Kluyveromyces marxianus 0.051514 0.37768 0.148179 0 0.004544 0 0 0.00717 0.005938 0 0 0.009269
Kazachstania unispora 0 0 0 0.080488 0.987949 0.994039 0.420266 0.532264 0.952498 0.650864 0.038774 0.835333
Naumovozyma castelli 0 0 0 0.024564 0.002371 0 0.575594 0.459245 0.003481 0.348245 0.960211 0.155035
Saccharomyces cerevisiae 0 0 0 0 0 0 0 0.000943 0 0 0 0
Davidiella tassiana 0 0 0 0 0 0 0 0 0 0 0 0
Penicillium sp. Vega 347 0 0 0 0 0 0 0 0 0 0 0 0
Pichia kudriavzevii 0 0 0 0 0 0 0 0 0 0 0 0
Dekkera anomala 0 0 0 0 0 0 0 0 0 0 0 0
Other 0.946086 0.616273 0.851821 0.894948 0.005136 0.005961 0.00414 0.000377 0.038084 0.000891 0.001015 0.000364                                      
Supplemental Table 6: Relative abundances for the ITS grain (Part 1) 
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IT1 SP1 UK1 UK2 UK3 UK4 UK5 US1 US2 US3 US5
Phylum 
Ascomycota 0.999812 0.998465 0.99963 0.998526 1 0.999309 0.999805 0.999086 1 0.997866 0.999453
Other 0.000188 0.001535 0.00037 0.001474 0 0.000691 0.000195 0.000914 0 0.002134 0.000547
Family  
Saccharomycetaceae 0.999812 0.98531 0.99963 0.998232 0.998414 0.99741 0.999805 0.999086 1 0.997672 0.999179
Davidiellaceae 0 0.002193 0 0 0 0 0 0 0 0 0
Trichocomaceae 0 0.001316 0 0 0 0 0 0 0 0 0
Pichiaceae 0 0.005701 0 0 0 0 0 0 0 0 0
Dothioraceae 0 0 0 0 0.000881 0 0 0 0 0 0
Other 0.000188 0.005481 0.00037 0.001768 0.000705 0.00259 0.000195 0.000914 0 0.002328 0.000821
Genus  
Kazachstania 0.045198 0.663451 0.046615 0.277925 0.003876 0.42058 0.029854 0.992455 0.696672 0.655801 0.57049
Kluyveromyces 0.249906 0.003947 0.384573 0.056882 0.014623 0.040573 0.009171 0 0.085102 0.139697 0.156584
Naumovozyma 0 0.305196 0.004624 0.183319 0.005814 0 0 0.001829 0.00134 0.015716 0.010129
Saccharomyces 0 0 0 0 0 0 0 0 0 0.004463 0
Davidiella 0 0.002193 0 0 0 0 0 0 0 0 0
Penicillium 0 0.001316 0 0 0 0 0 0 0 0 0
Pichia 0 0.005701 0 0 0 0 0 0 0 0 0
Dekkera 0 0.01184 0 0 0 0 0 0 0 0 0
Aureobasidium 0 0 0 0 0.000881 0 0 0 0 0 0
Other 0.704896 0.006358 0.564188 0.481874 0.974806 0.538847 0.960976 0.005716 0.216886 0.184323 0.262798
Species  
Kazachstania barnetti 0 0 0 0 0 0 0 0 0 0 0
Kluyveromyces marxianus 0.249906 0.003947 0.384573 0.056882 0.014623 0.040573 0.009171 0 0.085102 0.139697 0.156584
Kazachstania unispora 0.045198 0.663451 0.046615 0.277041 0.003876 0.42058 0.029854 0.992455 0.696002 0.655801 0.57049
Naumovozyma castelli 0 0.305196 0.004624 0.183319 0.005814 0 0 0.001829 0.00134 0.015716 0.010129
Saccharomyces cerevisiae 0 0 0 0 0 0 0 0 0 0 0
Davidiella tassiana 0 0.002193 0 0 0 0 0 0 0 0 0
Penicillium sp. Vega 347 0 0.001316 0 0 0 0 0 0 0 0 0
Pichia kudriavzevii 0 0.005701 0 0 0 0 0 0 0 0 0
Dekkera anomala 0 0.01184 0 0 0 0 0 0 0 0 0
Other 0.704896 0.006358 0.564188 0.482759 0.975687 0.538847 0.960976 0.005716 0.217556 0.188785 0.262798                                  
Supplemental Table 6: Relative abundances for the ITS grain (Part 2) 
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BEL1 FR1 GER1 GER2 IR1 IR2 IR4 IR5 IR6 IR8 IR9 IR10 IT1 SP1 UK1 UK2 UK3 UK4 UK5 US1 US2 US3 US5
Phylum 
Ascomycota 0.995031 0.999554 1 0.998212 0.952918 0.995828 0.998547 0.998515 0.998054 0.990595 0.938609 0.893837 1 0.990837 0.992322 0.999631 0.996476 0.999259 0.998893 0.89835 0.999275 0.999717 0.995446
Basidiomycota 0 0 0 0.000993 0.003879 0.000927 0 0 0.001297 0 0.010791 0.008748 0 0.003869 0.00664 0 0 0 0 0.015449 0 0 0
Uncultured Fungus 0.004472 0 0 0 0.003527 0.0017 0 0 0 0.001447 0.008633 0.007952 0 0.001425 0 0 0 0 0 0.013343 0 0 0.002024
Other 0.000497 0.000446 0 0.000795 0.039676 0.001545 0.001453 0.001485 0.000649 0.007958 0.041966 0.089463 0 0.003869 0.001038 0.000369 0.003524 0.000741 0.001107 0.072858 0.000725 0.000283 0.00253
Family 
Saccharomycetaceae 0.994783 0.997992 0.999211 0.997815 0.949921 0.994747 0.997717 0.998515 0.997622 0.985893 0.907914 0.887078 0.999446 0.64325 0.988172 0.998894 0.990257 0.999074 0.998339 0.833743 0.999275 0.997449 0.992158
Davidiellaceae 0 0 0 0 0 0 0 0 0 0 0.008393 0 0 0 0 0 0 0 0 0 0 0 0
Trichocomaceae 0 0 0 0 0.000705 0 0 0 0 0 0.004556 0.00159 0 0 0 0 0 0 0 0 0 0 0
Pichiaceae 0 0 0 0 0 0.000927 0 0 0 0 0 0 0 0.3427 0.00332 0 0.004768 0 0 0 0 0.001276 0.003289
Tremellomycetes 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Wallemiomycetes 0 0 0 0 0.002557 0 0 0 0 0 0 0.005765 0 0 0 0 0 0 0 0 0 0 0
Herpotrichiellaceae 0 0 0 0 0 0 0 0 0 0.001085 0 0 0 0 0 0 0 0 0 0 0 0 0
Teratosphaeriaceae 0 0 0 0 0 0 0 0 0 0 0.001199 0 0 0 0 0 0 0 0 0.001053 0 0 0
Valsaceae 0 0 0 0 0 0 0 0 0 0 0.008393 0 0 0 0 0 0 0 0 0 0 0 0
Debaryomycetaceae 0 0 0 0 0 0 0 0 0 0 0.003357 0 0 0 0 0 0 0 0 0 0 0 0
Phaffomycetaceae 0 0 0 0 0 0 0 0 0 0 0.002878 0 0 0 0 0 0 0 0 0 0 0 0
Malasseziaceae 0 0 0 0 0 0 0 0 0 0 0.002158 0 0 0 0 0 0 0 0 0 0 0 0
Bondarzewiaceae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.00664 0 0 0 0 0 0 0 0
Dermataceae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.006496 0 0 0
Pezizaceae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.003511 0 0 0
Ganodermataceae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.005794 0 0 0
Tricholomataceae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.005267 0 0 0
Other 0.005217 0.002008 0.000789 0.002185 0.046817 0.004326 0.002283 0.001485 0.002378 0.013022 0.061151 0.105567 0.000554 0.01405 0.001868 0.001106 0.004975 0.000926 0.001661 0.144136 0.000725 0.001276 0.004554
Genus 
Kazachstania 0.012174 0.346497 0.056816 0.548272 0.948598 0.991965 0.399045 0.997277 0.988973 0.982094 0.068585 0.885288 0.157029 0.627774 0.467939 0.004425 0.360904 0.716296 0.519195 0.600597 0.869471 0.980726 0.008854
Kluyveromyces 0.501615 0.033244 0.338726 0 0.000529 0 0 0 0 0.000904 0.001679 0.001193 0.114724 0.001018 0.359203 0.379425 0.058665 0.039815 0.046881 0.044066 0.05753 0.010062 0.024285
Naumovozyma 0 0.593039 0 0 0 0 0.594107 0 0.005622 0.000904 0.818705 0 0 0.009978 0.017639 0 0.5483 0 0 0.018083 0 0 0.005818
Saccharomyces 0 0 0 0 0 0 0 0 0 0 0.009353 0 0 0 0 0 0.001036 0 0 0 0 0.000709 0
Davidiella 0 0 0 0 0 0 0 0 0 0 0.008393 0 0 0 0 0 0 0 0 0 0 0 0
Pichia 0 0 0 0 0 0.000927 0 0 0 0 0 0 0 0.3427 0.00332 0 0.004768 0 0 0 0 0.001276 0.003289
Dekkera 0.002733 0.001116 0 0 0 0 0.00332 0 0 0 0 0 0.003695 0.002647 0.00498 0.002581 0.00228 0 0 0.001229 0 0.004677 0
Zygosaccharomyces 0 0 0 0 0.000441 0 0 0 0.002378 0.001266 0 0 0 0 0 0 0 0 0 0.001053 0 0.000709 0
Wallemia 0 0 0 0 0.002557 0 0 0 0 0 0 0.005765 0 0 0 0 0 0 0 0 0 0 0
Eurotium 0 0 0 0 0.000705 0 0 0 0 0 0 0.00159 0 0 0 0 0 0 0 0 0 0 0
Microdochium 0 0 0 0 0 0 0 0 0 0.001809 0 0 0 0 0 0 0 0 0 0 0 0 0
Cryptococcus 0 0 0 0 0 0 0 0 0 0.000904 0.006235 0 0 0 0 0 0 0 0 0 0 0 0
Teratosphaeria 0 0 0 0 0 0 0 0 0 0 0.001199 0 0 0 0 0 0 0 0 0 0 0 0
Debaromyces 0 0 0 0 0 0 0 0 0 0 0.002878 0 0 0 0 0 0 0 0 0 0 0 0
Cyberlindnera 0 0 0 0 0 0 0 0 0 0 0.002878 0 0 0 0 0 0 0 0 0 0 0 0
Malassezia 0 0 0 0 0 0 0 0 0 0 0.002158 0 0 0 0 0 0 0 0 0 0 0 0  
Supplemental Table 7: Relative abundances for the ITS milk (Part 1) 
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BEL1 FR1 GER1 GER2 IR1 IR2 IR4 IR5 IR6 IR8 IR9 IR10 IT1 SP1 UK1 UK2 UK3 UK4 UK5 US1 US2 US3 US5
Genus 
Heterobasidion 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.00664 0 0 0 0 0 0 0 0
Neofabraea 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.006496 0 0 0
Peziza 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.003511 0 0 0
Ganoderma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.005794 0 0 0
Mycena 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.005267 0 0 0
Dioszegia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.002107 0 0 0
Other 0.483478 0.026104 0.604458 0.451728 0.04717 0.007108 0.003528 0.002723 0.003027 0.012118 0.077938 0.106163 0.724552 0.015883 0.140278 0.613569 0.024046 0.243889 0.433924 0.311798 0.073 0.001842 0.957754
Species 
Kazachstania barnetti 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kluyveromyces marxianus 0.501615 0.033244 0.338726 0 0.000529 0 0 0 0 0.000904 0.001679 0.001193 0.114724 0.001018 0.359203 0.379425 0.058665 0.039815 0.046881 0.044066 0.05753 0.010062 0.024285
Kazachstania unispora 0.012174 0.346497 0.056816 0.548272 0.948598 0.991965 0.399045 0.997277 0.988973 0.982094 0.068585 0.885288 0.157029 0.627774 0.467939 0.004425 0.360904 0.716296 0.519195 0.600597 0.869471 0.980726 0.008854
Naumovozyma castelli 0 0.593039 0 0 0 0 0.594107 0 0.005622 0.000904 0.818705 0 0 0.009978 0.017639 0 0.5483 0 0 0.018083 0 0 0.005818
Saccharomyces cerevisiae 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Davidiella tassiana 0 0 0 0 0 0 0 0 0 0 0.008393 0 0 0 0 0 0 0 0 0 0 0 0
Penicillium  sp. Vega 347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pichia kudriavzevii 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3427 0.003113 0 0.004768 0 0 0 0 0.001276 0.003289
Pichia occidentalis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pichia fermentans 0 0 0 0 0 0.000773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dekkera anomala 0 0.001116 0 0 0 0 0.002283 0 0 0 0 0 0.00351 0.002647 0.00415 0 0.00228 0 0 0.001229 0 0 0
Dekkera bruxellensis 0.002733 0 0 0 0 0 0.001038 0 0 0 0 0 0 0 0 0.002581 0 0 0 0 0 0.004535 0
Zygosaccharomyces lentus 0 0 0 0 0.000441 0 0 0 0.002378 0.001266 0 0 0 0 0 0 0 0 0 0.001053 0 0.000709 0
Eurotium amstelodami 0 0 0 0 0.000705 0 0 0 0 0 0 0.00159 0 0 0 0 0 0 0 0 0 0 0
Wallemia sebi 0 0 0 0 0.002557 0 0 0 0 0 0 0.005765 0 0 0 0 0 0 0 0 0 0 0
Microdochium nivale 0 0 0 0 0 0 0 0 0 0.001809 0 0 0 0 0 0 0 0 0 0 0 0 0
Cryptococcus sp. Vega039 0 0 0 0 0 0 0 0 0 0.000904 0.001199 0 0 0 0 0 0 0 0 0 0 0 0
Teratosphaeria knoxdaviesii 0 0 0 0 0 0 0 0 0 0 0.001199 0 0 0 0 0 0 0 0 0 0 0 0
Cyberlindnera jadinii 0 0 0 0 0 0 0 0 0 0 0.002878 0 0 0 0 0 0 0 0 0 0 0 0
Malassezia pachydermatis 0 0 0 0 0 0 0 0 0 0 0.002158 0 0 0 0 0 0 0 0 0 0 0 0
Heterobasidion annosum 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.001038 0 0 0 0 0 0 0 0
Paziza campestri s 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.003511 0 0 0
Ganoderma lucidum 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.005794 0 0 0
Dioszegia hungarica 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.002107 0 0 0
Other 0.483478 0.026104 0.604458 0.451728 0.04717 0.007262 0.003528 0.002723 0.003027 0.012118 0.095204 0.106163 0.724737 0.015883 0.146918 0.613569 0.025083 0.243889 0.433924 0.32356 0.073 0.002693 0.957754  
Supplemental Table 7: Relative abundances for the ITS milk (Part 2) 
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Appendix B: Supplemental information for Chapter 5 
 
Sequence-based analysis of the microbial composition of water kefir from 
multiple sources 
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Supplemental Figure 1  
A) Rarefactions for the water kefir 16S samples  
B) Rarefactions for the water kefir ITS samples.  
Red = Ca fermentate, Blue = Ca grain, Orange = UK fermentate, Green = UK 
grain, Purple = US2 fermentate, Yellow = US2 grain, Light Blue = US1 
fermentate  
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Supplemental Figure 2 Principle Coordinate Analysis (PCoA) plot based on 
unweighted UniFrac distance matrices, show distribution of the bacterial 
populations of water kefir grains and fermentates 
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Supplemental Figure 3 pH analysis of the different water kefirs over a 4-day 
period 
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Chao1 Simpson Shannon Phylogenetic Diversity Observed Species
Ca Fermentate 41.17 0.55 1.58 1.98 32
Ca Grain 48 0.47 1.43 2.4 26
UK Fermentate 23 0.58 1.65 1.49 20
UK Grain 43 0.41 1.26 1.31 15
US2 Fermentate 19.5 0.41 1.09 1.25 17
US2 Grain 89 0.42 1.23 2.19 23
US1 Fermentate 22 0.67 1.98 1.35 20
US1 Grain 25 0.25 0.89 1.3 15
Averages 38.83 0.47 1.39 1.66 21  
 
 
 
 
Supplemental Table 1 
Alpha Diversities for the Water Kefir 16S Population 
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Ca UK US1 US2 Ca UK US1 US2
Total 3188 3186 3112 3633 3339 1408 3344 3062
Phylum 
Proteobacteria 0.5919 0.5964 0.5064 0.7479 0.7062 0.7571 0.8738 0.7495
Actinobacteria 0.005 0.0173 0 0.0014 0.0371 0.0781 0.0018 0.0251
Firmicutes 0.4015 0.3854 0.4923 0.2505 0.2558 0.1648 0.1241 0.224
Other 0.0016 0.0009 0.00129 0.0003 0.0009 0 0.0003 0.0013
Family 
Acetobacteraceae 0.0063 0.0298 0.0116 0.00712 0.0105 0 0.0039 0.0069
Sphingomonadaceae 0.5838 0.5659 0.4945 0.7407 0.6957 0.755 0.8696 0.7427
Bifidobacteriaceae 0.005 0.0172 0 0.0014 0.0362 0.0781 0.0018 0.0252
Lactobacillaceae 0.3896 0.3854 0.2346 0.2505 0.2549 0.1641 0.1196 0.2231
Leuconostocaceae 0.0116 0 0.2545 0 0 0 0.0045 0
Other 0.0038 0.0016 0.0048 0.0003 0.0027 0.0028 0.0006 0.0023
Genus 
Acetobacter 0.0035 0.0276 0.0103 0.0061 0 0 0 0
Zymomonas 0.5838 0.5659 0.4945 0.7407 0.6957 0.755 0.8696 0.7427
Lactobacillus 0.3883 0.3848 0.2339 0.2504 0.254 0.1641 0.1196 0.2231
Leuconostoc 0.0113 0 0.2526 0 0 0 0.0042 0
Gluconacetobacter 0 0 0 0 0.0093 0 0.0027 0.0052
Other 0.0132 0.0217 0.0087 0.0028 0.041 0.081 0.0039 0.0291
Fermentate Grain
 
 
 
 
 
Supplemental Table 2  
Relative abundances for the 16S population 
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Ca UK US1 US2 Ca UK US1 US2
Total Reads 1549 192 1144 440 80 1186 23 51
Phylum 
Ascomycota 1527 192 1138 437 79 1186 23 51
Other 22 0 6 3 1 0 0 0
Family 
Saccharomycetaceae 313 192 354 336 63 1005 23 49
Saccharomycodaceae 1214 0 719 22 16 181 0 0
Debaryomycetaceae 0 0 9 17 0 0 0 0
Other 22 0 62 65 1 0 0 2
Genus
Dekkera 212 185 0 139 42 260 0 25
Saccharomyces 99 0 279 181 0 629 0 0
Hanseniaspora 1214 0 719 22 16 181 0 0
Zygosaccharomyces 0 7 0 0 16 0 23 21
Meyerozyma 0 0 9 17 0 0 0 0
Torulaspora 0 0 69 15 0 37 0 0
Lachancea 0 0 0 0 0 74 0 0
Other 24 0 68 66 6 5 0 5
Species
Dekkera anomala 202 0 0 139 10 205 0 25
Dekkera bruxellensis 10 185 0 0 32 55 0 0
Hanseniaspora valbyensis 1179 0 164 0 0 34 0 0
Hanseniaspora vineae 0 0 262 16 15 6 0 0
Zygosaccharomyces lentus 0 7 0 0 16 0 22 21
Lachancea fermentati 0 0 0 0 0 74 0 0
Saccharomyces cerevisiae 0 0 0 0 0 15 0 0
Other 158 0 718 285 7 797 1 5
Fermentate 410 bp Grain 410 bp 
 
 
Supplemental Table 3  
Read numbers for the ITS 410 bp population 
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250 BP Ca Grain US2 Grain UK Fermentate US2 Fermentate
Total Reads 5540 6554 3524 8723
Phlyum 
Ascomycota 5540 6554 3524 8717
Family 
Saccharomycetaceae 5523 6553 3524 4497
Debaryomycetaceae 0 0 0 572
Genus 
Dekkera 5521 6549 3524 4493
Meyerozyma 0 0 0 572
Species 
Dekkera anomala 1008 6524 0 4489
Dekkera bruxellensis 4513 25 3523 0
Meyerozyma caribbica 0 0 0 23  
 
 
 
 
Supplemental Table 4  
Read numbers for the ITS 250 bp population 
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Appendix C: Supplemental information for Chapter 6 
 
Sequence-based analysis of the bacterial and fungal compositions of multiple 
kombucha (tea fungus) samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 305 - 
 
 
 
Supplemental Figure 1 
Chao1 and Shannon rarefaction curves for the bacterial (A) and fungal (B) 
portions of the kombucha microflora 
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16S Average Length (bp) Total Number of Reads Reads Removed Final Number 
CA1 D3 408 2741 366 2348
CA2 D3 408 3615 596 3019
IRE D3 408 3008 379 2629
UK1 D3 408 3486 378 3108
US D3 408 3125 440 2685
CA1 D10 408 2693 495 2198
CA2 D10 408 2934 637 2297
IRE D10 408 3592 839 2753
UK1 D10 408 4263 524 3739
US D10 408 3487 598 2889
CA1 Pellicle 408 3612 440 3172
CA2 Pellicle 408 3541 352 3189
IRE Pellicle 408 4204 589 3615
UK1 Pellicle 408 3384 462 2922
US Pellicle 408 3184 396 2788
ITS Average Length (bp) Total Number of Reads Reads Removed Final Number 
CA1 D3 ~400 1673 100 1573
CA2 D3 ~400 2147 116 2031
IRE D3 ~400 2196 89 2107
UK1 D3 ~400 605 13 592
US D3 ~400 184 140 44
CA1 D10 ~400 2468 118 2350
CA2 D10 ~400 2301 120 2181
IRE D10 ~400 2152 97 2055
UK1 D10 ~400 1081 77 1004
US D10 ~400 285 19 266
CA1 Pellicle ~400 6685 3564 3121
CA2 Pellicle ~400 2854 126 2728
IRE Pellicle ~400 2604 178 2426
UK1 Pellicle ~400 464 21 445
US Pellicle ~400 31 27 4
UK1 D3 ~200 12607 302 12305
US D3 ~200 1918 1780 138
UK D10 ~200 31280 980 30300
US D10 ~200 6439 188 6251
UK Pellicle ~200 3244 101 3143
US Pellicle ~200 678 217 461  
 
 
Supplemental Table 1 
Initial and post-trimming read numbers for 16S and ITS sequencing 
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Supplemental Table 2 
16S alpha diversities 
 
 
 
 
 
 
 
  Chao1 Simpson Shannon Phylogenetic Diversity Observed Species 
CA1 Pellicle 12.75 0.031374628 0.158306172 1.1386 12 
CA2 Pellicle 31.2 0.100538563 0.466323722 2.21427 24 
IRE Pellicle 37 0.617060664 2.044298202 2.03325 34 
UK1 Pellicle  32 0.165961616 0.696534652 1.72946 26 
US1 Pellicle 27 0.024860042 0.13105602 0.78142 13 
CA1 Day10 68.2 0.159216528 0.658246783 3.09973 34 
CA2 Day10 25.66666667 0.131629396 0.517323461 1.43357 21 
IRE Day10 39.09090909 0.236506545 0.90888707 2.43784 35 
UK1 Day10 59 0.122930401 0.511389832 2.27834 26 
US Day10 85 0.092146248 0.399950754 2.60514 28 
CA1 Day3 65.2 0.244559744 1.027258337 3.51059 38 
CA2 Day3 77 0.055905985 0.288686899 1.60541 22 
IRE Day3 51.2 0.151218666 0.681989713 2.95005 33 
UK1 Day3 29.5 0.061401348 0.304484265 1.32701 19 
US1 Day3 56.375 0.091382697 0.452585328 3.6393 35 
       
Averages 46.41217172 0.152446205 0.616488081 2.185598667 26.66666667 
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  Chao1 Simpson Shannon Phylogenetic Diversity Observed Species 
CA1 Pellicle 73 0.410208718 1.561938465 9.5337 52 
CA2 Pellicle 56.125 0.187998227 0.793375929 6.06477 37 
IRE Pellicle 32.5 0.128781358 0.570382027 4.24074 22 
CA1 Day3 42 0.524044423 1.246295154 2.24298 29 
CA2 Day3 49 0.331495757 1.094396875 3.1122 28 
IRE Day3 22.5 0.191558056 0.672859467 2.70784 19 
CA1 Day10 32.2 0.21865987 0.793709461 3.47621 25 
CA2 Day10 36.42857143 0.318411709 1.139318116 3.35537 30 
IRE Day10 17 0.106323059 0.465173629 2.07843 15 
       
Averages 40.08373016 0.26860902 0.926383236 4.090248889 28.55555556 
 
 
Supplemental Table 3 
ITS alpha diversities 
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Pellicle 
Phylum Ca1 Ca2 Ire UK US
Proteobacteria 0.99806 0.965049 0.600058 0.933216 0.998526
Firmicutes 0 0.032686 0.393599 0.065729 0
Actinobacteria 0 0 0.004325 0 0
Deinococcus-Thermus 0.001617 0 0 0 0
Other 0.000323 0.002265 0.002018 0.001054 0.001474
Family 
Acetobacteraceae 0.997736 0.957929 0.600058 0.932513 0.998526
Lactobacillaceae 0 0.017152 0.305652 0.046397 0
Streptococcaceae 0 0.012945 0.077566 0.016169 0
Thermaceae 0.001617 0 0 0 0
Propionibacteriaceae 0 0 0.003749 0 0
Enterococcaceae 0 0 0.007209 0.002109 0
Other 0.000647 0.011974 0.005767 0.002812 0.001474
Genus
Acetobacter 0 0 0.019319 0.002812 0
Gluconacetobacter 0.997736 0.957282 0.580161 0.929701 0.998158
Lactobacillus 0 0.017152 0.305652 0.046397 0
Lactococcus 0 0.012945 0.077566 0.016169 0
Enterococcus 0 0 0.00692 0.002109 0
Propionibacterium 0 0 0.003749 0 0
Other 0.002264 0.012621 0.006632 0.002812 0.001842
Day 3
Phylum Ca1 Ca2 Ire UK US
Proteobacteria 0.928695 0.982958 0.938383 0.983411 0.9596
Firmicutes 0.063526 0.016701 0.056122 0.015594 0.034244
Actinobacteria 0.003457 0 0.002747 0 0
Deinococcus-Thermus 0.002161 0 0.001962 0 0
Bacteroidetes 0 0 0 0 0.003848
Other 0.002161 0.000341 0.000785 0.000995 0.002309
Family
Acetobacteraceae 0.883319 0.97955 0.935636 0.982415 0.95883
Lactobacillaceae 0.039758 0.011247 0.035714 0.011944 0.017699
Streptococcaceae 0.015557 0.005112 0.017661 0.00365 0
Leuconostocaceae 0.005186 0 0 0 0
Bifidobacteriaceae 0.003025 0 0 0 0
Thermaceae 0.002161 0 0.001962 0 0
Propionibacteriaceae 0 0 0.001962 0 0
Ruminococcaceae 0 0 0 0 0.002693
Erysipelotrichaceae 0 0 0 0 0.00885
Lachnospiraceae 0 0 0 0 0.004617
Other 0.050994 0.00409 0.007064 0.001991 0.007311  
 
 
Supplemental Table 4 (Part 1) 
Relative abundances of the 16S bacterial populations at phylum, family and 
genus level. 
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Day 3
Genus Ca1 Ca2 Ire UK US
Acetobacter 0.008643 0 0.004317 0 0
Gluconacetobacter 0.869058 0.977846 0.930926 0.98142 0.957291
Lactobacillus 0.039326 0.011247 0.035714 0.011944 0.017699
Lactococcus 0.015557 0.005112 0.017661 0.00365 0
Leuconostoc 0.005186 0 0 0 0
Bifidobacterium 0.002593 0 0 0 0
Thermus 0.002161 0 0.001962 0 0
Allobaculum 0 0 0 0 0.00885
Ruminococcaceae Incertae Sedis 0 0 0 0 0.001924
Propionibacterium 0 0 0.001962 0 0
Other 0.057476 0.005794 0.007457 0.002986 0.014236
Day 10
Phylum Ca1 Ca2 Ire UK US
Proteobacteria 0.925422 0.933393 0.87848 0.944214 0.960246
Firmicutes 0.065197 0.064356 0.105342 0.017122 0.037947
Actinobacteria 0 0 0 0 0
Deinococcus-Thermus 0.007974 0 0.016178 0.037559 0
Bacteroidetes 0 0 0 0 0
Other 0.001407 0.00225 0 0.001105 0.001807
Family 
Acetobacteraceae 0.923077 0.932493 0.878104 0.94311 0.958439
Lactobacillaceae 0.059568 0.061656 0.095937 0.014361 0.034695
Streptococcaceae 0 0.00225 0.002257 0 0.001807
Thermaceae 0.006567 0 0.016178 0.037283 0
Bacillaceae 0 0 0 0.001381 0
Other 0.010788 0.0036 0.007524 0.003866 0.00506
Genus 
Acetobacter 0 0 0.001881 0 0
Gluconacetobacter 0.92167 0.931593 0.876223 0.942557 0.957355
Lactobacillus 0.059568 0.061656 0.095937 0.014361 0.034695
Lactococcus 0 0.00225 0.001881 0 0.001807
Thermus 0.006567 0 0.016178 0.037283 0
Other 0.012195 0.0045 0.007901 0.0058 0.006144  
 
 
 
Supplemental Table 4 (Part 2) 
Relative abundances of the 16S bacterial populations at phylum, family and 
genus level. 
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Pellicle
Phylum  Ca1 Ca2 Ire
Ascomycota 0.947164 0.943667 0.997093
Basidiomycota 0.008428 0.055596 0
Other 0.044408 0.000736 0.002907
Family 
Saccharomycetaceae 0.824311 0.942194 0.990864
Davidiellaceae 0.001621 0 0
Clavicipitaceae 0.001621 0 0
Pichiaceae 0.115397 0 0.006229
Wallemiaceae 0.005835 0 0
Leucosporidiaceae 0 0.055596 0
Debaryomycetaceae 0 0 0
Saccharomycodaceae 0 0 0
Other 0.051216 0.002209 0.002907
Genus 
Dekkera 0.010697 0.00405 0
Zygosaccharomyces 0.789627 0.932622 0.953904
Davidiella 0.001621 0 0
Pichia 0.115397 0 0.006229
Wallemia 0.005835 0 0
Lachancea 0 0.002946 0
Leucosporidiella 0 0.055596 0
Kazachstania 0 0 0.003322
Kluyveromyces 0 0 0.002492
Naumovozyma 0 0 0.005399
Meyerozyma 0 0 0
Saccharomyces 0 0 0
Hanseniaspora 0 0 0
Other 0.076823 0.004786 0.028654
Species 
Dekkera bruxellensis 0 0.001841 0
Dekkera anomola 0 0.002209 0
Zygosaccharomyces bisporus 0 0.060015 0
Zygosaccharomyces lentus 0.788655 0.872607 0.953904
Pichia kudriavzevii 0.114749 0 0.006229
Davidiella tassiana 0.001621 0 0
Wallemia sebi 0.005835 0 0
Lachancea fermentati 0 0.002946 0
Leucosporidiella fragaria 0 0.055596 0
Kazachstania unispora 0 0 0.003322
Kluyveromyces marxianus 0 0 0.002492
Naumovozyma castellii 0 0 0.005399
Hanseniaspora vineae 0 0 0
Other 0.089141 0.004786 0.028654  
 
 
Supplemental Table 5 (Part 1) 
Relative abundances of the ITS fungal populations at phylum, family, genus and 
species level. 
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Day 3 
Phylum Ca1 Ca2 Ire
Ascomycota 1 1 0.999047
Other 0 0 0.000953
Family 
Saccharomycetaceae 1 1 0.998571
Other 0 0 0.001429
Genus 
Dekkera 0.0057 0 0
Zygosaccharomyces 0.9943 0.998026 0.995712
Kazachstania  0 0 0
Other 0 0.001974 0.004288
Species 
Dekkera bruxellensis 0.0057 0 0
Dekkera anomola 0 0 0
Zygosaccharomyces bisporus 0.015833 0.173741 0
Zygosaccharomyces lentus 0.978467 0.824284 0.995712
Kazachstania unispora 0 0 0
Other 0 0.001974 0.004288
Day 10 
Phylum Ca1 Ca2 Ire
Ascomycota 1 1 1
Other 0 0 0
Family
Saccharomycetaceae 0.999573 0.99954 1
Other 0.000427 0.00046 0
Genus
Dekkera 0.004268 0.007363 0.008264
Zygosaccharomyces 0.991891 0.991256 0.986874
Kazachstania 0 0 0
Other 0.003841 0.001381 0.004861
Species
Dekkera bruxellensis 0.002988 0.006903 0.005348
Dekkera anomola 0 0 0.002917
Zygosaccharomyces bisporus 0.020487 0.147262 0
Zygosaccharomyces lentus 0.971404 0.843994 0.986874
Kazachstania unispora 0 0 0
Other 0.005122 0.001841 0.004861  
 
Supplemental Table 5 (Part 2) 
Relative abundances of the ITS fungal populations at phylum, family, genus and 
species level. 
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Pellicle 400bps Day 3 400bps Day 10 400bps Pellicle 250bps Day 3 250bps Day10 250bps
Reads 444 12888 1003 3142 12298 30292
Phlyum 
Ascomycota 436 12882 1002 3137 12292 30279
Basidiomycota 6 0 0 0 0 0
Other 2 6 1 5 6 13
Family 
Saccharomycetaceae 400 12881 1000 3100 12291 30279
Debaryomycetaceae 5 0 0 16 0 0
Saccharomycodaceae 6 0 0 0 0 0
Leucosporidiaceae 6 0 0 0 0 0
Other 27 7 3 26 7 13
Genus 
Dekkera 276 12379 143 3097 12282 30270
Zygosaccharomyces 76 502 857 0 9 0
Leucosporidiella 6 0 0 0 0 0
Kazachstania 0 0 0 0 0 5
Meyerozyma 5 0 0 16 0 0
Saccharomyces 46 0 0 0 0 0
Hanseniaspora 6 0 0 0 0 0
Other 29 7 3 29 7 17
Species 
Dekkera bruxellensis 203 12379 143 2375 12282 30260
Dekkera anomola 73 0 0 722 0 10
Zygosaccharomyces lentus 76 502 857 0 9 0
Leucosporidiella fragaria 6 0 0 0 0
Kazachstania unispora 0 0 0 0 0 5
Hanseniaspora vineae 5 0 0 0 0 0
Other 81 7 3 45 7 17  
 
 
Supplemental Table 6 
ITS read numbers for UK kombucha, from two sequencing pools of approximate 
sizes 400 bp and 250 bp 
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Bacteriocins are the focus of ever-increasing levels of interest. Currently, the 
commercial application of bacteriocins is limited to the treatment of skin 
infections, in food preservation and the use of bacteriocin producers in oral 
lozenges, but it is likely that additional clinical and vetinary applications will 
occur in the near future. The emergence of antibiotic-resistant bacteria 
combined with the poor rate of novel antibiotic discovery, represent enormous 
challenges for modern medicine, and bacteriocins have the potential to provide 
solutions to these issues. In a literature review for this thesis (chapter 1), 
strategies that can be used to identify novel antimicrobials are discussed. Of 
these strategies, we applied in-silico mining and high-throughput robotics with a 
view to identifying novel antimicrobials.  
 Genome mining for ribosomally synthesised products is a very useful 
technique (Velasquez and van der Donk, 2011), and in the past has been applied 
to screen for bacteriocin producers from Gram negative bacteria and from wine 
(Knoll et al., 2008, Dirix et al., 2004). We screened the fully sequenced genomes 
within the BLAST database for novel bacteriocins using the biosynthetic 
machinery enzymes from the bacteriocin nisin as driver sequences. By applying 
an in-silico screen to search for novel homologs, we revealed the presence of 
lantibiotic genes within multiple genomes of bacteria from diverse ecological 
niches, such as deep sea vents, soil and the gastrointestinal tract. This approach 
has been shown to translate to the identification of functional antimicrobial 
peptides by laboratory proof-of-concept investigations in the case of 
bacteriocins lichenicidin (Begley et al., 2009), Bsa (Daly et al., 2010) and 
venezuelin (Goto et al., 2010). 
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While the identification of gene clusters using in-silico approaches does 
not necessarily ensure that the strain in question is a bacteriocin producer, it is 
revealing that such antimicrobial genes are present in many different bacteria, 
reflecting a combination of the origin of these clusters as well as more recent 
gene transfers. This strategy has since been applied for lantibiotic LanM 
biosynthetic enzymes (O’Sullivan et al., 2011), sactibiotic radical SAM protein 
determinants (Murphy et al., 2011) and bacteriocins in cyanobacteria (Wang et 
al., 2011).  
The development of strategies for in-silico bacteriocin mining reflects 
the vast number of ribosomally synthesised antimicrobial genes in sequence 
databases. This is increasingly relevant with the rise in number of genome 
sequences, as evidenced by the fact that the number available at the time of 
our study, which was approximately 1178, has since increased over three fold. A 
specific online program, BAGEL (BActeriocin GEnome mining tooL) (de Jong et 
al., 2006), was designed for this purpose. When the studies in chapter 3 were 
carried out, BAGEL was in its first iteration. It has since undergone further 
revision, and is currently at BAGEL3 (van Heel et al., 2013). BAGEL recognises 
various antimicrobial operon motifs and has been utilised in several studies 
since. Additionally, the development of databases, such as Bactibase (Hammami 
et al., 2010), is reflective of the growing need to accurately accrue and organise 
bacteriocin data.  
The global functional food and drink market is expected to be worth 
$29.8 billion by 2014. A major factor in the success of fermented functional 
beverages are their bio-active components, i.e. microbes or bioactives produced 
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by microbes, which are usually supplied in the form of dairy beverages. Due to 
this success, there is a keen interest to access this market through the 
development of new beverages with functional properties. To this end, it is 
notable that there are many traditional fermented beverages which have been 
used by different societies throughout history, and many are believed to aid in 
the treatment of gastrointestinal ailments. These could be harvested for health-
promoting bacteria and used to derive commercial functional beverages for the 
modern health-conscious market. Additionally, such beverages have the 
potential to serve as cheap, effective means of delivering nutrition to deprived 
populations, and as a vehicle for probiotic delivery.  
 The majority of these beverages have not been extensively studied, with 
even fewer studies focusing on supporting health claims. However, the first step 
toward the commercial production of these beverages is to understand the 
microorganisms responsible for the fermentation, which can also shed light on 
the delicate symbiosis between the bacteria and yeast present. We were 
particularly interested in revealing the differences between the microbial 
populations within the solid inoculating materials and the resulting fermentates, 
the change in these populations over the course of the fermentation and the 
differences between beverages themselves sourced from geographically distinct 
regions.  
To achieve this goal, the aim was to use a culture-independent 
technology, i.e. high-throughput sequencing, to investigate the microbial 
populations. This technology, probably best known for its use by the human 
genome project, has since been applied to a variety of environments including 
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aqueous locations, forest soils and, frequently, the gastrointestinal tract, and 
has revolutionised many fields of research. With respect to fermented foods, 
the application of high-throughput sequencing has already been used to assess 
the populations of many fermented foods from kimchi to cheese (Roh et al., 
2010, Quigley et al., 2012), and has revealed a number of valuable insights. The 
advantages of such technologies over traditional culture-based methodologies 
are several fold, including the ability to detect populations which are either 
unculturable, or present in such low numbers that they avoid detection in 
culture-based methods, and also avoids bias due to culturing in the absence of 
appropriate nutrients or at specific temperatures. Additionally, this method is 
high-throughput, offering relative population abundance, unlike other 
molecular techniques such as DGGE which can also only detect 1-2% of the 
microbial population (Muyzer et al., 1993). The merit of our sequencing-based 
studies was enhanced by the inclusion of fungal-specific primers to investigate 
the fungal component, as well as the bacterial component, of these 
populations. This development was particularly important when studying these 
symbiotic microorganisms, and ultimately provided a comprehensive view of 
the microbial communities present.  
For the bacterial component of these populations, the degenerate PCR 
primers we used were designed to amplify the variable V4-V5 region of the 16S 
rRNA gene (Claesson et al., 2012), generating amplicons of of 408 bp. These 
amplicon sizes are relatively longer than those used in many previous microbial 
diversity studies and take full advantage of the longer reads provided by GS-FLX 
Titanium technologies. While this facilitated more confident assignments, it was 
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still not possible to assign reads beyond the genus level due to the high level of 
sequence similarity in the 16S rDNA gene. The limiting factor with respect to 
accurately assigning at the species level relates to technology rather than an 
issue with primer design, whereby current high-throughput sequencing systems 
are unable to generate the longer reads that could lead to greater taxonomic 
resolution. Currently, 16S Sanger-sequencing based analysis of specific colonies 
is still of some interest, if only to accurately identify species.  
The issue of accurately assigning at species level was not a problem for 
sequencing of the internal transcribed spacer regions of fungal species, which is 
sufficiently heterogenous to assign sequences at the species level. The 
metagenomic sequencing of yeast/fungal populations is not as routine as for 
bacterial populations and only recently has a consensus emerged that the ITS 
region should be used. Even still, it is argued that several approaches are 
required to accurately assess populations. While this might be true, this is 
unlikely to be as relevant for the relatively low diversity, and predominantly 
yeast populations, that have been the focus of our studies. The emergence of a 
larger database of ITS sequences will prove particularly useful for future studies.  
The use of culture-independent techniques to assess yeast environments 
is particularly advantageous from a taxonomic viewpoint. Many yeast exist in 
two forms, a sexual (teleomorphic) and asexual (anamorphic) state, and based 
on phenotypic classification have been classed as separate microorganisms (e.g. 
Dekkera/Bruxellensis, Candida/Pichia, Kloeckera/Hanseniaspora etc), despite 
having the same genetic content. It has been proposed that by this year (2013), 
studies refer to species in their teleomorphic state only, unless there are 
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extenuating circumstances. With the availability of increasing genetic 
information, yeast are regularly reclassified, further adding to the confusion. For 
example, at first glance, the population profile of fungi in kefir, as shown in 
chapter 4, are quite different to those of previous studies. There is a noticeable 
lack of Candida and Saccharomyces, conventionally associated with kefir, but 
the explanation for this pattern is that species of these genera have been 
reclassified to Kluyveromyces and Kazachstania, respectively. Many yeast are 
considered unculturable and reliable culture-independent identification is likely 
to reveal many new species in the future. In our studies, there are a number of 
reads that, while belonging to the phylum Ascomycota, could not be assigned to 
a genus within the molecular database. This is most likely due to the fact that 
there remain so many microorganisms to be identified and corresponding ITS 
sequences deposited in such databases. In fact, it has even recently been 
suggested that the volume of yeast set to be uncovered by molecular inspection 
might be best served by numerical assignments rather than Latin nomenclature 
(Money, 2013).  
The analysis of kefir was devised as a follow-up study to a previous 
publication by Dobson et al, which used 454 sequencing to analyse the 
population of a single kefir grain and milk (Dobson et al., 2011). Our aim was to 
expand on these results, and to use the same technology to assess both the 
grains and milks of kefirs sourced from distinct regions around the world, and 
was the largest of our three microbial diveristy studies. Our results confirm the 
findings of Dobson et al, by showing that kefir grains are most often dominated 
by Lactobacillus, while the most abundant population in the milks were 
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Lactococcus. It was also shown that the proportions of Acetobacter vary from 
kefir to kefir while Leuconostoc increased from all grains to milks. The 
abundance of both these genera in the milk are likely to effect the composition 
through acetic acid and slime production respectively. With regards fungal 
composition, our analysis revealed the most prominent genera to be 
Kazachstania, Naumovozyma and Kluyveromyces. The identification of 
Naumovozyma is particularly interesting, in that it has not been revealed as a 
component of kefir previously. Beta analyses revealed that the different kefirs 
did not cluster, and were dissimilar from one another regardless of geography.   
Water kefir is a beverage that has become increasingly popular beverage 
with putative functional properties, that is available from artisanal health stores 
in the western world. Currently, it is most popularly advertised as a non-dairy 
alternative to milk-based kefir, offering similar health-promoting microbes. 
However, as our study shows, this is not always the case. A 16S high-throughput 
sequencing study based on the microbial populations of water kefir released 
shortly before our publication (Gulitz et al., 2013), showed that the populations 
are dominated by Lactobacillus, with a significant number of bifidobacteria. The 
single biggest difference between our study and theirs, and, indeed, all other 
existing water kefir studies, was the dominant presence of Zymomonas in each 
of the four water kefirs analysed. This was a surprising find, especially given its 
consistent presence in each sample, and in similar proportions in the grains and 
fermentates. Although the sucrose/mineral-water solution had been sterilized 
before inoculation, the addition of a single fig to each culture may have 
provided a means through which this microorganism became part of the water 
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kefir population. The purpose of the adding the fig was to simulate a traditional 
fermentation, whereby dried fruit (most popularly a fig) are included to provide 
additional nutrients and flavour. The study by Gulitz et al. instead used a sterile 
fig solution which is less reflective of traditional approaches. This observation 
raises several questions regarding the stability of the the microbial populations 
traditionally associated with the water kefir, the proportion of dextran-
producing bacteria required for grain formation and the significance of the 
apparently transient nature of the microbial population with respect to safety. 
Further research is required to understand the nature of the relationship 
between the individual components of water kefir microbes, the effects 
different substrates exert on this microbial population and the effects that 
individual taxa and substrates have on the physiochemical attributes of the 
beverage. Ultimately, however, although water kefir has yet to be 
commercialised on a significant scale, further studies with a view to its use as a 
vehicle for health-promoting microorganisms, merit attention.   
Kombucha population analysis was useful in that it underscored the 
benefits of using molecular techniques for accurate taxonomic classification. 
More specifically, many species of Acetobacter have been reclassified as  
Gluconacetobacter, which was identified as the dominant genus in kombucha. 
Gluconacetobacter may also have been overlooked previously due to the 
difficulties in the phenotypic differentiation of acetic acid bacteria. It should also 
be noted that the bacterial component of kombucha has not been the focus of 
recent studies, possibly as a consequence of the perception that these 
populations are composed of acetic acid bacteria only. By investigating this 
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component, we found that Lactobacillus constituted a greater proportion of the 
consortium than was previously appreciated. It is suspected that this is due to 
the difficulty in culturing the strains present, as no lactobacilli were isolated 
from kombucha during our screening studies. The fact that up to one fifth of the 
bacterial component of kombucha can be LAB, and that quantities of 
bifidobacteria can also be present, shows promise for the inclusion of health-
promoting starter cultures in the future.  
Intruigingly, in certain water kefir and kombucha samples, DNA 
amplification of the ITS region generated two bands of approximately 250 bps 
and 410 bps in size. Prior to DNA sequencing, it was not apparent which taxa 
were represented by the different bands, and there are very few references in 
the literature to this phenomenon. As shorter reads are preferentially 
sequenced, pooling of the different-sized amplicons was not possible. It was 
therefore necessary to sequence both bands seperately. Almost all reads from 
the 250 bp pool were assigned to Dekkera, with only a small number assigned to 
Meyerozyma.  
  The field of bioinformatics is constantly evolving. As an example, 
MEGAN, which we used for DNA sequence assignments, was updated with a 
new version of the SILVA ribosomal database (version 106) during the course of 
our studies. Prior to this, most sequences from the water kefir samples could 
only be assigned to the level of family, namely, Sphingomonadales, with few 
reads assigned at the genus level. However, use of the new version allowed us 
to assign reads from this family to the genus Zymomonas.  
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The information gained from these analyses highlights how significantly 
the microbial content of these beverages can vary. This should prove valuable 
for the design of starter cultures to facilitate large scale commercial production 
of these beverages and in linking specific populations with specific 
physiochemical attributes.  
 With the advancement of technology and bioinformatics, these 16S 
analyses should become more affordable and commonplace. In the future, 
more integrated systems, with uniform methods for DNA extraction and 
amplification, and improvements in taxonomic databases and data analysis, will 
emerge. We are still at the beginning of this emerging field, and it is likely that 
these technologies will play a role in examining the microbiology of food for 
quite some time to come (Ercolini, 2013).  
The final chapter of this thesis focused on both microbes sourced from 
fermented beverages and bacteriocins. Bacteriocins have many applications in 
the food industry, where they can be used as natural alternatives to chemical 
preservatives, can aid in the ripening of cheese and have also been associated 
with probiotic function (Dobson et al., 2012, Cleveland et al., 2001). Bacteriocin 
producers sourced from food environments are more likely to be of value with 
respect to subsequent food applications.  
It was our intention to screen the fermented beverages kefir, water kefir 
and kombucha for the presence of antimicrobial bacterial producers, as 
fermented foods have long proven to be a good source of bacteriocin-
producers. A large bank of isolates was created using robotics. Unfortunately, 
no novel bacteriocins were discovered, which was surprising considering the 
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geographical diversity and number of samples included in the screen. It could be 
that antimicrobials are only produced by these isolates under specific 
circumstances, and that the appropriate temperature, pH, nutrients or indicator 
were not employed.  
However, the accidental discovery of a yeast strain producing a 
proteinaceous antimicrobial was interesting. Purification of the antimicrobial 
proved difficult, but was determined to be >30 kDa, and possibly contains more 
than one component. Yeast are known to produce large antimicrobial proteins, 
which are analogous to bacteriocins, but these are typically active against other 
yeast. Despite screening against some species of yeast, no activity was seen, but 
it could be that a larger range of indicators is required. To determine the exact 
nature of the protein, further analysis is required, which time did not permit. At 
the very least, the screen suggests that yeast from these environments are also 
a potential source of novel antimicrobials, and should be the focus of further 
screens in the future.  
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